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SUMMARY / RESUMEN
SUMMARY / RESUMEN 
Mitochondrial respiratory chain (MRC) complexes I, III and IV are associated in large 
supramolecular structures termed supercomplexes (SCs) and respirasomes, whose biogenesis 
and functional and pathophysiological relevance remain unclear. Such superstructures 
originate interdependences between the individual OXPHOS complexes, with major biomedical 
implications for the diagnosis of mitochondrial disorders because combined deficiencies of 
these complexes can be attributed to a genetic defect of a single MRC complex. Furthermore, 
the functional implication of the mitochondrial protein COX7A2L / COX7RP / SCAFI in the 
biogenesis of SCs is a subject of intense and controversial debate. To elucidate the role of 
COX7A2L in the structural organization of human MRC, blue native electrophoresis, proteomic 
analyses and COX7A2L downregulation assays were performed in control and mutant 
transmitochondrial cybrids lacking one of each MRC complexes. Our results showed that 
human COX7A2L binds primarily to the SC-unbound complex III dimer (CIII2) and to a minor 
extent to free complex IV, to specifically promote the stabilization of the SC III2+IV without 
affecting the respirasomes formation. Further analyses in TALEN-mediated COX7A2L knockout 
(COX7A2L-KO) HEK293T cells demonstrated that the lack of COX7A2L prevents SC III2+IV 
formation without affecting de novo complex IV biogenesis, enhances the biogenetic rates of 
CIII2, and delays the formation of the complex III-containing respirasomes that, nonetheless, 
accumulate to control steady-state levels. Functional substrate competition assays revealed 
that, upon the induction of complex I deficiency, COX7A2L-KO cells significantly favour electron 
flux through complex II. Altogether, our data suggest that COX7A2L establishes a regulatory 
checkpoint for the biogenesis of CIII2 and complex III-containing SCs that limits succinate 
oxidation when complex I activity is compromised, and that independent regulatory 
mechanisms co-exist for the biogenesis of SC III2+IV and the respirasomes. 
The primary role of COX7A2L in the biogenesis of complex III-related MRC structures 
was confirmed through comparative analyses of the assembly and composition of human SCs 
between control cells and two mutant cybrids lacking complex IV due to pathogenic nonsense 
mutations in the COX1 and COX2 subunits, respectively. In the absence of complex IV, three 
different bands corresponding to fully-assembled SC I+III2 were identified, which also 
contained COX7A2L. Surprisingly, two of these SC I+III2 bands showed the presence of specific 
complex IV subunits that regularly take part in late steps of complex IV assembly. Reversible 
inhibition of mitochondrial translation demonstrated that the biogenesis of COX7A2L-
containing SC I+III2 is completed prior to the stepwise association of complex IV subunits. 
Radioactive pulse-chase analyses additionally showed that the insertion of COX subunits is 
essential to stabilize the COX7A2L-containing SC I+III2. Our results thus reveal the existence of 
alternative COX assembly lines for the synthesis of free- versus SC-associated complex IV. 
SUMMARY / RESUMEN 
Los complejos I, III y IV (CI, CIII, CIV) de la cadena respiratoria mitocondrial (CRM) están 
asociados en estructuras supramoleculares denominadas supercomplejos (SCs) y 
respirasomas, cuya biogénesis y relevancia tanto funcional como fisiopatológica todavía no 
están claras. Estas superestructuras originan interdependencias entre los complejos 
individuales del sistema OXPHOS, lo que conlleva importantes implicaciones para el 
diagnóstico de las patologías mitocondriales. Ello se debe a que algunos déficits enzimáticos 
combinados de los complejos de la CRM se pueden atribuir a mutaciones en genes 
estructurales de un solo complejo. Además, existe un debate intenso y controvertido sobre el 
papel de la proteína mitocondrial COX7A2L / COX7RP / SCAFI en la función y biogénesis de los 
SCs. Para dilucidar el papel de COX7A2L en la organización estructural de la CRM en humanos, 
se realizaron análisis bioquímicos y proteómicos sobre cíbridos transmitocondriales control y 
mutantes carentes de uno de los complejos de la CRM, así como ensayos de silenciamiento del 
ARN mensajero de COX7A2L. Los resultados demostraron que COX7A2L se une principalmente 
al dímero del complejo III (CIII2) y en menor medida al CIV, para promover específicamente la 
estabilización del SC III2+IV sin afectar a la formación del respirasoma. El estudio se extendió a 
células HEK293T carentes de COX7A2L (COX7A2L-KO), creadas en el laboratorio mediante la 
tecnología TALEN. La ausencia de COX7A2L impide la formación del SC III2+IV sin afectar a la 
biogénesis de novo del CIV; además, promueve un aumento tanto en la cinética de ensamblaje 
como en los niveles estacionarios del CIII2, al tiempo que retrasa la formación de los SCs que 
contienen al CIII (que no obstante, alcanzan los niveles estacionarios del control). Ensayos 
funcionales de competición de sustratos revelaron que en las células COX7A2L-KO aumenta 
significativamente el flujo de electrones desde el CII al CIII2 al inducir un déficit parcial en la 
actividad del CI. En conclusión, COX7A2L establecería un punto de control de la biogénesis del 
CIII2 y de los SCs que contienen al CIII, lo cual limitaría la oxidación del succinato cuando la 
actividad enzimática del CI está disminuida. Asimismo, estos datos muestran la coexistencia de 
mecanismos reguladores independientes en la biogénesis del SC III2+IV y de los respirasomas.  
La función principal de COX7A2L sobre la biogénesis del CIII se confirmó mediante 
análisis del ensamblaje y composición de los SCs en cíbridos humanos control y mutantes sin 
CIV debido a mutaciones patogénicas en las subunidades COX1 y COX2. En ausencia del CIV, se 
identificaron tres bandas correspondientes a diferentes especies del SC I+III2 que también 
contienen a COX7A2L; de ellas, dos bandas mostraron la presencia de subunidades COX 
específicas del ensamblaje tardío del CIV. Este trabajo demuestra que la formación del SC I+III2 
ocurre antes de la asociación gradual de las subunidades del CIV, las cuales son esenciales para 
estabilizar dicha estructura y revela la existencia de líneas de ensamblaje alternativas para la  
síntesis del CIV en su forma individual o asociada a los SCs. 
  
 
 
 
 
INDEX
INDEX 
ABBREVIATIONS ........................................................................................................................ 3 
INTRODUCTION .......................................................................................................................... 7 
1. Mitochondria: overall features of a unique organelle .......................................................... 9 
2. Mitochondrial respiratory chain ......................................................................................... 10 
2.1. COMPLEX I....................................................................................................................... 11 
2.2. COMPLEX II...................................................................................................................... 13 
2.3. COMPLEX III..................................................................................................................... 13 
2.4. COMPLEX IV .................................................................................................................... 14 
3. Models for the structural organization of the respiratory chain ........................................ 16 
3.1. SOLID-STATE MODEL ......................................................................................................... 16 
3.2. LIQUID-STATE MODEL ........................................................................................................ 16 
3.3. DYNAMIC AGGREGATE OR PLASTICITY MODEL ........................................................................ 17 
4. Structural architectures of the respiratory chain supercomplexes .................................... 18 
4.1. TYPES OF RESPIRATORY CHAIN SUPERCOMPLEXES ................................................................... 18 
4.2. SUPERCOMPLEXES I+III2 AND III2+IV1-2 .................................................................................. 20 
4.3. RESPIRASOME OR SUPERCOMPLEX I+III2+IV1 .......................................................................... 21 
4.4. EFFECT OF CARDIOLIPIN ON THE STABILIZATION OF SUPERCOMPLEXES ........................................ 22 
5. Function of respiratory chain supercomplexes ................................................................... 22 
5.1. CATALYTIC ENHANCEMENT OF THE ELECTRON FLUX THROUGH SUBSTRATE CHANNELLING .............. 22 
5.2. ASSEMBLY AND STABILITY OF COMPLEX I ............................................................................... 23 
5.3. MODULATION OF ROS PRODUCTION ..................................................................................... 24 
6. Biogenesis of respiratory chain supercomplexes ................................................................ 25 
6.1. THE RESPIRASOME ASSEMBLY PATHWAY ............................................................................... 25 
6.2. SUPERCOMPLEX ASSEMBLY FACTORS .................................................................................... 26 
6.2.1.COX7A2L/COX7RP/SCAFI ....................................................................................... 27 
6.2.2.Respiratory complex factor 1, RCF1 ....................................................................... 28 
HYPOTHESIS AND GOALS ..................................................................................................... 29 
EXPERIMENTAL PROCEDURES .............................................................................................. 33 
1. Human cell lines .................................................................................................................. 35 
1.1. TRANSMITOCHONDRIAL CYBRIDS ......................................................................................... 35 
1.2. STABLE HEK293T-DERIVED CELL LINES .................................................................................. 36 
1.2.1.TALEN constructs and generation of gene COX7A2L knockout cell lines ............... 36 
1.2.2.Plasmids and reconstitution of COX7A2L-KOs with the long and short-version of 
COX7A2L gene ................................................................................................................. 38 
INDEX 
2. Mitochondrial samples provided by other research groups ............................................... 39 
3. Reagents, solutions and buffers .......................................................................................... 39 
4. Cell culture .......................................................................................................................... 39 
5. Reversible inhibition of mitochondrial translation (Doxycycline assay) ............................. 40 
6. Functional characterization of the mitochondrial respiratory chain .................................. 41 
6.1. RESPIRATORY CHAIN ENZYME ACTIVITIES ............................................................................... 41 
6.1.1.Sample Preparation ............................................................................................... 41 
6.1.2.Enzyme activities of CI-CIV and citrate synthase ................................................... 41 
6.2. CELL RESPIRATION MEASURED BY SEAHORSE ANALYZER ........................................................... 42 
6.3. CELL RESPIRATION MEASURED BY POLAROGRAPHY .................................................................. 43 
7. Indirect immunofluorescence ............................................................................................. 43 
8. COX7A2L transient overexpression ..................................................................................... 44 
9. COX7A2L siRNAs Transfection ............................................................................................. 44 
10. NDUFB8 siRNAs Transfection ............................................................................................ 44 
11. Mitochondrial protein synthesis ....................................................................................... 45 
12. Purification of Whole Cell and Mitochondrial protein extracts ........................................ 45 
12.1. WHOLE CELL EXTRACTS .................................................................................................... 45 
12.2. MITOCHONDRIA-ENRICHED FRACTIONS .............................................................................. 46 
12.3. MITOCHONDRIAL ISOLATION ............................................................................................. 46 
13. Immunoprecipitation ........................................................................................................ 46 
14. SDS-PAGE Electrophoresis ................................................................................................ 47 
15. Western-blot ..................................................................................................................... 47 
16. Blue Native Electrophoresis and In-Gel Activity (IGA) assays ........................................... 47 
16.1. SAMPLES PREPARATION FOR BN-PAGE ................................................................................ 48 
16.2. BIDIMENSIONAL BLUE NATIVE ELECTROPHORESIS (2D-BN/SDS-PAGE) ...................................... 48 
16.3. IN-GEL ACTIVITY (IGA) ASSAYS ........................................................................................... 49 
17. Antibodies ......................................................................................................................... 50 
18. Protein identification by liquid chromatography coupled to tandem mass spectrometry
 ................................................................................................................................................. 51 
19. Statistical data analysis ..................................................................................................... 52 
RESULTS .................................................................................................................................... 53 
CHAPTER 1. COX7A2L IS A MITOCHONDRIAL COMPLEX III BINDING PROTEIN THAT STABILIZES THE III2+IV 
SUPERCOMPLEX WITHOUT AFFECTING RESPIRASOME FORMATION .......................................................... 55 
1. Human COX7A2L co-localizes with respiratory chain complex III and IV and CIII-containing 
SCs ........................................................................................................................................... 57 
INDEX 
2. Overexpressed COX7A2L is imported into Mitochondria and incorporated into MRC 
complexes and SCs, without significantly enhanced SC formation ........................................ 60 
3. Overexpressed COX7A2L binds to CIII and CIV ................................................................... 63 
4. Endogenous COX7A2L associates with respiratory chain CIII and CIV and with SCs during 
their assembly process ............................................................................................................ 64 
5. COX7A2L associates with CIII and SC III2+IV prior to the insertion of the RISP catalytic 
subunit .................................................................................................................................... 66 
6. COX7A2L downregulation causes SC III2+IV disassembly without altering respirasome 
stability .................................................................................................................................... 68 
7. COX7A2L downregulation does not affect the respiratory chain function ......................... 71 
8. Mouse Cox7a2l is essential for SC III2+IV formation .......................................................... 72 
CHAPTER 2. MITOCHONDRIAL COX7A2L REGULATES THE BIOENERGETIC RATES OF DIMERIC COMPLEX III AND OF 
COMPLEX III-CONTAINING SUPERCOMPLEXES TO FINE TUNE SUCCINATE OXIDATION ................................... 77 
1. TALEN-mediated generation of COX7A2L knockout (KO) cell lines .................................... 79 
2. COX7A2L-KO cells display absence of SC III2+IV with normal respirasome levels and 
increased CIII2 levels and activity. ............................................................................................ 79 
3. The absence of COX7A2L does not affect the stability of the respirasomes ...................... 82 
4. Overexpressed COX7A2L restores the wildtype phenotype in COX7A2L-KO cells ............. 84 
5. COX7A2L-KO cells display a boost in CIII2 biogenesis in parallel with slower assembly 
kinetics of the respirasomes ................................................................................................... 86 
6. In normal cultured cell physiological conditions, COX7A2L does not have a significant 
impact on mitochondrial respiration ...................................................................................... 88 
7. Induction of CI deficiency significantly enhances succinate oxidation in COX7A2L-KO cells.
 ................................................................................................................................................. 89 
8. A mutant COX7A2L variant carrying a 6-base-pair deletion present in C57BL/6 mice retains 
the ability to bind CIII2 but does not rescue SC III2+IV assembly, in humans .......................... 92 
CHAPTER 3. IN THE ABSENCE OF COMPLEX IV, COX7A2L-CONTAINING SUPERCOMPLEX I+III2 IS STABILIZED 
THROUGH THE STEPWISE ASSOCIATION OF FREE COX SUBUNITS .............................................................. 95 
1. Human cybrids lacking CIV form diverse SC I+III2 species that contain COX7A2L and differ 
in their COX subunit composition ........................................................................................... 97 
2. Human cybrids lacking holo-CIV display a differential accumulation of stabilized COX 
subunits ................................................................................................................................. 101 
3. COX7A2L-containing SC I+III2 is fully-assembled prior to the insertion of COX subunits . 103 
4. COX subunits are integrated into fully-assembled SC I+III2 in a stepwise fashion ............ 107 
5. The association of free COX subunits confers stability to SC I+III2 .................................... 108 
DISCUSSION ........................................................................................................................... 113 
1. Functional characterization of human COX7A2L .............................................................. 115 
INDEX 
2. Role of COX7A2L on the structural organization of the respiratory chain in human cybrids 
lacking complex IV ................................................................................................................. 123 
CONCLUSIONS / CONCLUSIONES..................................................................................... 131 
BIBLIOGRAPHY ...................................................................................................................... 137 
APPENDIX ................................................................................................................................ 165 
1. Comparative table of the MRC subunits from complexes I, III and IV analyzed by 
proteomics ............................................................................................................................ 167 
2. Published papers during the development of the present work ...................................... 168 
2.1. PART OF THE PRESENT THESIS ............................................................................................ 168 
2.2. PUBLISHED DURING THIS PERIOD ....................................................................................... 168 
3. Papers under review during the development of the present work ................................ 168 
 
  
 
 
 
 
ABBREVIATIONS 
 
 
ABBREVIATIONS 
3 
 
1D-BN-PAGE First non-denaturing dimension of the blue native gel electrophoresis  
2D-BN/SDS-PAGE Second denaturing dimension of the blue native gel electrophoresis  
ADNc Complementary DNA 
ADNg Genomic DNA 
ADNn Nuclear DNA 
ATP Adenosine 5’-triphosphate  
BN-PAGE Blue native polyacrylamide gel electrophoresis 
BSA Bovine serum albumin 
CI Complex I or NADH dehydrogenase:ubiquinone oxidoreductase  
CII Complex II or succinate:ubiquinone oxidoreductase 
CIII Complex III or ubiquinol:cytochrome c oxidoreductase or cytochrome bc1 complex 
CIII2 Complex III dimer 
CIV Complex IV or cytochrome c oxidase 
CIV2 Complex IV dimer 
CV Complex V or ATP synthase 
CID Collision induced dissociation 
CMV Cytomegalovirus 
CO-IP Co-immunoprecipitation  
CoQ Coenzyme Q or ubiquinone 
COX Complex IV or Cytochrome c oxidase 
CS Citrate synthase 
CYBRID Cytoplasmic hybrid 
CYTB Cytochrome b 
Cyt c Cytochrome c 
DAB 3.3’-diamidobenzidine tetrahydrochloride 
DCPIP 2,6-dichlorophenol indophenol 
DIG Digitonin 
DMEM Dulbecco’s Modified Eagle Medium 
DMSO Dimethyl sulfoxide 
DQ Decyl ubiquinone 
DQH2 Decyl ubiquinol 
DTNB  5,5′-dithiobis 2-nitrobenzoic acid 
EDTA Ethylene diamine tetra acetic acid 
FAD+ Flavin adenine dinucleotide, oxidized  
FADH2 Flavin adenine dinucleotide, reduced 
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FDR False discovery rate 
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IMM Inner mitochondrial membrane 
IMS Intermembrane space 
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KCN Potassium cyanide 
kDa KiloDalton 
LC-MS Liquid Chromatography – Mass Spectrometry 
LM Lauryl maltoside 
MS Mass Spectrometry 
MITRAC Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase 
MRC Mitochondrial respiratory chain 
mtDNA Mitochondrial DNA 
Myc Gene c-myc -derived Tag 
NAD+ Nicotinamide adenine dinucleotide, oxidized 
NADH Nicotinamide adenine dinucleotide, reduced 
NTB Nitro tetrazolium Blue 
OMM Outer mitochondrial membrane 
OXPHOS Oxidative phosphorylation system 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
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ROS Reactive oxygen species 
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SC Supercomplex 
SD Standard deviation 
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1. Mitochondria: overall features of a unique organelle 
Mitochondria are cytoplasmic organelles of eukaryotic cells that take part in a variety of 
cellular metabolic functions. These capsule-shaped organelles are divided by an outer 
membrane (OMM) and an inner membrane (IMM), which are composed of phospholipid 
bilayers and proteins. Together, they create two separate compartments: the internal matrix 
and the intermembrane space (IMS). The outer membrane encloses the entire organelle and 
contains multiple copies of integral membrane proteins that allow ions and small molecules (of 
5000 Da or less) to freely diffuse between cytosol and mitochondria (Alberts et al., 2007). The 
inner membrane contains numerous carriers and translocases that mediate transport and 
membrane insertion of precursor proteins into mitochondria (Neupert, 2015). 
The main mitochondrial role is the production of adenosine 5’-triphosphate (ATP), the key 
energy source of the cell, through the aerobic substrate oxidation carried out by the oxidative 
phosphorylation (OXPHOS) system (Reid et al., 1966). The OXPHOS system is embedded in the 
lipid bilayer of the IMM and it is composed of five multiprotein enzyme complexes and two 
mobile electron carriers (Figure 1). The first four enzyme complexes (CI-CIV) comprise the 
mitochondrial respiratory chain (MRC), which facilitates electron transfer from reducing 
equivalents to molecular oxygen. During oxidative phosphorylation, organic nutrients are 
catabolized into small electron donor molecules, NADH2 and FADH2, which transfer the 
electrons to CI and CII, respectively. CoQ uptakes the electrons from both sources, transferring 
them to dimeric CIII (CIII2), then to cyt c and finally to CIV, that yields the electrons to 
molecular oxygen. This electron flux is coupled to a proton pump from the matrix to the 
intermembrane space through complexes I, III and IV, generating an electrochemical gradient 
across the IMM that provides the necessary free energy for the ATP synthase (complex V, CV) 
to synthesize ATP. 
 
Figure 1.The oxidative 
phosphorylation (OXPHOS) system. 
All complexes are represented as 
monomers. cyt c: cytochrome c; Q: 
ubiquinone; QH2: ubiquinol; ims: 
intermembrane space. Adapted 
from (Nijtmans et al., 2004). 
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Mitochondria contain a separate autonomously replicating DNA genome, the 
mitochondrial DNA (mtDNA), a closed-circular double-stranded DNA molecule formed by a 
heavy (H) strand and a light (L) strand, which contains 16.569-base pairs (Anderson et al., 
1981; Andrews et al., 1999) and which is replicated within the organelle matrix (Clayton, 1991). 
Mammalian mtDNA encodes 37 genes: 24 components of the mitochondrial translational 
machinery (22 tRNAs and 2 rRNAs, 12S and 16S), and 13 structural proteins of four out of the 
five mitochondrial OXPHOS complexes. Thereby, due to its limited coding capacity, the 
mitochondrial genome requires to coordinate with the nuclear genome, which encodes the 
remainder OXPHOS subunits as well as the factors involved in the regulation of mtDNA gene 
expression, replication and maintenance (Garesse and Vallejo, 2001). Despite the small size of 
the mitochondrial genome, mtDNA mutations are an important cause of uniparental inherited 
metabolic disease. Mitochondrial genetics have an important feature due to the polyploid 
nature of its genome (up to several mtDNA copies per cell), homoplasmy and heteroplasmy. 
Homoplasmy is the existence of identical mtDNA copies within a cell and heteroplasmy is the 
mixture of two or more mitochondrial genotypes. The value of these terms gains relevance 
when considering pathogenic mtDNA mutations, where some affect all copies of the 
mitochondrial genome (homoplasmic mutations) whereas others are only present in some 
copies of the mitochondrial genome (heteroplasmic mutations) (Taylor and Turnbull, 2005). 
Experimental evidence in the cellular distribution of both mutated and wild-type mtDNA in 
muscle determined a ”threshold level” of any mtDNA mutation that is required to cause a 
biochemical defect, and hence the clinical expression of the disease (Sciacco et al., 1994).  
 
2. Mitochondrial respiratory chain 
In the late 50s, the redox enzymes and prosthetic groups responsible for the classic 
mitochondrial electron transfer chain were defined (Chance and Williams, 1955), followed by 
their reconstitution in the early 60s (Hatefi et al., 1962). The overall MRC activity was 
postulated as a sequential transfer of electrons between four major multi-enzymatic 
complexes that carry out cellular respiration (Figure 1): NADH dehydrogenase:ubiquinone 
oxidoreductase (complex I, CI), succinate:ubiquinone oxidoreductase (complex II, CII), 
ubiquinol:cytochrome c oxidoreductase or cytochrome bc1 complex (complex III, CIII), and 
cytochrome c oxidase (complex IV, CIV). In addition, the electron transfer is ensured by the 
diffusion of two mobile electron carriers: the lipophilic ubiquinone, also designated as 
coenzyme Q (CoQ, Q), embedded in the membrane lipid bilayer, and the hydrophilic heme 
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protein cytochrome c (cyt c) located on the external surface of the IMM (Kröger and 
Klingenberg, 1973; Margoliash et al., 1973).  
 
2.1. COMPLEX I 
Complex I (CI) or NADH dehydrogenase:ubiquinone oxidoreductase is the largest enzyme of 
the OXPHOS system. It catalyses the transfer of two electrons from NADH to ubiquinone 
coupled to the translocation of four protons across the membrane, and it is an important 
generation site of mitochondrial reactive oxygen species (Barja, 1999; Cadenas et al., 1977; 
Genova et al., 2001; Herrero and Barja, 2000; Kussmaul and Hirst, 2006) (further described in 
section 5.3). Mammalian CI has 45 subunits encoded by 44 genes, among which 14 are the 
core subunits (7 of them encoded by mtDNA) that are highly conserved from bacteria to 
human, and the remainder 31 are supernumerary subunits (Baradaran et al., 2013; Carroll et 
al., 2003; Efremov et al., 2010; Fiedorczuk et al., 2016; Letts, Degliesposti, et al., 2016; Stroud 
et al., 2016; Vinothkumar et al., 2014; Zhu et al., 2016; Zickermann et al., 2015). All the 
subunits are resolved within the L-shaped arrangement consisting of two arms: a hydrophilic 
peripheral arm projecting into the matrix, and a hydrophobic membrane arm, embedded in 
the IMM (Berrisford and Sazanov, 2009; Efremov and Sazanov, 2011; Hunte et al., 2010; 
Sazanov and Hinchliffe, 2006). The complex can be divided into three structurally and 
functionally defined modules (Guerrero-Castillo et al., 2017; Hunte et al., 2010; Zhu et al., 
2015) (Figure 2): the matrix arm N-module, which preserves the entire path for NADH 
oxidation and it is composed by three core subunits (NDUFS1, NDUFV1 and NDUFV2); the 
quinone-binding Q module, which accommodates the Fe-S clusters that transfer electrons to 
ubiquinone and it is composed by four core subunits (NDUFS2, NDUFS3, NDUFS7 and NDUFS8); 
and the P-module in the membrane arm that is subdivided in two parts: proximal (PP) and 
distal (PD), which is responsible for proton pumping and it is composed by seven highly 
hydrophobic mtDNA-encoded subunits (ND1-6 and ND4L). 
 
Figure 2. High-resolved structure of human 
mitochondrial complex I. CI is divided in 
three functional modules. The P module is 
subdivided in the distal and proximal 
membrane arms. In total, 14 core subunits 
(orange) and 31 supernumerary subunits 
(cyan) form the entire structure. The figure 
was created using the 5XTH.pdb structure 
(Guo et al., 2017).  
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Due to its size, L-shaped asymmetry, membrane-bound location and multi-component 
structure, mammalian CI has proved difficult to crystallize. However, the past five years have 
been distinguished by fascinating breakthroughs in the understanding of the complete CI 
structure (Figure 2). The 3.4, 3.7, and 3.7 Å of the matrix arm, membrane arm, and overall CI 
maps (Fiedorczuk et al., 2016; Zhu et al., 2016) respectively, allowed building up all the 45 
subunits into the human CI structure (Guo et al., 2017). The structural observations of the 
entire human CI was found consistent with the previous conclusions from the cryoEM maps of 
the bovine (Zhu et al., 2016) and ovine (Fiedorczuk et al., 2016) highly-resolved CI. The 
stoichiometry of proton translocation, considered historically to be four in bacteria and yeast 
(Baradaran et al., 2013; Galkin et al., 2006) has been recently corroborated in mammals (Jones 
et al., 2017). Moreover, depending on its catalytic status (e.g. such as during hypoxia) 
mammalian CI exists in different “active” or “de-active” states (Babot et al., 2014; Dröse et al., 
2016; Galkin et al., 2009). Wide studies have provided insights into the biosynthesis of 
mammalian CI as a stepwise assembly process (Antonicka et al., 2003; Guerrero-Castillo et al., 
2017; Lazarou et al., 2007; Perales-Clemente et al., 2010; Ugalde et al., 2004; Vartak et al., 
2015; Vogel et al., 2007) addressed by sub-modules that could be either part of membrane-
associated or matrix-associated subcomplexes (Dieteren et al., 2008) (Figure 3). Importantly, CI 
enzyme deficiency is the most frequent mitochondrial disorder and presents with a diverse 
range of clinical manifestations associated with mutations in both mitochondrial and nuclear-
encoded subunits or assembly factors (Nouws et al., 2012; Valsecchi et al., 2009). 
 
 
 
 
 
 
 
 
 
 
Figure 3. The assembly pathway of mitochondrial complex I. CI subunits assemble into discrete 
modules before joining to form the functional complex in associations with complexes III and IV. The Q 
module integrates with the ND1 module and further associates with the ND2 module. The ND4 and ND5 
modules associate together followed by integration with the Q/ND1/ND2 modules to form a late stage 
intermediate comprised of the Q-module and the completed membrane arm of CI. The N-module then 
associates with this late stage intermediate to form the fully assembled complex. Adapted from 
(Formosa et al., 2017). 
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2.2. COMPLEX II 
Complex II or succinate:ubiquinone oxidoreductase, the smallest enzyme of the MRC, couples 
the oxidation of succinate to fumarate in the mitochondrial matrix, with the reduction of 
ubiquinone (Q) in the membrane. Despite its function in the MRC, complex II plays its main 
functional role as a succinate dehydrogenase in the Krebs cycle (Lenaz and Genova, 2010). 
Eukaryotic CII is composed of four subunits (SDHA, SDHB, SDHC and SDHD) encoded by the 
nuclear genome. The crystal structure of mammalian CII purified from porcine (Sun et al., 
2005) and avian (Huang et al., 2006) heart revealed a hydrophilic head (or catalytic domain) 
that protrudes into the matrix and a hydrophobic tail (or membrane anchor domain) that is 
embedded within the IMM, with a short segment projecting into the soluble IMS (Sun et al., 
2005). The two core subunits, SDHA and SDHB, form the catalytic domain and contain the 
redox cofactors; SDHA contains the FAD and the binding site for succinate and SDHB contains 
the three iron-sulphur (Fe/S) centres that mediate electron transfer to ubiquinone. The 
membrane domain encloses the other two subunits, SDHC and SDHD, which contain the heme 
group, another succinate binding site and the transmembrane helices that hold the complex to 
the IMM (Sun et al., 2005; Yankovskaya, 2003). Besides the two protons generated from the 
oxidation of succinate, another two protons are required for the full ubiquinone reduction, 
thereby with no net proton translocation. Four assembly factors (SDHAF-1 to 4) have been 
reported to play a role in the stepwise assembly of holo-CII; briefly, following the flavination of 
SDHA through SDHAF2 and other putative factors (Bezawork-Geleta et al., 2016; Hao et al., 
2009; Huang et al., 2013; Kounosu, 2014), the chaperone-like assembly factor SDHAF4 binds to 
SDHA to reduce auto-oxidation (Van Vranken et al., 2014). The insertion of [Fe–S] clusters into 
SDHB requires the assembly factor SDHAF1 and later SDHAF3 (Bezawork-Geleta et al., 2014; 
Ghezzi et al., 2009; Maio et al., 2016; Na et al., 2014) to protect the system from oxidative 
damage. Little is known about the biogenesis of the SDHC and SDHD subunits and the heme 
group insertion, to form the complete holoenyme (Bezawork-Geleta et al., 2017). 
2.3. COMPLEX III 
Complex III, cytochrome bc1 complex or ubiquinol:cytochrome c oxidoreductase catalyzes the 
transfer of electrons from ubiquinol (reduced coenzyme Q) to cyt c and it link this redox 
reaction to translocation of protons across the membrane. The CIII structures from several 
species including yeast, chicken and bovine have been crystallized, and solved to atomic 
resolution (Hunte et al., 2000; Iwata, 1998; Xia D et al., 1994). Recent highly-resolved human 
CIII has been also first described (Guo et al., 2017). This structure of ~480 kDa is a symmetrical 
homodimer that contains three core protein subunits with redox prosthetic groups: 
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cytochrome b (MTCYB), which contains a low-potential (bL) and a high-potential (bH) heme b 
moieties as prosthetic groups; cytochrome c1 (CYC1), containing a c-type heme group; and the 
Rieske protein (UQCRFS1 or RISP) with a 2Fe-2S cluster. Another eight supernumerary subunits 
(UQCRC1, UQCRC2, UQCRH, UQCRB, UQCRQ, Subunit 9, UQCR10 and UQCR11) conform the 
entity (Schägger et al., 1986; Xia et al., 2013), and possibly function in the structural stability 
and regulation of the coordinated activity of the dimeric enzyme. The so-called Q-cycle theory 
is the most accepted hypothesis describing the molecular mechanism of electron transfer and 
proton translocation through CIII (Mitchell, 1975; Zhang et al., 1998).  
CIII2 assembly studies in yeast models (Atkinson et al., 2011; Cui et al., 2012; Gruschke 
et al., 2012; Smith et al., 2012; Wagener et al., 2011; Zara et al., 2004, 2009a), as well as on 
CIII2-associated human disease models (Fernández-Vizarra and Zeviani, 2015) have provided 
some insight into the intriguing assembly pathway of the complex (Figure 4), although more 
research is needed to unravel its biogenesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Mitochondrial CIII2 assembly pathway. The biogenesis of CIII2 involves a dynamic multi-step 
process considered to be similar to that in yeast. After the formation of an early intermediate composed 
of subunits MTCYB+UQCRB+UQCRQ, an additional sub-assembly containing UQCRC1, UQCRC2, and CYC1 
is incorporated, followed by UQCRH and later UQCR10, to form the pre-complex III (pre-CIII2). At this 
point, the complex is already dimeric (Fernandez-Vizarra et al., 2007). Finally, UQCRFS1 is translocated 
from the matrix into the inner mitochondrial membrane and it is incorporated into pre-CIII2. In the 
matrix, UQCRFS1 is bound and stabilized by MZM1L (Sánchez et al., 2013). Finally the last subunit 
(UQCR11) joins the nascent complex, so that assembly is completed. Adapted from (Bottani et al., 2017; 
Fernández-Vizarra and Zeviani, 2015). 
 
2.4. COMPLEX IV 
Complex IV (CIV), or cytochrome c oxidase (COX), catalyses the complete reduction of 
molecular oxygen to water and promotes the translocation of two protons across the IMM. 
Mammalian COX is a multimeric enzyme that comprises 14 subunits, three of which (MT-CO1 
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or COX1, MT-CO2 or COX2 and MT-CO3 or COX3) are encoded by the mtDNA and form the 
hydrophobic catalytic core embedded in the IMM. The remainder subunits (COX4, COX5A, 
COX5B, COX7A, COX6C, COX7C, COX6B, COX6A, COX7B, COX8 and NDUFA4), are encoded in 
the nuclear DNA and they may be involved in the stabilization of the dimeric state of the 
oxidase, in the modulation of its catalytic activity and in its protection from oxidative damage 
(Fontanesi et al., 2008; Timón-Gómez et al., 2017). The COX1 and COX2 subunits harbour the 
redox centres: COX1 harbours a heme a centre and a binuclear heme a3-copper (CuB) centre, 
and COX2 contains a dinuclear copper center (CuA). The first crystal structure of the enzyme 
was resolved from bovine heart (Tsukihara et al., 1995; Yoshikawa et al., 1998), data that 
represented a real step forward in the understanding of the function and biogenesis of the 
complex. Recent highly-resolved human CIV has been also described for the first time (Guo et 
al., 2017).  
Over the last 50 years, experimental data in yeast models have shed light into the CIV 
assembly pathway (McStay et al., 2013), gathering useful information to be compared with the 
biogenesis of mammalian CIV (Dennerlein and Rehling, 2015; Nijtmans et al., 1998; Soto et al., 
2012; Vidoni et al., 2017). However, due to the specific features of mammalian CIV, such as the 
presence of tissue-specific isoforms or the more than 30 COX assembly factors involved in its 
biogenesis among others, numerous hypotheses and models have been proposed for the 
assembly of mammalian CIV (Vidoni et al. 2017; Timón-Gómez et al. 2017) (Figure 5). 
Around 75% of the CIV enzyme deficiencies originate from mutations in nuclear-
encoded subunits (Blázquez et al., 2016), although mutations on the mtDNA-encoded subunits 
have also been described leading to a wide range of clinical features (Barrientos et al., 2002). 
 
Figure 5. Mitochondrial CIV assembly 
pathway. Model for the biogenesis of 
monomeric CIV. The catalytic core subunits 
(MT-CO1, MT-CO2 and MT-CO3) form 
subassembly modules with other subunits and 
assembly factors prior to their incorporation in 
the main pathway. Proteins whose genes have 
been found mutated in mitochondrial 
disorders are displayed in red. Adapted from 
(Vidoni et al., 2017). 
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3. Models for the structural organization of the respiratory chain 
Despite the well-known functional relevance of the respiratory chain, the structural 
organization of its components remains unclear. 
3.1. SOLID-STATE MODEL 
The pioneering spectrophotometric studies of Chance and Williams represented the MRC as a 
solid state assembly of prosthetic groups that carry out sequential redox reactions in a protein 
matrix (Chance and Williams, 1955). The evidences in favour of this “rigid” or “solid-state 
model” were based on the isolation of CI-CIII and CII-CIII active units in a stoichiometric molar 
ratio of 1:1 during intermediate purification steps of the individual enzymes, that were 
interpreted as secondary enzymatically active complexes (Fowler and Hatefi, 1961); and on the 
reconstitution of a “repeating unit of electron transfer” containing all MRC complexes from 
bovine heart mitochondria (Blair, 1967). This model implied the notion of permanently-bound 
CoQ to the MRC units. Accordingly, vesicle reconstitution experiments showed stoichiometric 
associations between CI and CIII2 at high protein concentrations with no exchange between 
free and bound ubiquinone, i.e., no 'CoQ-pool' behaviour (Ragan and Heron, 1978). Only when 
sufficient lipid was added the CoQ-pool behaviour was restored, but this was interpreted as 
the movement of complex-associated CoQ rather than of free CoQ (Heron et al., 1978). Later 
studies in Saccharomyces cerevisiae provided evidence that CoQ and cyt c only diffused freely 
along the membrane upon the addition of chaotropic agents, suggesting that the respiratory 
chain in yeast also behaves as one functional unit that at least comprises complexes III and IV 
with bound CoQ and cyt c (Boumans et al., 1998).  
3.2. LIQUID-STATE MODEL 
The general vision gradually evolved into a “random collision”, “fluid” or “liquid-state” model, 
proposed by Hackenbrock and co-workers, that pictured all membrane proteins and redox 
components that catalyse electron transport and ATP synthesis in constant and independent 
diffusional motion, where electron transfer takes place through diffusion-based collisions 
among the redox partners (Höchli and Hackenbrock, 1976). Evidence in favour of the “liquid-
state model” arose from kinetic analyses proposing not only that electron transfer in the CoQ 
and cyt c regions obeyed a pool behaviour in mammalian mitochondria, but also that it 
followed saturation kinetics with regards to CoQ and cyt c concentrations (Gupte and 
Hackenbrock, 1988; Kröger and Klingenberg, 1973). Furthermore, enzymatic activities were 
retained upon isolation of the individual OXPHOS complexes (Hatefi et al., 1962) and the use of 
fluorescent antibodies against CIII2 and CIV caused independent aggregation of these 
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complexes, suggesting that they diffuse laterally in the membrane plane independent of one 
another (Höchli et al., 1985). 
3.3. DYNAMIC AGGREGATE OR PLASTICITY MODEL 
The two previous models were proposed for the way in which MRC components interact to 
accomplish a maximal-efficient electron transfer, representing extreme examples where 
intermediate modes of operation are feasible. Alternative studies by Ferguson-Miller and 
collaborators that analysed the role of lateral diffusion of cyt c in electron transfer within 
native mitochondrial membranes, gave rise to the “dynamic aggregate” model (Hochman et 
al., 1982). In this model, a dynamic equilibrium exists between freely diffusing and associated-
forms of the MRC components, all active in electron transfer. This new representation of the 
respiratory chain reconciled the two classical models, as it incorporated transient aggregates 
as well as free lateral diffusion of redox components to account for the electron transport 
rates. The reversible formation of specific MRC aggregates additionally offered a mechanism 
for localized proton flow and the possibility of regulating the direction and efficiency of 
electron transfer (Ferguson-Miller et al., 1986; Hochman et al., 1985). This idea was 
disregarded in favour of the “fluid” model until new data from two groups, based on the use of 
blue native polyacrylamide gel electrophoresis (BN-PAGE) developed by Schägger and 
collaborators, showed the co-existence of individual MRC complexes together with their inter-
associations in supramolecular assemblies that were termed supercomplexes (SCs) (Cruciat et 
al., 2000; Schägger and Pfeiffer, 2000). Experimental evidences demonstrated that SCs are 
evolutionarily conserved stable structures in both prokaryotes and eukaryotes, and not 
random associations of MRC complexes (Chaban et al., 2014; Melo and Teixeira, 2016), and 
recent high-resolution cryo-electron microscopy (cryo-EM) analyses showed the detailed 
structural architecture of mammalian respiratory SCs (Guo et al., 2017; Letts, Fiedorczuk, et al., 
2016; Sousa et al., 2016; Wu et al., 2016) (Figure 6). The coexistence of individual MRC 
complexes and SCs thus supports the principles of the “dynamic aggregate” model, which was 
lately renamed as the “plasticity” model by Enríquez and co-workers (Acín-Pérez et al., 2008; 
Acin-Perez and Enriquez, 2014). In its current form, this model proposes that the switch 
between freely moving MRC complexes to fixed SCs would optimize electron flux from 
different substrates (NADH and FADH2), adapting the efficiency of the respiratory chain to 
changes in cellular metabolism via partitioned CoQ and cyt c pools (Lapuente-Brun et al., 
2013).  
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Figure 6. Architectures of human 
supercomplexes. Side views along the 
membrane from the loose respirasome or 
SC I+III2+IV1 (top) and SC I+III2 (bottom), 
according to the 5XTH structure in the 
PDB database proposed by (Guo et al., 
2017). The structural models of CI, CIII2, 
and CIV are coloured in salmon, 
turquoise, and navy blue, respectively. 
The transmembrane region is indicated 
by two dashed lines. M, matrix; IMM, 
inner mitochondrial membrane; IMS, 
intermembrane space. 
 
4. Structural architectures of the respiratory chain supercomplexes 
4.1. TYPES OF RESPIRATORY CHAIN SUPERCOMPLEXES 
The notion of “supercomplexes” first appeared upon the observations of preferential 
associations between bacterial MRC complexes (Berry and Trumpower, 1985; Sone et al., 
1987). Respiratory chain SCs of different compositions and stoichiometries were later reported 
by means of BN-PAGE analyses of mitochondrial fractions solubilized with the mild detergent 
digitonin. This method allows the retention of labile supramolecular assemblies of membrane 
protein complexes that would otherwise be dissociated. The solubilization of OXPHOS 
complexes from yeast and bovine heart mitochondria using varying digitonin-to-protein ratios 
and subsequent BN-PAGE allowed to separate assorted types of stoichiometric associations of 
complexes I, III and IV within the molecular mass range from ~750 to ~2100 kDa, in an overall 
1:3:6 stoichiometry (Schägger and Pfeiffer, 2001). Additional BN-PAGE, single-particle electron 
microscopy (EM) and cryo-electron tomography studies, consistently reported specific 
associations between CI, CIII2 and CIV in a wide range of organisms (Chaban et al., 2014). It is 
worth mentioning that for a long time, many researchers attributed the appearance of SCs on 
BN-PAGE gels to protein aggregation as a consequence of detergent solubilization. However, 
the migrations of these bands in the gels are consistently reproducible, as shown by many 
different laboratories in the last 17 years, and well-defined structures from these bands 
extracted from the gels are now available. 
The composition and abundance of the respiratory chain SCs may vary among 
organisms and tissues depending on the metabolic and physiological conditions (Cogliati et al., 
2013; Dencher et al., 2007; Greggio et al., 2017; Helbig et al., 2009; Jang et al., 2017; Lapuente-
Brun et al., 2013; Ramírez-Aguilar et al., 2011; Rosca et al., 2008; Schägger and Pfeiffer, 2000), 
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as well as on the lipid content of the IMM (Böttinger et al., 2012; Pfeiffer et al., 2003; Tasseva 
et al., 2013; Zhang et al., 2002). In most CI-containing eukaryotes, CI primarily interacts with 
CIII2 and CIV to form the most abundant SC, I+III2+IV1, to which additional CIV monomers are 
added to form SCs I+III2+IV2-4. These structures are known as the respirasomes (Schägger and 
Pfeiffer, 2000), since they contain all the components required to transfer electrons from 
NADH to molecular oxygen. Additionally, CI associates with CIII2 to form SC I+III2; and CIII2 
binds one to two CIV monomers to assemble SCs III2+IV1-2. In mammals, most CI, ~40-50% of 
CIII2 and ~20-30% of CIV are localized in the largest SCs I+III2 and I+III2+IV1-4 (Figure 7). CIII2 and 
CIV may also interact to form SC III2+IV1 that scarcely represents 5-10% of the total MRC 
structures (Moreno-Lastres et al., 2012; Schägger and Pfeiffer, 2001). In higher plants 
mitochondria, CIV-containing SCs are barely detectable, and SC I+III2 is the predominant 
macrostructure (Dudkina et al., 2005). In Saccharomyces, which lacks CI, two bands of ~750 
and ~1000 kDa corresponding to SCs III2+IV1 and III2+IV2, respectively, are predominant (Cruciat 
et al., 2000; Schägger and Pfeiffer, 2000). These variations in the relative abundance of SCs 
may reflect different stoichiometries of CI, CIII2 and CIV among organisms. 
 
Figure 7. Distribution of human 
respiratory chain complexes and 
supercomplexes. Most CI (blue), ~half 
of CIII2 (green) and ~20-30% of CIV 
(red) are localized in the respirasome 
(I+III2+IV0-1). SC III2+IV1 represent ~5% 
of the total amount of MRC structures, 
as well as CIV dimers (IV2). Free CI 
(light blue) requires being associated 
in SCs to minimize destabilization and 
ROS generation.  
 
 
 
 
Regarding CII and CV, these enzymes form oligomers that do not interact with 
complexes I, III and IV under normal physiological conditions (Dudkina et al., 2011; Moreno-
Lastres et al., 2012; Muster et al., 2010; Quarato et al., 2011; Schäfer et al., 2006; Schägger and 
Pfeiffer, 2000, 2001). Based on the differential solubilisation of MRC complexes and SCs on BN-
PAGE, a higher organization level of SCs in “respiratory strings” was proposed for mammals 
and yeast (Wittig, Carrozzo, et al., 2006), where respirasomes would be interconnected by CIV 
tetramers at regular intervals, thus generating linear assemblies of respiratory SCs. The 
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observation of CI dimers (CI2) in Yarrowia lipolytica (Nubel et al., 2009) redefined this model as 
“respiratory patches” generated by the interactions between two CI monomers within 
adjacent respiratory strings. An alternative model for plants based on single-particle EM, 
proposed the repetition of I2III2IV2 units into a respiratory string mediated by the interaction of 
two neighbouring CIV through a dimeric interface (Bultema et al., 2009), which differed from 
the previous model by the lower abundance of CIV copies. In this regard, recent structural 
analyses in HEK293 cells have shown the arrangement of the MRC complexes in a novel 
circular structure termed the megacomplex (MC) I2+III2+IV2 (Guo et al., 2017), where CIII2 forms 
a central core surrounded by two copies each of CI and CIV. Guo et al. also hypothesized that 
in emergency conditions, CII could join the megacomplex molecular machine creating the MC 
I2+II2+III2+IV2, to provide a most effective pathway to release the high-energy electrons.  
The structural and functional characterization of the SCs among different species 
would benefit very much from in situ studies without disrupting the mitochondrial membranes 
with detergents; for example, using fluorescence life-time imaging, as recently published 
(Rieger et al., 2017). 
4.2. SUPERCOMPLEXES I+III2 AND III2+IV1-2 
The first structure of SC I+III2 from Arabidopsis thaliana mitochondria was determined at 18Å 
resolution (Dudkina et al., 2005), revealing the lateral association of CIII2 to the membrane-
embedded distal part of CI. However, the lack of an atomic CI structure failed to decipher the 
precise subunit interactions within this SC. Recently, the architecture of the mammalian SC 
I+III2 was resolved at high resolution in human (Guo et al., 2017) (Figure 6), ovine (Letts, 
Fiedorczuk, et al., 2016) and bovine (Sousa et al., 2016). In these structures, contacts between 
CI and CIII2 were similar to the ones detected for SC I+III2+IV1 (described in Section 4.3).  
A pseudo-atomic model at 15Å resolution of yeast SC III2+IV1-2 (Heinemeyer et al., 
2007) revealed that CIII2 is attached to the convex side of two CIV monomers, leaving the 
opposite interfaces open for CIV dimerization. Cardiolipin and phosphatidylethanolamine lipids 
were identified at the CIII2-CIV interface. This structure also revealed cyt c bound to CIII2, which 
moves and rotates within a distance of 40Å (~4 nm) to mediate electron transfer between CIII2 
and CIV. Later studies based on 3D-cryo-EM maps specified the distance between the cyt c 
binding sites of CIII2 and CIV as ~6nm, considered to be sufficiently short to enable the 
channelling of cyt c between these complexes (Mileykovskaya et al., 2012), although this was 
previously refuted (Trouillard et al., 2011). The yeast CIII2 subunits cytochrome b (MT-CYB), 
cytochrome c1 (CYC1), Qcr6 (Hinge protein or UQCRH), Qcr7 (UQCRQ), Qcr8 (UQCRB) and Qcr9 
(UQCR10) were identified at the CIII2-CIV interface, as well as the CIV subunits CoxI (COX1), 
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CoxII (COX2), CoxIII (COX3), CoxV (COX4), CoxVIIa (COX6C), CoxVII (COX7A) and CoxVIII (COX7C) 
(Heinemeyer et al., 2007). However, direct evidence supporting precise subunit interactions 
was missing. Due to its low relative abundance, SCs III2+IV1-2 from higher organisms await 
structural characterization. 
4.3. RESPIRASOME OR SUPERCOMPLEX I+III2+IV1 
In mammalian mitochondria, I+III2+IV1 is the most abundant SC. The first 3D maps of bovine 
heart SC I+III2+IV1 (Althoff et al., 2011; Dudkina et al., 2011; Schäfer et al., 2006, 2007) revealed 
the lateral binding of CIII2 to the middle part of the CI membrane arm, with CIV positioned in 
the distal tip of CI while laterally interacting with CIII2, and cardiolipin molecules filling the gaps 
between the transmembrane domains at the interfaces between the individual complexes 
(Althoff et al., 2011; Dudkina et al., 2011). The recent characterization of the atomic structure 
of mammalian CI by cryo-EM (Fiedorczuk et al., 2016; Zhu et al., 2016) represented a major 
step forward that enabled to obtain high-resolution projection maps of the mammalian 
respirasomes (Gu et al., 2016; Guo et al., 2017; Letts, Fiedorczuk, et al., 2016; Sousa et al., 
2016; Wu et al., 2016) (Figure 6). Yang and collaborators solved the conformation of porcine 
SC I+III2+IV1 (Gu et al., 2016; Wu et al., 2016), where CIV would loosely bind CI and CIII2. In 
addition, Letts et al. (Letts, Fiedorczuk, et al., 2016) distinguished two architectures for the 
ovine respirasome, a major “tight” and a minor “loose” conformations, where CIV would 
contact both CI and CIII2 within the tight form, but only CI within the loose form. Sousa et al. 
also resolved two classes of SC I+III2+IV1 in bovine (Sousa et al., 2016). The tight form of the 
ovine respirasome was essentially identical to the bovine respirasome class 1. However, the 
bovine respirasome class 2 differed in the conformational flexibility of CIII2, as this rotates by 
25º relative to CI while CIV remains unchanged. The bovine respirasome additionally showed 
clear density in one of the two membrane extrinsic iron-sulphur domains of CIII2, suggesting 
that only one CIII monomer would be active (Sousa et al., 2016). The heterogeneity among 
these structures deserves further consideration (Milenkovic et al., 2017), as it could reflect the 
existence of independent structural entities resulting from the dynamic association and 
dissociation of the MRC complexes in response to, eg., tissue-specific phospholipid 
environments or ROS levels.   
The respirasome-bound CI is more compact than free CI due to its associations with 
CIII2 and CIV (Fiedorczuk et al., 2016; Zhu et al., 2016). Although several interaction points exist 
between CI, CIII2 and CIV, the most extensive and stable interactions take place between CI 
supernumerary subunits (absent in bacteria) and CIII2 at two major points: CI subunits 
NDUFA11 (B14.7 in bovine) and NDUFB4 (B15) directly interact with CIII2 subunit UQCRQ at the 
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matrix and inner membrane interface, and CI subunits NDUFB4 and NDUFB9 (B22) bind CIII2 
subunits UQCRC1 and UQCRFS1 in the matrix (Letts, Fiedorczuk, et al., 2016; Wu et al., 2016). 
Another important interaction occurs between CI subunit NDUFB7 (B18) and subunit UQCRH 
on CIII2. Both subunits contain disulphide bonds, suggesting that redox regulation might 
modulate the interactions between MRC complexes (Letts, Fiedorczuk, et al., 2016). Since the 
long helix of NDUFB7 is poised at the interface of the three complexes, it may also interact 
with CIV through the COX7A and COX8B subunits at the intermembrane space and inner 
membrane interface (Letts, Fiedorczuk, et al., 2016; Wu et al., 2016). CIV is less tightly bound 
to the respirasomes and major contacts differ among structures, reflecting its varying location. 
There is a close association of CIV subunit COX7C and ND5 on CI, as well as an interaction of 
COX7A on CIV with CIII2 subunits UQCR11, UQCRC1 and UQCRB at the matrix and inner 
membrane interface (Letts, Fiedorczuk, et al., 2016; Wu et al., 2016). This interaction between 
CIII2 and IV seems to swing away in the loose respirasome form, where only COX7A would 
contact CI through subunit ND5 (Letts, Fiedorczuk, et al., 2016).  
4.4. EFFECT OF CARDIOLIPIN ON THE STABILIZATION OF SUPERCOMPLEXES 
Supporting the idea that phospholipids mediate protein–protein interactions in the IMM, 
cardiolipin molecules were detected within yeast SCs III2+IV1-2 (Mileykovskaya et al., 2012), 
where they stabilize these structures (Pfeiffer et al., 2003; Zhang et al., 2002). Moreover, 
studies in lymphocytes from patients with Barth syndrome, a mitochondrial disorder in which 
cardiolipin levels are drastically reduced due to mutations affecting Tafazzin (an enzyme 
involved in cardiolipin maturation), revealed the specific destabilization of SC I+III2+IV1 
(McKenzie et al., 2006). A pluripotent stem cell model system of this disorder later confirmed 
the role of cardiolipin content for SCs stabilization (Dudek et al., 2013). Consistent with these 
observations, the atomic structure of the respirasome revealed clear gaps between CI, CIII2 
and CIV that were occupied by cardiolipin molecules to further stabilize the respirasome 
(Althoff et al., 2011; Wu et al., 2016). Although cardiolipin is considered to stabilize SCs, 
phosphatidylethanolamine, another phospholipid of the inner membrane, seems to exert the 
opposite effect (Böttinger et al., 2012).  
5. Function of respiratory chain supercomplexes 
5.1. CATALYTIC ENHANCEMENT OF THE ELECTRON FLUX THROUGH SUBSTRATE CHANNELLING 
The arrangement into SCs was initially proposed to maximize the efficiency of the electron flux 
across the MRC (Schägger and Pfeiffer, 2000). Indeed, spectrophotometric assays of the MRC 
activities of isolated SCs from bovine heart mitochondria showed that CI in SC I+III2 displays 
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about half the activity of that in SC I+III2+IV1, suggesting that the full respirasome was the most 
active unit (Schäfer et al., 2006). Substrate channelling was proposed as a possible mechanism 
to explain the increased rates of electron transfer within SCs based on flux control analyses of 
the MRC complexes in bovine heart mitochondria (Blanchi et al., 2004). The authors suggested 
that CI and CIII2 behave as a single enzymatic unit, where electron transfer through CoQ is 
accomplished by channelling between the two redox enzymes without following a pool 
behaviour, in agreement with other reports in yeast (Boumans et al., 1998) and bovine 
mitochondria (Ragan and Heron, 1978). Following studies that analysed the roles of CoQ and 
cyt c in the attenuation of CIII2 and CIV pharmacological inhibition on the respiratory flux 
supported the dynamic compartmentalization of the respiratory substrates (Benard et al., 
2008), as well as studies based in the competition of substrates for NADH and succinate 
oxidation (Lapuente-Brun et al., 2013). The proposal that SCs may provide distinct electron 
translocation pathways through the partition of CoQ into different pools to mediate metabolic 
adaptation (Lapuente-Brun et al., 2013), was questioned by kinetic and flux control studies 
showing that the metabolic pathways for NADH and succinate oxidation comprise different 
CoQ redox steady states, but communicate and converge on a single non-partitioned CoQ pool 
(Blaza et al., 2014; Milenkovic et al., 2017). It has also been argued that the cyt c pool is equally 
compartmentalized (Lapuente-Brun et al., 2013), but studies monitoring the reduction 
potential of CIII upon addition of NADH, succinate or both (Blaza et al., 2014), evidenced 
against cyt c partitioning. In agreement, time-resolved spectroscopic analysis of cyt c oxidation 
in intact yeast cells showed that cyt c is not trapped within SCs and, therefore, there are no 
restrictions that limit its diffusion (Trouillard et al., 2011). Moreover, the respirasome 
structures showed no evidence of a protein-mediated substrate channel connecting the CoQ 
binding sites of CI and CIII2 (Letts, Fiedorczuk, et al., 2016), since both active sites are open to 
the membrane and separated by 10 nm, as also evidenced for cyt c, in agreement with 
previous studies that questioned substrate channelling based on the distances between the 
substrates binding sites on SCs (Dudkina et al., 2011). Therefore, the function of a direct 
catalytic role for mitochondrial SCs remains questionable (Milenkovic et al., 2017).  
5.2. ASSEMBLY AND STABILITY OF COMPLEX I 
Experimental evidence accumulated on respiratory chain disease models, suggests that the 
formation of mammalian SCs confer stability to their individual components, and most 
particularly to CI. The first description of a patient with progressive exercise intolerance due to 
a nonsense mutation in the CIII2 subunit gene MT-CYB associated with a combined enzyme 
deficiency of complexes I and III (Lamantea et al., 2002), was followed by a more extensive 
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study showing that genetic alterations leading to a loss of CIII2 prevented respirasome 
formation and led to the secondary loss of CI (Schägger et al., 2004). Further studies confirmed 
that not only the structural integrity of CIII2 (Acín-Pérez et al., 2004), but also that of CIV (Diaz 
et al., 2006; Hornig-Do et al., 2012; Li et al., 2007), were essential to maintain the stability of 
mammalian CI. Despite these evidences, ostensible CI functional alterations are relatively 
infrequent to most patients presenting with CIII2 or CIV enzyme deficiencies (Fernández-
Vizarra and Zeviani, 2015; Rak et al., 2016), indicating that only severe structural alterations of 
these two complexes induce a parallel CI dysfunction. On the contrary, a dramatic decrease in 
CI levels does not generally lead to CIII2 and CIV functional defects in mammals (Schägger et 
al., 2004). In agreement, the depletion of 28 different CI accessory subunits in human HEK293T 
cells showed a loss of SCs I+III2 and I+III2+IV1 with no alterations in the steady-state levels of 
CIII2 or CIV (Stroud et al., 2016). However, the fact that CI is purified and remains active in its 
free form adds to the debate whether CI stability may rely on additional molecular 
mechanisms, like alterations in the mitochondrial membrane potential (Quarato et al., 2011) 
or ROS levels. In this regard, the absence of respirasomes due to the lack of cyt c (Vempati et 
al., 2009), CIII2 or CIV induced reverse electron transport from reduced CoQ to CI, triggering 
local superoxide generation and CI degradation (Guarás et al., 2016). 
5.3. MODULATION OF ROS PRODUCTION 
Because CI and CIII2 constitute the main redox centres responsible for oxygen reduction to 
superoxide (Genova et al., 2001; Sun and Trumpower, 2003), it has been hypothesized that 
their arrangement into SCs could minimize ROS production. Measurements in bovine heart 
mitochondria provided the first demonstration that the disruption of SC I+III2 enhanced the 
generation of superoxide from CI (Maranzana et al., 2013), and a direct correlation between 
ROS levels and CI dissociated from SCs was established in neurons and astrocytes (Lopez-
Fabuel et al., 2016). According to the ovine respirasome structure (Letts, Fiedorczuk, et al., 
2016), the two CoQ binding cavities on CIII2 are arranged in such way that the symmetry of CIII2 
is broken, and this asymmetry could limit ROS production at the expense of maximal activity. 
Although decreased ROS production may be a functional consequence of SCs, oxygen levels 
can also modulate the assembly of these superstructures and the efficiency of mitochondrial 
respiration. For instance, during prolonged hypoxia, potato mitochondria showed a 
rearrangement of CI from SC I+III2 to its free form (Ramírez-Aguilar et al., 2011). Or studies in 
mouse fibroblasts lacking the Rieske Fe-S protein of CIII2 showed that enhanced ROS disrupted 
SCs and produced a deleterious effect on the stability of complexes I and IV (Diaz et al., 2012). 
One way the cells adapt to hypoxic conditions is by building a more efficient respiratory chain 
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through CIV, a key enzyme composed of oxygen-regulated subunit isoforms in yeast and 
mammals (Aras et al., 2013; Cogliati et al., 2016; Liu and Barrientos, 2012). Variations in 
oxygen levels may thus affect the assembly state of CIV and its incorporation into 
respirasomes. Aging, a fundamental biological process that affects all eukaryotic lives, is 
generally attributed to increased oxidative damage induced by ROS, and this is usually 
accompanied by a decay of SCs levels (Frenzel et al., 2010).  
 
6. Biogenesis of respiratory chain supercomplexes 
6.1. THE RESPIRASOME ASSEMBLY PATHWAY 
The precise mechanisms that regulate the biosynthesis of mammalian mitochondrial SCs 
remain unsolved and two models have been proposed to explain the association of CI with 
complexes III and IV (Guerrero-Castillo et al., 2017; Moreno-Lastres et al., 2012). The first 
model (Figure 8) proposes that CI gets fully-assembled prior to its binding to SCs. Time-course 
incorporation analyses of the 13 radiolabelled mitochondrial-encoded polypeptides into 
complexes and SCs showed the existence of a temporal gap between the formation of the 
complexes and their co-localization in SCs, suggesting that SCs originate by the direct 
association of single preassembled complexes (Acín-Pérez et al., 2008). Recent proteomic 
studies based on BN-PAGE and complexome profiling of CI intermediates upon mitochondrial 
translation inhibition with chloramphenicol, agreed that CI was independently assembled 
before SC formation (Guerrero-Castillo et al., 2017).  
 
 
 
 
 
 
 
 
Figure 8. Respirasome biogenesis through direct association of fully assembled respiratory chain 
complexes. This model proposes that the mammalian respirasome (I+III2+IV1) originates by the direct 
association of single preassembled CI (blue), CIII2 (green) and CIV (red).  
 
The possibility that the formation of the respirasome could be achieved instead 
through a coordinated association of submodules and free subunits was supported by the 
observation in Neurospora crassa that the assembly of SC I+III2 occurs before the individual CI 
is formed (Marques et al., 2007), and by studies showing that, in mitochondria from patients 
with chronically reduced CIV levels, newly-imported COX subunits preferentially integrate into 
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SCs (Kovářová et al., 2012; Lazarou et al., 2009). In accordance with this idea and previously to 
this work, our group analyzed the formation of SC assembly intermediates by reversibly 
depleting control cell lines of OXPHOS complexes by long treatment with doxycycline, a 
reversible inhibitor of mitochondrial translation. Results led to propose a second model (Figure 
9) that involves the sequential binding of subcomplexes from CIII2 and CIV to an almost 
complete CI scaffold that lacks the N catalytic module, which would be incorporated at the end 
of the assembly process to ensure the activation of the respirasome once all the essential 
structural components are present (Moreno-Lastres et al., 2012). 
 
Figure 9. Respirasome 
biogenesis through the 
stepwise association of 
partially assembled 
respiratory chain complexes 
and submodules. This model 
proposes the sequential and 
coordinated association of 
submodules and free subunits 
from CIII2 (green) and CIV 
(red) to a CI-scaffold (blue) 
that lacks the N catalytic 
module, which is incorporated 
at the latest assembly stage to 
ensure respirasome activation 
in the presence of all the 
necessary structural 
components. The assembly 
pathways of individual CIII2 
and CIV are depicted 
according to stablished 
models, and SC III2+IV1 is 
formed independently of the 
respirasomes. Supercomplex 
assembly factors COX7A2L 
and HIGD2A are marked in 
green/red. 
 
 
6.2. SUPERCOMPLEX ASSEMBLY FACTORS 
An important issue is the regulatory function that chaperones or assembly factors play on the 
assembly of SCs and respirasomes. In this regard, the two protein types defined as SC assembly 
factors, COX7A2L and the RCFs, are the best-studied ones. 
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6.2.1. COX7A2L/COX7RP/SCAFI 
An interesting debate concerns the regulatory role of the protein COX7A2L/COX7RP in the 
formation and stabilization of mitochondrial SCs. Cox7a2l was first reported in mice to be 
present in the respirasomes and SC III2+IV1 but not in CIII2 or free CIV, therefore constituting 
the first SC-specific assembly factor that was renamed SCAFI (Lapuente-Brun et al., 2013). The 
authors discovered that certain wild-type mouse strains widely used in biological research 
were homozygous for a 6 bp deletion in the Cox7a2l gene and expressed a short, unstable 
Cox7a2l isoform that failed to support CIV association into SCs, thereby promoting differences 
in mitochondrial respiration rates and ATP production. The authors proposed that Cox7a2l was 
a SC-specific assembly factor that aids CIV integration into SCs to adapt respirasomes 
formation and mitochondrial function to metabolic variations (Barrientos and Ugalde, 2013; 
Lapuente-Brun et al., 2013). This hypothesis was challenged by a depth characterization in 
isolated heart and liver mitochondria from control mouse strains that contained either the full-
length Cox7a2l gene (i.e., CD1 mice) or the variant with the 6-bp deletion (i.e.,C57BL/6J, 
C57BL/6N, and BALB/c mice), that demonstrated that all mice had normal formation of 
respirasomes and normal respiratory chain function, thus showing that the truncated version 
of the Cox7a2l gene does not impact the bioenergetic capacity in vivo (Mourier, Matic, et al., 
2014). This observation was conclusively supported by other studies (Davoudi et al., 2016; 
Ikeda et al., 2013; Jha et al., 2016; Sun et al., 2016; Williams et al., 2016).  
Variations observed among tissues in the relative distribution of BN-PAGE bands above 
the canonical respirasome (SC I+III2+IV1) in mice strains bearing the short Cox7a2l isoform 
(Davoudi et al., 2016; Jha et al., 2016; Williams et al., 2016), opened the possibility that the 
assembly of specific SCs could be regulated in a tissue-specific manner. Interestingly, the short 
Cox7a2l isoform in C57BL/6 mice induced tissue-specific differences in the levels of the larger 
respirasomes I+III2+IV2-4, which were less abundant in liver than in heart mitochondria 
(Williams et al., 2016). The canonical respirasome (I+III2+IV1) was observed in the heart and 
skeletal muscle of mice expressing the short Cox7a2l isoform but not in the liver (Cogliati et al., 
2016), whereas other studies observed its presence in the liver of mice expressing the short 
Cox7a2l isoform (Jha et al., 2016; Mourier, Matic, et al., 2014; Williams et al., 2016) (Table 1). 
The high sequence similarity between Cox7a2l and tissue-specific isoforms of the CIV subunit 
Cox7a, led to speculate that Cox7a2l may replace Cox7a within SCs, acting as a bridge to 
stabilize the interaction between CIII2 and CIV (Letts, Fiedorczuk, et al., 2016). Mass 
spectrometric analyses of SCs from CD1 mice mitochondria (that express the long Cox7a2l 
isoform), revealed that the Cox7a2 subunit was present almost exclusively in CIV1-2, whereas 
Cox7a2l was present in SCs III2+IV and I+III2+IV1-4 (Cogliati et al., 2016).  
INTRODUCTION 
28 
 
Table 1. Literature overview on the SCs organization reported in the C57BL/6 mouse strain harbouring 
the short COX7A2L isoform. 
Study Mouse Tissue Respirasome I+III2+IVn SC III2+IV1 
Lapuente-Brun et al., 2013 Liver - - 
Ikdea et al., 2013 Sk. Muscle + nd 
Mourier et al., 2013 Heart/liver + - 
Jha et al., 2016 Liver + - 
Williams et al., 2016 Liver/heart + - 
Cogliati et al., 2016 Heart/sk. Muscle + - 
Cogliati et al., 2016 Liver/kidney/brain - - 
+: present; -: absent; nd: not determined. 
 
6.2.2. Respiratory complex factor 1, RCF1 
Three independent groups identified the respiratory complex factor Rcf1 that belongs to the 
conserved hypoxia induced gene 1 (Hig1) protein family and that controls the formation and 
stabilization of yeast SC III2+IV1-2 (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 
2012). Rcf1 deletion yeast mutants (Rcf1Δ) resulted in defective CIV activity, decreased SC 
III2+IV1-2 levels and increased ROS production (Chen et al., 2012; Vukotic et al., 2012). Latest 
studies showed that Rcf1 interacts with CIV to regulate late stages of its assembly process 
(Garlich et al., 2017), suggesting that it functions in the assembly of individual CIV rather than 
playing a direct role in SC III2+IV1-2. Rcf1 eukaryotic homologs include two variants, HIGD1A and 
HIGD2A, that display the broadest expression pattern in mammals (Chen et al., 2012). 
Whereas HIGD1A was shown to bind CIV in early assembly stages (Römpler et al., 2016), and to 
upregulate CIV activity under hypoxic cellular stress (Hayashi et al., 2015), HIGD2A knockdown 
caused the depletion of SC III2+IV1 and of CIV-containing bands above the SC I+III2+IV1 without 
altering free CIV levels (Chen et al., 2012), suggestive of a true SC stabilizing role.  
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Mitochondrial respiratory chain complexes associate in larger structures named 
supercomplexes (SCs) and respirasomes. The functional relevance of these respirasomes and 
intermediate supercomplexes, such as SC I+III2 and SC III2+IV, is currently under intense debate 
and remain to be fully determined. These entities are thought to offer functional and 
structural advantages to the system, including the stabilization and prevention of degradation 
of the component enzymes. In this regard, MRC organization in SCs is biomedically relevant 
because disease-causing genetic defects affecting only one MRC complex often cause 
alterations in the assembly and stability of other complexes. Hence, structural 
interdependences exist among MRC complexes, yet to be fully understood. High-resolution 
cryo-electron microscopic structures of mammalian SCs became recently available, only to 
heighten the intrigue of trying to understand how are they assembled and how their dynamics 
is regulated. Therefore, a controversial question on the field of mitochondrial membrane 
biogenesis is how respirasomes biosynthesis is regulated and which players are involved in 
controlling this process. Regarding the role of SC assembly factors, recent relevant studies 
have highlighted opposing roles for the COX7A2L / COX7RP / SCAFI protein in the formation 
and function of the mitochondrial SCs and respirasomes. 
Based on previous studies of the pathways and chaperones that regulate the 
biosynthesis of macromolecular enzymatic oxidative phosphorylation complexes, the main 
purpose of this work has been to address how the biogenesis of human mitochondrial SCs is 
regulated and to clarify the role of the COX7A2L assembly factor in this process. In particular, 
the goals have been: 
 
1. To functionally characterize COX7A2L and to shed light on the regulatory role that 
this protein plays in the biosynthetic process of human mitochondrial SCs and 
respirasomes.  
 
2. To gain insight into the mechanisms that regulate the structural interdependences 
among respiratory chain complexes in human cell lines depleted of one MRC complex, 
by studying the alterations and specific accumulations of assembly intermediates, 
which will allow elaborating a more detailed map of the biosynthetic pathway of SCs. 
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1. Human cell lines 
1.1. TRANSMITOCHONDRIAL CYBRIDS 
To better understand how genetic defects in mtDNA-encoded OXPHOS subunits affect the 
regulation of the OXPHOS system in vivo, cytoplasmic hybrid (cybrid) cell lines have proved to 
be a valuable tool. Cybrids allow studying the pathogenic mechanisms associated to mtDNA 
mutations (King and Attardi, 1989), due to the expression of a specific mtDNA within cells with 
a fixed nuclear background. Cybrids are generated using a cell line that has been completely 
depleted of mtDNA by long-term exposure to ethidium bromide, termed rho zero (ρ0) (Hayashi 
et al., 1991; King and Attardi, 1989). These cells can be repopulated with enucleated cytoplasts 
or platelets containing either functional mitochondria or pathogenic mtDNA (Chomyn et al., 
1994; King and Attardi, 1989) and therefore, the studied cells differ only in their mtDNA 
genotype.  
The cybrid cell lines used in this study were generated through the fusion of ρ0 cells 
with enucleated fibroblasts isolated from patient’s blood that contained the mtDNA mutation 
of interest in the presence of polyethylene glycol, as described elsewhere (King and Attardi, 
1989). Specifically, four cybrids cell lines were used that presented MRC enzymatic defects due 
to homoplasmic mutations in the mtDNA: 
 
 A CI-deficient (CI-KD [knockdown]) cell line which harbours a homoplasmic m.4681T > 
C mutation in the MT-ND2 subunit gene that leads to a severe CI assembly defect due 
to a p.L71P substitution (Ugalde et al., 2007). 
 A CIII mutant (CIII-KO) cell line which contains a homoplasmic 4-bp deletion in the MT-
CYB gene affecting the de novo synthesis of cytochrome b (Rana et al., 2000).  
 A CIV mutant cell line (CIV-KO or COX1∆) that lacks holo-COX due to the homoplasmic 
m.6930G > A transition in the MT-COI gene, that creates a stop codon that results in a 
predicted loss of the last 170 amino acids of the COX1 polypeptide (Bruno et al., 1999).  
 A CIV mutant cell line (COX2∆) that lacks holo-COX due to the homoplasmic m.7896 
G>A nonsense mutation in the MT-COII gene, which presumably causes a loss of 123 
amino acids at the C-terminus of COX2 (Campos et al., 2001). 
 
Besides, the cell line from human osteosarcoma 143B-TK- was used as an experimental control, 
as well as the human embryonic kidney HEK293T cell line (CRL-3216), obtained from ATCC. 
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1.2. STABLE HEK293T-DERIVED CELL LINES 
 COX7A2L- knockout (KO) clone 1 and clone 2 (COX7A2L -KO1 and COX7A2L-KO2), 
created in HEK293T cells using TALEN vectors and described in section 1.2.1. 
 Reconstituted COX7A2L-KO clone 1 and clone 2 and control HEK293T cells, shown in 
Table 2 and described in section 1.2.2. 
 
1.2.1. TALEN constructs and generation of gene COX7A2L knockout cell lines 
 To analyse the specific function of COX7A2L, stable human knockout (KO) lines were created 
in control HEK293T cells using the TALEN (Transcriptor activator-like effector nucleases) 
strategy, a widely used technology for precise and efficient gene editing in live cells. TALEN is 
based on a class of proteins derived from transcription activator–like effector or TALE proteins 
(Romer et al., 2007; Schornack et al., 2006). TALEs are highly specific DNA-binding proteins 
that feature an array of 33 or 34-amino acid repeats. Each repeat is highly conserved, with the 
exception of the so-called repeat variable di-residues (RVDs) at amino acid positions 12 and 13 
(Figure 10A). The RVDs determine the DNA sequence to which the TALE will bind, meaning that 
the structure of the DNA-binding domain can be manipulated to produce a protein domain 
that binds specifically to any DNA sequence of interest in the genome (Boch et al., 2009; 
Moscou and Bogdanove, 2009). These TALEs can be fused to the catalytic domain from a DNA 
nuclease, FokI, to generate a transcription activator-like effector nuclease, TALEN, capable of 
precisely targeting DNA manipulation (Figure 10B). The resulting TALEN constructs combine 
high specificity and activity, effectively generating engineered sequence-specific nucleases that 
bind and cleave DNA sequences only at pre-selected sites.  
The activity of the TALEN system involves two steps. First, a double-strand break is 
introduced into eukaryotic DNA in the region of the spacer sequence separating the TALEN 
recognition sites. Second, the cell's ability to resolve the double-break via one of two well-
conserved repair pathways is harnessed to generate a modification of choice at that genomic 
location. In the absence of a homologous donor DNA, the break is repaired by non- 
homologous end joining that mediates deletions or insertions of several nucleotides in the 
target site and, as one of the results, knockout due to reading frame mutations and stop codon 
formation. This sequence-targeting technology is known to function in a variety of host 
systems, including bacteria, yeast, plants, insects, zebrafish, and mammals.  
The TALEN constructs used in this work were obtained from Thermo Fisher Scientific. 
The left and right TALENs were designed to bind the TGGGCGTCATGTACTACAA and the 
GCAGAAGTTGGCAGGAGCA DNA sequences, respectively, at the human COX7A2L locus. Both 
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vectors were transformed in NEB 5-alpha Competent E.coli High Efficiency Kit (Invitrogen) and 
amplified using PureLinkTM HiPure Plasmid Filter Midiprep Kit (Invitrogen), according to the 
manufacturer’s instructions. For TALENs transfection HEK293T cells were transfected three 
times, with three-day intervals, with 10 µl of LipofectamineTM (Thermo Fisher Scientific) mixed 
with 4 µg of vector DNA in OPTIMEM-I media (Gibco) according to the manufacturer’s 
instructions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Scheme for TALEN proteins. (A) Example of a TAL effector containing the sequence of a 
representative repeat region is shown; RVD residues (HD) that recognize cytosines are in red. Modified 
from (Mak et al., 2013). (B) TALENs work as pairs of monomers and their binding sites are chosen so that 
they are located on opposite DNA strands of the target DNA sequence and are separated by a spacer 
sequence (12–25 bp), distance sufficient for dimerization of the FokI catalytic domains. Dimerized FokI 
introduces a double-strand break into DNA. Two amino acid residues in the monomer are responsible 
for binding. The recognition code (single-letter annotation is used to designate amino acid residues) is 
shown (Nemudryi et al., 2014). 
 
After eight days single cells were isolated using Fluorescence Activated Cell Sorting 
(FACS) and the surviving colonies screened by immunoblotting against COX7A2L. To sequence 
the selected clones, COX7A2L-KO clones 1 and 2 were first amplified by polymerase chain 
reaction (PCR) from isolated HEK293T cDNA with the forward primer 5’-aagttaggcgatcttcgggc-
3’ and with the reverse primer 5’ gctcggacatgagaagtggc-3’. Secondly, the PCR-amplified DNA 
fragments were purified according to the Wizard® Genomic DNA Purification Kit (Promega) 
and cloned directly into a sequencing vector, following the TOPO® TA Cloning® Kit for 
Sequencing (Invitrogen) procedure. Finally, the cloning reaction product was transformed in 
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NEB 5-alpha competent E.coli (Invitrogen) cells, amplified with the PureLinkTM HiPure Plasmid 
Filter Midiprep Kit (Invitrogen), and validated by sequencing with the M13 Reverse primer.  
 
1.2.2. Plasmids and reconstitution of COX7A2L-KOs with the long and short-version of 
COX7A2L gene 
The wild-type (long) version of COX7A2L will be herein designated as COX7A2L, unless 
otherwise indicated. Due to the natural resistance of HEK293T cells to the antibiotic neomycin, 
COX7A2L was subcloned from the commercial vector pCMV6-COX7A2L-Myc-DDK-Neo 
(Origene, PS100001) with neomycin resistance, to the pCMV6-AEntry-Hygro plasmid (Origene, 
PS100024) , with hygromycin resistance, using the SfaAI and MssI sites. Briefly, 100 μl of the 
digestion reaction of both plasmids were separated in an agarose gel electrophoresis. The 
digested DNA-bands were purified using the Wizard® Genomic DNA Purification Kit (Promega) 
and subsequently ligated using the T4 DNA Ligase (NEB) according to manufacturer’s 
instructions. 1 μl of the ligation reaction was transformed in NEB 5-alpha competent E.coli cells 
(Invitrogen), amplified with the PureLinkTM HiPure Plasmid Filter Midiprep Kit (Invitrogen) and 
validated by sequencing with the VP1.5 primer 5’-ggactttccaaaatgtcg3’. 
The short version of mouse Cox7a2l comprises an in-frame 6 base pairs deletion that 
leads to the absence of 2 amino acids (V72 and P73) (Lapuente-Brun et al., 2013). To generate 
the short variant form of human COX7A2L (herein designated as COX7A2Lshort), the Q5® Site-
Directed Mutagenesis Kit from NEB was used. ~ 20 ng of template DNA extracted from 
HEK293T cells were used, along with the primers GTTTTTCCAGAAAGCTGATGGT (forward) and 
GCCTCGTTTCAGGTAGAC (reverse), designed to flank the region to be deleted. After 
exponential amplification and the treatment with kinase and ligase, 5 μl of the reaction were 
transformed in NEB 5-alpha competent E.coli cells (Invitrogen), using the pCMV6-A-Entry-
Hygro plasmid (Origene, PS100024), according to the manufacturer’s instructions. Further 
sequencing of the pCMV6-COX7A2Lshort-Hygro using the VP1.5 primer 5’-ggactttccaaaatgtcg3’ 
confirmed the correct cloning.  
Stable cell lines were established by transfection of WT HEK293T cells and COX7A2L-KO 
clones 1 and 2 in a six well plate with 10 l of Lipofectamine 2000 (Invitrogen), mixed with 
either the long-COX7A2L-Myc-DDK-Hygro or the short-COX7A2L-Myc-DDK-Hygro plasmids in 
OPTIMEM-I media (Gibco). Two days after transfection, the media was supplemented with 200 
μg/ml of hygromycin and drug selection was maintained for at least 1 month. After drug 
removal, the stable cell lines were screened by immunoblotting against COX7A2L.  
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Table 2. Stable cell lines created in the laboratory. 
Background Cell Line 
HEK293T COX7A2L-KO1  COX7A2L-KO2  
HEK293T + EV COX7A2L-KO1 + EV COX7A2L-KO2 + EV 
HEK293T + COX7A2L COX7A2L-KO1 + COX7A2L COX7A2L-KO2 + COX7A2L 
HEL293T + 
COX7A2Lshort 
COX7A2L-KO1 + 
COX7A2Lshort 
COX7A2L-KO2 + COX7A2Lshort 
Three different cells were used to transfect plasmids and to create the indicated stable cell lines. KO1: 
knockout clone 1; KO2: knockout clone 2; EV: empty vector; COX7A2L: pCMV6-COX7A2L-Hygro plasmid; 
COX7A2L
short
: pCMV6-COX7A2Lshort-Hygro plasmid. 
 
2. Mitochondrial samples provided by other research groups 
 Isolated mitochondrial extracts from HeLa cells, either transduced with the empty 
pWPXLd-ires-PuroR vector or stably overexpressing hemagglutinin (HA)-tagged 
LYRM7 / MZM1L (MZM1L-HA), generated as previously described (Sánchez et al., 
2013) were kindly provided by Dr. Erika Fernández-Vizarra.  
 Isolated heart mitochondria from the following mice models (Mourier, Matic, et al., 
2014) were kindly provided by Dr. Nils Göran Larsson: 
- Wild-type CD1 mice, which express high levels of the long COX7A2L protein 
isoform of 113 amino acids. 
- Wild-type C57BL/6J and C57BL/6N mice, which express low levels of a shorter and 
unstable COX7A2L protein isoform of 111 amino acids. 
- Mutant LrpprKO mice, CIV-conditional knockout mice with C57BL/6N genetic 
background, generated as previously described (Ruzzenente et al., 2012).  
 
3. Reagents, solutions and buffers 
Commonly used solutions and buffers used in this work were performed according to the 
descriptions detailed in (Sambrook and Russell, 2001). The compositions of the specific media 
and reagents used are detailed in each experimental procedure section or in the 
corresponding bibliography. 
4. Cell culture 
Cells were cultured at 37°C in DMEM (Dulbecco’s Modified Eagle Medium, Life Technologies) 
supplemented with 4.5 g/L glucose, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM 
sodium pyruvate, and 100 U/ml of penicillin/streptomycin antibiotics (Lonza). In the case of 
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the cybrids, 50 µg/ml of uridine (Lonza) were also added to the medium. Culture vessels were 
used to subculture the adherent mammalian cells. 
To cryopreserve the cultured cells, the adherent cells were washed in PBS, dettached 
with trypsin-EDTA (0.2 mg/ml trypsin, 0.22 mg/ml EDTA) (Lonza) and centrifuged for 5 minutes 
at 1500 rpm at 4°C. Subsequently, cells were resuspended in 1 ml of the freezing solution, 
containing 10% of the cryoprotective agent dimethyl sulfoxide (DMSO) in DMEM culture 
medium, transferred to cryovials (Thermo Fisher Scientific) into a CoolCell (at room 
temperature, with 2-propanol) and put into a -80°C freezer. After approximately 24 hours, the 
cryovials were transferred into liquid nitrogen for long term storage. Frozen cell lines were 
rapidly thawed by placing the cryovials in a 37⁰C water bath and subsequently transferred into 
a culture vessel. 
 
5. Reversible inhibition of mitochondrial translation (Doxycycline assay) 
Doxycycline is a specific reversible inhibitor of mitochondrial translation when used at low 
concentrations in the culture media, and it allows to synchronously resume the translation of 
coding mitochondrial proteins once removed from the medium (Van den Bogert et al., 1988). 
Doxycycline treatment has proven to be a successful strategy to follow the accumulation of 
newly synthesized MRC complexes and their further association in SCs (Moreno-Lastres et al., 
2012; Ugalde et al., 2004). In this work, 15 mg/ml doxycycline was added to the culture 
medium. Cells were grown in exponential conditions and harvested at different time points 
(Figure 11) after the drug removal. Samples were then processed according to the 
experimental assays and stored until use. 
 
Figure 11. Reversible inhibition of 
mitochondrial translation with 
doxycycline. Upon 6 days of 
doxycycline treatment (T0h), the 
drug was removed and cells were 
grown in fresh medium and 
harvested at different time points 
(hours) after doxycycline removal 
(T6h to T96h).  
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6. Functional characterization of the mitochondrial respiratory chain 
6.1. RESPIRATORY CHAIN ENZYME ACTIVITIES 
The respiratory chain enzyme activities from complexes I, II, III and IV were measured for 3 
minutes at 37°C using a DU-650 spectrophotometer (Beckman) with minor variations relative 
to established methods (Medja et al., 2009). Values were expressed relative to the citrate 
synthase (CS) activity. Schematic examples of the enzyme activity measurements of the MRC 
complexes are shown in Figure 12.  
 
6.1.1. Sample Preparation 
Whole cell extracts were prepared from 15 x106 cells resuspended in 400-700 µl of Mannitol 
buffer (225 nM mannitol, 75 mM sucrose, 10mM Tris-HCl, 01 M EDTA at pH 7.2). Cells were 
lysed by sonication and protein concentration was measured using the MicroBCA Protein 
Assay kit (Pierce). All samples were set to a final concentration of 3 µg/ml prior to enzyme 
activity measurements.  
 
6.1.2. Enzyme activities of CI-CIV and citrate synthase 
In brief, CI enzyme activity was measured by following the decrease of NADH absorbance at 
340 nm that results from NADH oxidation. 20 µg of the cellular homogenates were dissolved in 
the reaction medium containing 500 mM of phosphate buffer at pH 7.5, 50 mg/ml of BSA, and 
25 mM of decilubiquinone as the electrons acceptor.  
CII activity was measured by following the increase of absorbance at 600 nm resulting 
from the reduction of 2,6-dichlorophenol-indophenol (DCPIP). 20 µg of the cellular 
homogenates were added to the reaction medium containing 500 mM of phosphate buffer at 
pH 7.5, 5 mM of DCPIP, 10 mM of potassium cyanide (KCN), 0.2 % BSA-EDTA and 200 mM of 
succinate as the electrons donor.  
CIII activity was measured by following by the increase in cytochrome c absorbance at 
550 nm which results from cytochrome c reduction. 20 µg of the cellular homogenates were 
added to the reaction medium containing 500 mM of phosphate buffer at pH 7.5, 1 mM of 
cytochrome c, 10 mM of KCN, 50 mM of EDTA, 5.5 % of Tween-20 and 10 mM of 
decylubiquinol as the electrons donor.  
CIV activity was measured by following the decrease in absorbance at 550 nm resulting 
from the oxidation of reduced cytochrome c, which acts as the electrons donor. 40 µg of the 
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cell homogenates were added to the reaction medium containing 100 µM of cyrochrome c 
(Reduced 90-95%) in 50 mM phosphate buffer at pH 7.0.  
 The citrate synthase (CS) activity, an enzyme of the tricarboxylic acids cycle, was used 
to normalize the respiratory chain enzyme activities. CS activity was measured by following the 
increase in absorbance at 412 nm that results from the reduction of DTNB (5,5′-dithiobis 2-
nitrobenzoic acid), for 3 minutes at 37°C. 40 µg of cellular homogenates were added to the 
reaction medium containing 1 mM of Tris-HCl at pH 8.1, 10% of Triton X-100, 5 mM DTNB in 
95% ethanol, 10 mM of acetyl coenzyme A and 10 mM of oxaloacetate as the electrons donor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. Graphical scheme of the respiratory chain enzyme activities. Up and left: CI enzyme activity; 
Up and right: CII enzyme activity; Middle and left: CIII enzyme activity; Middle and right: CIV enzyme 
activity; Down: CS activity. 
 
6.2. CELL RESPIRATION MEASURED BY SEAHORSE ANALYZER 
Oxygen consumption rates were measured in 143B cells and transmitochondrial cybrids using 
an XF24 Extracellular Flux Analyzer (Seahorse Bioscience). The day before the experiment, 
around 9.0 ×104 143B cells per well were plated in order to obtain a total amount of 150-200 
µg protein per well on the day of the experiment. The cells were previously incubated with 
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either scrambled or specific COX7A2L siRNAs for 24 hours. As controls for the oxygen 
consumption measurements in siRNA-treated cells, around 5.0 ×103 143B cells and 1.0 ×104 CI-
KD cells (CI defective mutant cybrids) per well were plated two days before the experiment, 
from which 150-200 µg protein per well were obtained on the day of the experiment. The cells 
were then incubated for 1 hour in unbuffered DMEM supplemented with 1 g/l glucose, 1 mM 
sodium pyruvate and 2 mM glutamine at 37⁰C in a CO2-free incubator. Respiration was 
calculated after the addition of mitochondrial inhibitors rotenone and antimycin at 1 µM final 
concentration. In all experiments, the protein concentration in each well was determined using 
the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific) after cell lysis in extraction buffer, 
and was used to calibrate the oxygen consumption data. 
 
6.3. CELL RESPIRATION MEASURED BY POLAROGRAPHY 
Endogenous cell respiration was measured polarographically at 37°C using a Clark-type 
electrode from Hansatech Instruments (Norfolk, UK). Substrate-driven respiration was assayed 
in digitonin-permeabilized cultured cells as reported (Barrientos et al., 2009). Briefly, 
trypsinized cells were washed with permeabilized-cell respiration buffer (PRB) containing 0.3 
M mannitol, 10 mM KCl, 5 mM MgCl2, 0.5 mM EDTA, 0.5 mM EGTA, 1 mg/ml BSA and 10 mM 
KH3PO4 (pH 7.4). Cells were resuspended at ~4 × 10
6 cells/ml in 1.5 ml of the same buffer air 
equilibrated at 37 °C and supplemented with 10 units of hexokinase and 2 mM ADP. 1 ml of 
cell suspension was immediately placed into the polarography chamber to measure 
endogenous respiration. Subsequently, digitonin was added at the optimal concentration (60 
μg/106 HEK293T cells). The respiration measurements in permeabilized cells were then started 
by addition to the chamber of site I substrates (5 mM glutamate and 5 mM malate) to monitor 
their oxidation, followed by addition of site II substrates (5 mM succinate) to explore substrate 
competition. The order of the substrate addition did not influence the respiratory rates 
measured. In each case, the respiration was uncoupled by adding 18 μM FCCCP and 
subsequently inhibited with 240 μM KCN. 
 
7. Indirect immunofluorescence 
Cells were fixed with 4% paraformaldehyde for 15 minutes, permeabilized for 15 minutes with 
0.1% Triton X-100, and incubated for 1 hour in blocking buffer containing 10% goat serum. 
Coverslips were incubated with an antibody against monoclonal complex V α subunit and a 
Texas Red-conjugated anti-mouse secondary antibody (Abcam). Coverslips were rinsed and 
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mounted in ProLong Gold antifade reagent (Molecular Probes) on glass slides, and cells were 
viewed with a Zeiss LSM 510 Meta confocal microscope and a 63x Plan-Apochromat oil 
inmersion objective (NA, 1.42). Sequential scanning of green and red channels was performed 
to avoid bleed-through effect. Cells were imaged randomly with 0.5- to 1.0-μm slices and 
1,024- x 1,024-pixels resolution. For colocalization analysis, the ‘‘Merge channels’’ plugin from 
the ImageJ 1.48v software was used. 
 
8. COX7A2L transient overexpression 
Vectors pCMV6-Entry (C-terminal Myc-DDK-tagged), pCMV6-COX7A2L-Myc-DDK, pCMV6-AC-
GFP and pCMV6-AC-COX7A2L-GFP were purchased from Origene (catalogue numbers 
PS100001, RC202697, PS100010 and RG202697, respectively), transformed in One Shot TOP10 
chemically competent E.coli cells (Invitrogen) and amplified using PureLinkTM HiPure Plasmid 
Filter Midiprep Kit (Invitrogen), according to the manufacturer’s instructions. For DNA 
transfection, 143B cells cultured in serum-free medium were transfected for 48 hours with 10 
µg of plasmid DNA using 40 µl of FuGENE® HD Transfection Reagent (Promega), and 
alternatively, HEK293T cells were transfected with LipofectaminTM (Thermo Fisher Scientific) 
according to the manufacturer’s instructions. Cells were harvested and processed according to 
each experimental assay requirements. 
 
9. COX7A2L siRNAs Transfection 
For siRNAs transfection, 143B cells and COX1∆ mutant cybrids were plated in 10 ml of DMEM 
supplemented with 10% FBS in 10-cm dishes with a cell density of 7.8x105 cells per plate. The 
next day, cells were transfected with two mixed COX7A2L siRNAs (references 
SASI_Hs01_00081409 and SASI_Hs02_00338185, Sigma Aldrich) in the presence of 52 µl X-
treme GENE siRNA Transfection Reagent (Roche) to achieve a final concentration of 0.15 µM 
siRNA in a total volume of 10 ml per plate. The negative control used was MISSION® siRNA 
Universal Negative Control (Sigma Aldrich). Cells were incubated at 37 ºC in a CO2 incubator for 
48 hours prior to experimental analyses. 
 
10. NDUFB8 siRNAs Transfection 
For siRNAs transfection, wild-type HEK293T cells and COX7A2L-KO clones 1 and 2 were plated 
in 10 ml of DMEM supplemented with 10% FBS in 10-cm dishes with a cell density of 7.8x105 
cells per plate. The next day, cells were transfected with 4μg of two mixed NDUFB8 siRNAs 
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(references SASI_Hs01_00049514 and SASI_Hs02_00338754, Sigma Aldrich) that targeted 
NDUFB8 mRNA (reference sequence NM_005004) in the presence of 52 μl X-treme GENE 
siRNA Transfection Reagent (Roche) to achieve a final concentration of 0.15 μM siRNA in a 
total volume of 10 ml per plate. Cells were incubated at 37 ºC in a CO2 incubator for 48 hours 
prior to experimental analyses. 
 
11. Mitochondrial protein synthesis 
Mitochondrial protein synthesis was determined by pulse-labelling in 80% confluent cells, as 
described by (Leary and Sasarman, 2009) with some adaptations. Cybrids were grown in a six- 
well plates pre-coated for 1 hour at room temperature with 0.1 mg/ml collagen in PBS to 
increase cell adherence. Cells were washed twice in PBS and incubated 20 minutes in DMEM 
devoid of methionine. Then, the media was supplemented with 100 µg/mL emetine for 10 
minutes to inhibit cytoplasmic protein synthesis, followed by the addition of 10 µLCi of [35S]-
methionine and incubation for 2 hours pulse time. For pulse samples, after incubation cells 
were washed one time with PBS and collected. For chase samples, cells were washed twice 
with PBS and incubated in complete media for the indicated chase time. Cells were then 
harvested by trypsinization and mitochondria- enriched fractions were prepared for 2D-
BN/SDS-PAGE as previously described (section 16.2). After electrophoresis, the gel was 
transferred to a nitrocellulose membrane and exposed to a film.  
 
12. Purification of Whole Cell and Mitochondrial protein extracts 
12.1. WHOLE CELL EXTRACTS 
Cells were cultured until an approximately 70% confluent in a 175 cm2 vessel, harvested with 
trypsin, washed twice with phosphate-buffered saline (PBS), and resuspended in 1 ml of cold 
phosphate-buffered saline (PBS). After 5 minutes centrifugation at 1500 rpm at 4°C, whole cell 
extracts were solubilised in HEPES buffer (20 mM HEPES NaOH pH 7.4; 150 mM NaCl; 10% 
glycerol, 1% Triton X-100) with 1x mammalian protease inhibitor cocktail (Roche). After 30 
minutes on ice, extracts were cleared by 10 minutes centrifugation at 13000 rpm at 4°C. The 
protein concentration in the supernatant was determined using the MicroBCA Protein Assay 
Kit (Pierce) according to the manufacturer's instructions. After quantification, the supernatant 
was mixed with an equal volume of Laemmli 2X commercial solution (BioRad) containing 5% β-
mercaptoethanol (Sigma). The samples were then boiled at 95°C for 10 minutes and stored at -
20°C until use. 
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12.2. MITOCHONDRIA-ENRICHED FRACTIONS 
Mitochondria-enriched fractions were isolated from cell cultures, as previously described with 
minor modifications (Nijtmans, 2002). Briefly, cells were cultured until an approximately 70% 
confluent, harvested with trypsin, washed twice with PBS, and resuspended in 100 µl PBS plus 
100 µl of digitonin solubilized in PBS (4mg/ml). The cell solution was kept on ice for 10 minutes 
to dissolve the membranes. 1 ml of cold PBS was added to the cells, which were spun for 10 
min at 10000 rpm at 4⁰C. The supernatant was removed, the pellet washed once more in 1ml 
cold PBS, and the protein concentration was determined using the MicroBCA protein assay kit 
(Pierce). After quantification, the supernatant was mixed with an equal volume of Laemmli 2X 
commercial solution (BioRad) containing 5% β-mercaptoethanol (Sigma). The samples were 
then boiled at 95⁰C for 10 minutes and stored at -20°C until use. 
 
12.3. MITOCHONDRIAL ISOLATION 
Mitochondria from human cells were isolated from at least ten 80–100% confluent 175 cm2 
flasks as described previously (Enríquez and Attardi, 1996). Briefly, the cells were resuspended 
in ice-cold T-K-Mg buffer (10 mM Tris–HCl, 10 mM KCl, 0.15 mM MgCl2, pH 7.0) and disrupted 
with 10 strokes in a homogenizer (Kimble/ Kontes, Vineland, NJ, USA). Using a 1 M sucrose 
solution, the homogenate was brought to a final concentration of 0.25 M sucrose and a 
postnuclear supernatant was obtained by centrifugation of the samples twice for 3 minutes at 
1500 g. Mitochondria were pelleted by centrifugation for 10 minutes at 8000 g and 
resuspended in 0.6 M Sorbitol 10 mM Hepes pH 7.4. Samples were stored at -80°C until use. 
 
13. Immunoprecipitation 
Co-immunoprecipitation (CO-IP) is a technique used to analyze protein-protein interactions. 
The goal is to know which proteins interact with the protein of interest. 1 mg of mitochondrial 
protein from HEK293T-transduced cells was solubilized in 600 ml of 4 g/g digitonin-to-protein 
buffer, as for BN electrophoresis (BNE) analyses. After centrifugation for 30 minutes at 13000 
rpm at 4⁰C, 50 mg supernatant was separated as the input fraction. The remaining supernatant 
was co-immunoprecipitated in resin spin columns (Pierce CoIP Kit, Thermo Fisher Scientific), in 
which 15 mg antibodies against DDK-tag (Oncogene), CORE2, or COX1 (Abcam) had been 
previously immobilized. The mixture was gently incubated overnight at 4⁰C in a rotating shaker 
and centrifuged at 1000 g for 1 minute to separate the flow through fraction. The column was 
washed three times with lysis buffer containing 1% NP-40, and proteins were eluted. The 
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immunoprecipitate was divided in three aliquots, treated with 53 µl of loading sample buffer, 
and heated at 95⁰C for 5 minutes prior to loading. 
 
14. SDS-PAGE Electrophoresis 
For denaturing electrophoresis, 20–60 μg of whole cell or mitochondrial protein extracts were 
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) in the 
Laemmli buffer system (Laemmli, 1970) using 0.2 M Tris-HCl buffer (pH 8.9) as anode buffer 
and 0.1 M Bis-Tris buffer, 0.1 M Tricine (pH 8.2) and 0.1% SDS as cathode buffer. 
 
15. Western-blot 
After electrophoresis, proteins were transferred to a PROTAN nitrocellulose membrane (GE 
Healthcare) at 30 V and at room temperature overnight, or at 90 V for 90 minutes at 4°C. The 
membranes were then incubated in blocking solution (0.1% Tween-20 and 5% skimmed 
powder milk in PBS) either for 14-16 hours at 4°C, or for 2 hours at room temperature. After 
blocking, the membranes were hybridized with specific primary antibodies (section 16, Table 
3). They were then washed three times with 0.1% Tween-20 in PBS and incubated with the 
corresponding secondary antibody at a 1: 2000 dilution (section 16, Table 4). Both primary and 
secondary antibodies were prepared in 0.1% Tween-20 solution and 2.5% skimmed powder 
milk in PBS. After incubation with the secondary antibody, each membrane was washed three 
times with 0.1% Tween-20 in PBS, and then revealed using the ECL plus Western Blotting 
Detection System (GE Healthcare) in a ChemiDoc™ MP imaging apparatus (BioRad), following 
the manufacturer’s instructions. Quantification of the chemiluminiscent signals was performed 
using the image analysis program ImageJv.1.45g (Wayne Rasband, NIH). 
 
16. Blue Native Electrophoresis and In-Gel Activity (IGA) assays 
Blue native polyacrylamide gel electrophoresis (BN-PAGE) is a method for the isolation of 
native protein complexes. In the first dimension, separation of the complexes under non-
denaturing conditions occurs according to their molecular mass, and in the second dimension, 
where electrophoresis is performed under denaturing conditions, the individual subunits of 
the complexes are resolved and individually separated again on the basis of their molecular 
mass (Figure 13A). 
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16.1. SAMPLES PREPARATION FOR BN-PAGE 
To extract mitochondrial proteins in native conditions, mitochondria extracts (previously 
explained in sections 11.1 and 11.2), were pelleted and solubilized in 200 μl buffer containing 
1.5 M aminocaproic acid and 50 mM Bis-Tris (pH 7.0). To optimize solubilization conditions, 
protein-to-digitonin concentrations between 1-40 g/g were used; upon optimization, a 
protein-to-digitonin concentration of 4 g/g was used unless otherwise indicated. In some 
experiments, lauryl maltoside (LM) was used instead at 1%. Solubilized samples were 
incubated on ice for 15 minutes and centrifuged for 30 minutes at 13000 rpm at 4°C, and the 
supernatant was combined with 20 μl of sample buffer (750 mM aminocaproic acid, 50 mM 
Bis-Tris, 0.5 mM EDTA, 5% Serva Blue G-250) prior to loading.  
 
16.2. BIDIMENSIONAL BLUE NATIVE ELECTROPHORESIS (2D-BN/SDS-PAGE) 
For the first dimension electrophoresis (1D-BN-PAGE), precast NativePAGE™ 3-12% Bis-Tris 
Protein Gels (Thermo Fisher Scientific) were loaded with 60-80 μg of mitochondrial protein 
extracts as previously described (Nijtmans, 2002), using 50 mM Bis-Tris as the anode buffer 
and 15 mM Bis-Tris, 50 mM tricine, 0.02% Serva Blue G-250 as the cathode buffer. After 
electrophoresis, proteins were transferred to a PROTAN nitrocellulose membrane (Schleicher 
& Schuell) at 30 V overnight and probed with specific antibodies. Duplicate gels were further 
used to perform either IGA assays (described in section 16.3) or second-dimension 
electrophoresis. 
 The second dimension electrophoresis (2D-BN/SDS-PAGE) was performed following 
previously described methods (Nijtmans, 2002). Briefly, a 1D-BN-PAGE lane was cut out with a 
razorblade and placed on a small glass plate. The lane was incubated with a dissociating 
solution (01% SDS and 1% β -mercaptoethanol) for one hour at room temperature. Excess 
dissociating solution was drained away using a filter paper. The gel strip was placed at the top 
of the glass plate (Figure 13B) and the gel sandwich was further assembled. A 10% SDS-PAGE 
resolving gel was first cast, followed by casting of a 4% stacking gel around the gel strip. After 
polymerization, electrophoresis started using 0.2 M Tris-HCl buffer (pH 8.9) as the anode 
buffer and 0.1 M Bis-Tris buffer, 0.1 M Tricine (pH 8.2) and 0.1% SDS as the cathode buffer. 
Then proteins were transferred to nitrocellulose membranes, as described in section 14, and 
probed with specific antibodies. 
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16.3. IN-GEL ACTIVITY (IGA) ASSAYS 
In this work, two different IGA assays were used: 
 For the complex I-IGA assay, gels were incubated for 2 hours at room temperature 
with the following solutions: 2 mM Tris-HCl, pH 7.4, 0.1 mg/ml NADH, and 2.5 mg/ml NTB 
(nitrotetrazolium blue). Gels were washed in distilled water, scanned and photographed 
immediately. 
 For the complex IV-IGA assay, gels were incubated for 48 hours at 37°C with the 
following solutions: 5 mg 3.3’-diamidobenzidine tetrahydrochloride (DAB) dissolved in 9 ml 
phosphate buffer (0.05 M, pH 7.4), 1 nM catalase (20 g /mL), 10 mg cytochrome c, and 750 mg 
sucrose). Gels were washed in distilled water, scanned and photographed immediately. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Blue native gel electrophoresis. (A) Example of a visualised separation of supramolecular 
assemblies of OXPHOS complexes by 1D-BN-PAGE using different concentrations of digitonin, and 
subsequent identification of their constituent individual complexes by 2D-BN/SDS-PAGE (Wittig, Braun, 
et al., 2006). I, II, III and IV refer to MRC complexes I–IV. 0, 1 and 2 indicate respiratory chain SCs 
containing monomeric CI, dimeric CIII, and zero (0), one (1) or two (2) copies of CIV, respectively. (B) 
Schematic representation of a second dimension gel casting followed by electrophoresis. The first 
dimension gel strip is turned 90° on top of the sandwich (1) and after polymerization of the resolving 
gel, the stacking gel is poured around the gel strip (2). (C) After electrophoresis, possible subassemblies 
are observed by coomasie staining or immunoblotting. The arrows indicate the direction of the first and 
second dimension. The individual subunits of the hypothetical red complex are resolved on the basis of 
their molecular mass. CI-CV: MRC complexes I to V. Modified from (Calvaruso et al., 2008). 
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17. Antibodies 
The main technical features of the primary and secondary antibodies used in this work are 
detailed in Tables 3 and 4, respectively.  
 
Table 3. Primary antibodies used in this work. 
ANTIBODY MOLECULAR WEIGHT ORIGIN MANUFACTURER 
USE AND 
DILUTION 
CI- NDUFA9 39 kDa Mouse Abcam WB 1:1000 
CI- NDUFB3 12 kDa Mouse Santa Cruz WB 1:500 
CI- NDUFB6 18 kDa Mouse Abcam WB 1:1000 
CI- NDUFB8 20 kDa Mouse Abcam WB 1:1000 
CI- NDUFS1 75 kDa Rabbit Gentex WB 1:1000 
CI- NDUFS2 49 kDa Mouse Abcam WB 1:1000 
CI- NDUFV2 24 kDa Rabbit Sigma WB 1:1000 
CII- SDHA 70 kDa Mouse Abcam WB 1:10000 
CII- SDHAB 30 kDa Rabbit Abcam WB 1:1000 
CIII-CORE2 48 kDa Mouse Abcam IP/WB 1:2000 
CIII- CYC1 35 kDa Rabbit Abcam WB 1:1000 
CIII- RISP 25 kDa Mouse Santa Cruz WB 1:600 
CIII- UQCRB 14 kDa Rabbit Proteintech WB 1:500 
CIII- UQCRQ 10 kDa Rabbit Sigma WB 1:500 
CIV- COX1 37 kDa Mouse Abcam IP/WB 1:1000 
CIV- COX2 24 kDa Mouse Abcam WB 1:1000 
CIV- COX4 16 kDa Mouse Abcam WB 1:2000 
CIV- COX5A 14 kDa Mouse Abcam WB 1:1000 
CIV- COX5B 14 kDa Mouse Santa Cruz WB 1:1000 
CIV- COX6C 9 kDa Mouse Abcam WB 1:1000 
CV- ATP synthase 
subunit alpha 
50 kDa Mouse Abcam IF 1:1000 
COX7A2L 12 kDa Mouse Proteintech WB 1:500 
EXPERIMENTAL PROCEDURES 
51 
 
COX7A2L 12 kDa Rabbit Proteintech WB 1:500 
VDAC 39 kDa Mouse Abcam WB 1:5000 
-actin 43 kDa Mouse Sigma WB 1:5000 
HA Tag Mouse Roche WB 1:1000 
Myc Tag Mouse Origene IP/WB 1:1000 
Turbo GFP Tag Mouse Origene IF/WB 1:1000 
The table indicates the proteins that are targeted by the antibodies, their apparent molecular weights 
on SDS-PAGE, the animal origin of the antibodies, the manufacturer company from which the antibodies 
were purchased, their experimental utility and the dilutions used. CI-CV: Mitochondrial OXPHOS 
complexes I to V; WB: Western blot; IF: Immunofluorescence; IP: Immunoprecipitation. 
 
Table 4. Secondary antibodies used in this work. 
ANTIBODY ORIGIN ATTACHED TO MANUFACTURER 
USE AND 
DILUTION 
Mouse Anti-IgG Goat Peroxidase ThermoFisher WB 1:2000 
Rabbit Anti-IgG Goat Peroxidase ThermoFisher WB 1:2000 
TXRD mouse anti-IgG2b 
 
Goat Texas Red Molecular probes IF 1:1000 
The table indicates the secondary antibodies used, the animal origin of the antibodies, the fluorophore 
or enzyme to which antibodies are coupled, the manufacturer company from which the antibodies were 
purchased, as well as their experimental utility and the dilutions used. WB: Western blot; IF: 
Immunofluorescence. 
 
18. Protein identification by liquid chromatography coupled to tandem mass 
spectrometry 
Gel bands of interest were excised from blue native gels. All samples were reduced by adding 
10 mM DTT for 30 minutes at 37⁰C and alkylated with 55 mM iodacetamide during 20 minutes 
in the dark. Next, digestion was performed by adding recombinant sequencing grade Trypsin 
(Roche) 1:20 (w/w) overnight at 37⁰C. The produced peptides were cleaned up with Omix tips 
(Agilent technologies), eluted with 80% ACN in 0.1% TFA, dried in a Speed-vac and 
resuspended in 0.1% formic acid.  
To identify proteins, the resulting tryptic peptide mixtures were analyzed by nano-
liquid chromatography coupled to mass spectrometry. Peptides were loaded onto a C18-A1 
ASY-Column 2 cm precolumn (Thermo Fisher Scientific) and then eluted onto a Biosphere C18 
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analytic column (C18, inner diameter 75 μm, 15 μm long, 3 μm particle size) (NanoSeparations) 
and separated using a 150 min gradient from 0-45% Buffer B (Buffer A: 0.1% formic acid/2% 
ACN; Buffer B: 0.1% formic acid in ACN) at a flow-rate of 250 nL/min on a nanoEasy HPLC 
(Proxeon) coupled to a nanoelectrospay ion source (Proxeon). Mass spectra were acquired on 
the LTQ-Orbitrap Velos (Thermo Scientific) in the positive ion mode. Full-scan MS spectra (m/z 
400-1800) were acquired in the Orbitrap at a resolution of 60,000 at m/z 400 and the 15 most 
intense ions were selected for collision induced dissociation (CID) fragmentation in the LTQ 
with a normalized collision energy of 35%. Precursor ion charge state screening and 
monoisotopic precursor selection were enabled. Singly charged ions and unassigned charge 
states were rejected. Dynamic exclusion was enabled with a repeat count of 1 and exclusion 
duration of 45 seconds.  
Peptide identification from raw data (MS/MS spectra) was carried out using a licensed 
version of search engine MASCOT 2.3.0 through Proteome Discoverer Software 1.2.0.208 
(Thermo Fisher Scientific). Database search was performed against a Uniprot- SwissProt with 
taxonomy restriction to Human (date 2012/12/11; 20233 sequences). The following 
parameters were used for the searches: tryptic cleavage after Arg and Lys, up to two missed 
cleavage sites allowed, tolerances of 10 ppm for precursor ions and 0.8 Da for MS/MS 
fragment ions. Oxidation of Methionine was selected as dynamic modification and 
carbamidomethylation of Cysteine as fixed modification. Search against decoy database 
(integrated decoy approach in MASCOT) was used for FDR calculation and this filter was 
applied to MASCOT results. The acceptance criteria for proteins identification were FDR < 1% 
and at least one peptide identified with high confidence (CI>95%).  
 
19. Statistical data analysis 
Unless indicated, all experiments were performed at least in triplicate and results were 
presented as mean ± standard deviation (SD) relative to either absolute values or percentages 
of the control. Statistical p values were obtained by application of the Mann-Whitney U test 
using the SPSS v21.0 program. p < 0.05 was considered to be significant. 
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CHAPTER 1. COX7A2L IS A MITOCHONDRIAL COMPLEX III BINDING PROTEIN 
THAT STABILIZES THE III2+IV SUPERCOMPLEX WITHOUT AFFECTING 
RESPIRASOME FORMATION 
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1. Human COX7A2L co-localizes with respiratory chain complex III and IV and CIII-
containing SCs 
In humans, only one COX7A2L protein of 114 amino acids has been reported in the NCBI Gene 
database ([Gene ID: 9167] http://www.ncbi.nlm.nih.gov/gene/9167). The analysis of the 
distribution pattern of COX7A2L in relation to free MRC complexes and SCs was performed by 
BN-PAGE, followed by western blot, in digitonin-solubilized mitochondria from control 143B 
cells and in mutant cybrids lacking CI (CI-KD), CIII (CIII-KO) and CIV (CIV-KO) (Figure 14A and 
14B). In controls, COX7A2L co-localized not only with SC III2+IV and the respirasomes (SC 
I+III2+IVn), as previously described in murine models (Lapuente-Brun et al., 2013; Williams et 
al., 2016), but also with SC I+III2, the CIII dimer (CIII2) and monomeric CIV. The CI-KD cybrids 
showed a strong reduction in the levels of SC I+III2+IVn, SC III2+IV and curiously, of monomeric 
CIV. Consistently, the amounts of COX7A2L within those structures were also reduced in the 
CI-defective cells compared with the controls. Lack of CIII (CIII-KO) caused the complete 
disruption of SC I+III2+IVn and SC III2+IV, accompanied by increased levels of monomeric CIV 
and CIV oligomers. Only a minor residual COX7A2L signal co-migrating with free CIV was seen 
at the longest exposures (Figure 14C), suggesting that the lack of CIII profoundly affects the 
stability of COX7A2L and its binding to CIV. The CIV-KO cybrids showed the disappearance of 
monomeric CIV, SC III2+IV, and SC I+III2+IVn, accompanied by an accumulation of SC I+III2 and 
CIII2. Interestingly, COX7A2L retained the ability to bind SC I+III2 and CIII2 in the absence of CIV, 
whereas very small amounts of COX7A2L were bound to CIV in the absence of CIII. In addition, 
a dramatic reduction in COX7A2L levels, comparable to that of the CIII structural subunits, was 
observed in the CIII-KO mutant cybrids (Figure 15). On the contrary, a slight reduction in 
COX7A2L levels was observed in the CIV-KO mutant, whereas no differences were observed in 
the CI-KD mutant, compared with the control 143B cells (Figure 15). 
The presence of COX7A2L in CIII2, SC I+III2, and I+III2+IVn was further confirmed by high-
resolution nano-LC/ESI-MS (nano-liquid chromatography/electrospray ionization-mass 
spectrometry) proteomics analysis. The excised blue native gel bands corresponding to SC 
I+III2+IVn in 143B cells and to SC I+III2 and CIII2 in the CIV-KO cybrids (Figure 16A) revealed the 
presence of the unique peptide corresponding to the COX7A2L protein (Figure 16B). This result 
confirmed the BNE-PAGE analyses.  
Altogether, these results suggest that, in human cells, COX7A2L preferentially 
associates with CIII2 and CIII-containing structures, and only to a minor extent with free CIV, 
suggesting that COX7A2L principally behaves as a CIII interactor rather than an assembly factor 
exclusive to CIV-containing SCs (Lapuente-Brun et al., 2013).  
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Figure 14. COX7A2L comigrates with respiratory chain supercomplexes and free complexes III and IV. 
Mitochondria from control 143B cells and mutant cybrids were extracted with a digitonin:protein ratio 
of 4 g:1 g and analyzed by BN-PAGE, followed either (A) by CI in gel activity (IGA) assay and western-blot 
or alternatively, (B) by 2D-BN/SDS-PAGE and immunoblotting with antibodies raised against human 
COX7A2L and the indicated OXPHOS subunits. (C) 2D-BN/SDS-PAGE analysis of COX7A2L distribution in 
control and mutant cybrids at long exposure times. I+III2+IVn, SC containing CI, CIII and CIV; I+III2, SC 
containing CI and CIII; III2+IV, SC containing CIII and CIV; I*, CI-containing structure; III2, complex III 
dimer; IV, complex IV; IV2, complex IV dimer; II, complex II. CIV-KO (COX1Δ cybrid). 
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Figure 15. Comparison of the steady-state levels of MRC subunits and COX7A2L. Mitochondrial lysates 
from control 143B cells and mutant cybrids were analyzed by SDS-PAGE and western blot with the 
indicated antibodies that target COX7A2L and subunits from MRC complexes I, II, III and IV. 
 
 
 
Figure 16. Proteomics for the identification of COX7A2L within MRC structures. (A) BN-PAGE and CI-
IGA analysis of control 143B cells and CIV-KO mutant cybrids. After coomassie staining, the SC I+III2+IV1 
band was excised from the control lane, and the bands corresponding to SC I+III2 and CIII2 were excised 
from the CIV-KO lane and subsequently analyzed by LC coupled to tandem MS (MS/MS). (B) MS/MS 
spectra from the doubly charged COX7A2L tryptic peptide unambiguously detected by LC-ESI/MS in two 
independent experiments per sample. The amino acids sequence of the identified COX7A2L unique 
peptide is highlighted in red. The most intense signals on the MS/MS spectra correspond to the main 
fragmentation series (b-amino and y-carboxy). Doubly charged fragments are marked with superscript 
2+. I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and 
CIV; III2, CIII dimer; MW, molecular weight. 
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2. Overexpressed COX7A2L is imported into Mitochondria and incorporated into 
MRC complexes and SCs, without significantly enhanced SC formation 
To confirm the mitochondrial localization of human COX7A2L, control 143B cells were 
transfected with a construct expressing COX7A2L with a C-terminal GFP-tag, yielding a product 
of ~39.3 kDa (Figure 17A). COX7A2L-GFP was effectively overexpressed by ~15-fold relative to 
the endogenous COX7A2L. Subsequent confocal microscopy showed co-localization of 
COX7A2L-GFP with the ATP synthase (complex V), thus confirming the mitochondrial 
localization of the fusion protein (Figure 17B).  
 
 
Figure 17. Tagged-COX7A2L is efficiently overexpressed in 143B cells and imported into the 
mitochondria. (A) Western blot analysis of the over expressed COX7A2L-GFP or GFP-empty constructs in 
143B cells. (B) Confocal microscopy of 143B cells transiently transfected with the COX7A2L-GFP 
construct and with the empty-GFP vector used as a control. Upper images show the fluorescent GFP 
signal. Middle images show the mitochondrial network using an antibody against the ATP synthase 
alpha subunit. Lower images show the merge between the two signals.  
 
Next, to examine the mitochondrial distribution of exogenous COX7A2L and the effect 
of COX7A2L overexpression on the assembly of the OXPHOS system, transfected exogenous 
COX7A2L followed by BNE-PAGE analysis was performed in the control 143B cells. To this end, 
143B cells were transfected with the MYC-DDK-tagged COX7A2L construct, yielding a product 
of ~16.2 kDa (Figure 18A). COX7A2L-MYC-DDK was overexpressed by ~2-fold. BN-PAGE 
analyses confirmed the co-migration of exogenous COX7A2L with CIII2, monomeric CIV, SC 
III2+IV, and the respirasomes in digitonin-solubilized mitochondria (Figures 18B and 18C). In 
order to compare the different structures in which exogenous COX7A2L was incorporated, 
antibodies against CI subunit NDUFS1, CIII subunit CORE2 and CIV subunit COX5B were 
determined in parallel, thus showing that COX7A2L, with both tags, is efficiently incorporated 
into MRC complexes and SCs (Figure 18B and 18C). 
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Densitometry analyses of OXPHOS subunit distribution showed that the 
overexpression of tagged-COX7A2L induced no significant increase in the amounts of CIII- and 
CIV- containing structures (Figure 18D).  
 
 
Figure 18. Overexpressed COX7A2L localizes to mitochondria with minor effects on the levels of MRC 
complexes and SCs. (A) Western blot analysis of the overexpressed COX7A2L-MYC-DDK construct and its 
corresponding empty vector (Myc) in control 143B cells. (B) 1D-BN-PAGE and (C) 2D-BN/SDS-PAGE 
analyses of 143B cells transiently transfected with either the COX7A2L-GFP or COX7A2L-MYC-DDK 
constructs and with their corresponding empty vectors. Membranes were incubated with antibodies 
raised against COX7A2L and the indicated OXPHOS subunits. (D) Densitometry analysis of the MRC 
complexes and SCs in 143B cells transfected with both COX7A2L-tagged constructs. The optical densities 
of immunoreactive bands that had not reached saturation levels were measured with the ChemiDoc MP 
Image Analyzer software package (Biorad). The antibody signals within the same structures were 
quantified; the mean values were normalized by CII and expressed as percentages of the cells 
transfected with the empty vectors (horizontal bar). Values represent the means ± SD from four 
independent experiments. I+III2+IVn, SC containing CI, CIII and CIV; I+III2, SC containing CI and CIII; III2+IV, 
SC containing CIII and CIV; III2, complex III dimer; IV, complex IV; IV2, complex IV dimer; II, complex II. 
 
To further validate these results, the same analysis was extended to wild-type human 
embryonic kidney (HEK293T) cells, transfected with either the MYC-DDK-tagged COX7A2L 
construct or with the MYC-DDK tag alone. In HEK293T cells, COX7A2L-MYC-DDK was effectively 
overexpressed by ~10-fold, relative to endogenous COX7A2L (Figure 19A), and co-migrated 
with CIII2, monomeric CIV, SC III2+IV, and the respirasomes (SC I+III2+IVn), as observed by BN-
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PAGE analysis (Figure 19B). Overexpression of tagged-COX7A2L in HEK293T cells did not alter 
the levels of MRC complexes or SCs. 
 
 
Figure 19. Overexpressed COX7A2L in HEK293T cells does not affect the levels of MRC complexes or 
SCs. (A) Western blot analysis of the overexpressed COX7A2L-MYC-DDK construct and its corresponding 
empty vector (Myc) in HEK293T cells. (B) BN-PAGE followed by western-blot analyses of control 
HEK293T cells transiently transfected either with the COX7A2L-MYC-DDK construct, or with the MYC-
empty vector. Membranes were incubated with antibodies raised against COX7A2L and the indicated 
OXPHOS subunits. Two independent transfection experiments per experimental condition are shown on 
the same gel. Asterisks indicate unspecific signals that do not appear on 2D-BN/SDS-PAGE gels (see 
Figure 18C). I+III2+IVn, SC containing CI, CIII and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing 
CIII and CIV; III2, complex III dimer; IV, complex IV; IV2, complex IV dimer; II, complex II. 
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3. Overexpressed COX7A2L binds to CIII and CIV 
To test whether the COX7A2L co-localization with MRC CIII and CIV was due to a direct physical 
interaction, co-immunoprecipitation assays were performed in digitonin-solubilized 
mitochondrial lysates from HEK293T cells transfected with either the COX7A2L-MYC-DDK 
construct or with the empty vector (Figure 20A). Immunoprecipitation with an anti-DDK 
antibody specifically pulled down the tagged-COX7A2L protein in cells overexpressing 
COX7A2L-MYC-DDK. In addition, the CIII subunits CORE1, CORE2, CYC1, RISP, and UQCRQ and 
the CIV subunits COX1, COX4, COX5B, and COX6C were detected in the co-immunoprecipitate 
(coIP). The CI subunits NDUFA9 and NDUFS1 were barely detectable, and CII was not detected 
in the coIP samples. When reverse immunoprecipitation assays were performed using 
antibodies against CORE2 (Figure 20B) or COX1 (Figure 20C) proteins, both the tagged and the 
endogenous COX7A2L proteins were successfully pulled down. Importantly, 
immunoprecipitation with CORE2 (but not with COX1) pulled down the endogenous COX7A2L 
protein in cells transfected with the empty vector (Figures 20B and 20C). These results suggest 
that COX7A2L physically interacts with CIII and CIV but it presents a higher affinity for CIII.  
 
 
Figure 20. COX7A2L physically binds to CIII and CIV. (A) COX7A2L co-immunoprecipitation assay. 
Digitonin-solubilized mitochondrial extracts (4 g digitonin/1 g protein) from HEK293T cells transiently 
transfected with either the COX7A2L-MYC-DDK construct (+) or with the empty vector (-) were 
immunoprecipitated using an anti-DDK antibody. The same digitonin-solubilized mitochondrial extracts 
were used for reverse co-immunoprecipitation using antibodies against (B) CORE2 or (C) COX1. Samples 
were subsequently analyzed by SDS-PAGE and western blot with the indicated antibodies. IP, 
immunoprecipitate. 
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4. Endogenous COX7A2L associates with respiratory chain CIII and CIV and with SCs 
during their assembly process 
Once the structural relationship between COX7A2L and the MRC complexes and SCs was 
confirmed, our next step was to analyze the assembly kinetics of COX7A2L into those 
structures by using doxycycline-induced reversible inhibition of mitochondrial translation in 
control 143B cells (Moreno-Lastres et al., 2012). Doxycycline was removed from cell-culture 
media after 6 days of treatment, and samples were collected at different time points (0, 6, 15, 
24, 48, 72, and 96 hours). To follow the integration of endogenous COX7A2L into newly 
assembled CIII, CIV, and SCs, digitonin-solubilized mitochondria were separated by 2D-BN/SDS-
PAGE and subsequently analyzed by western blot using antibodies that recognize COX7A2L and 
CORE2 (CIII), RISP (CIII), and COX5A (CIV) (Figure 21A). Signals from at least three independent 
experiments were quantified by densitometry and normalized to CII levels, and values were 
expressed relative to the levels in untreated cells (SS) (Figure 21B-E). After 6 days of 
doxycycline treatment (time 0 hours, 0h), there was a drastic decrease (80%–95%) in the levels 
of CIII2, CIV, SC III2+IV, and SC I+III2+IVn, as well as in the levels of COX7A2L that co-localizes 
with these structures. The CII levels remained normal after doxycycline treatment, as expected 
(Moreno-Lastres et al., 2012), because this complex lacks mtDNA encoded subunits. Once 
mitochondrial translation resumed (times 6 to 96 hours, 6h-96h) a gradual increase in the 
levels of the COX7A2L protein that co-localized with CIII2 was observed. The incorporation of 
COX7A2L into CIII2 occurred in parallel to the insertion of the CORE2 subunit, which forms a 
partially-assembled pre-CIII prior to the incorporation of RISP (Figure 21B). In contrast, CIV 
levels increased prior to the binding of COX7A2L (Figure 21C). Moreover, COX7A2L was 
incorporated into SC III2+IV in parallel with the CORE2 and COX5A subunits, but again prior to 
the integration of RISP in this structure (Figure 21D). The incorporation of COX7A2L into the 
respirasomes occurred in parallel with CORE2 and COX5A, and earlier than the integration of 
RISP (Figure 21E).  
In order to compare the assembly rates of COX7A2L within the different structures, the 
densitometric values corresponding to the accumulation of COX7A2L in CIII2, CIV, SC III2+IV and 
SC I+III2+IV were drew together (Figure 22A and 22B). Interestingly, once COX7A2L had bound 
to CIV, there was a simultaneous accumulation of COX7A2L within CIV and SC III2+IV.  
Altogether, these results suggest that COX7A2L associates with CIII2 during its assembly 
course, that it binds to CIV once this complex is fully assembled, and that it is incorporated into 
SC III2+IV and SC I+III2+IVn before their formation is completed. 
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Figure 21. Comparison of the assembly kinetics of COX7A2L, CORE2, RISP and COX5A in CIII- and CIV- 
containing structures. (A) Mitochondria from doxycycline-treated 143B cells were extracted with a 
digitonin:protein ratio of 4 g:1 g and analyzed by 2D BN/SDS-PAGE and western blot with the indicated 
antibodies. (B-E) Densitometric profiles representing the incorporation rates of COX7A2L into CIII2, CIV, 
SC III2+IV and SC I+III2+IVn relative to the CIII subunits RISP and CORE2 and to the CIV subunit COX5A. The 
signals from three independent experiments were quantified and normalized by CII. Time point values 
are expressed as percentages of the untreated cells (SS) and indicated as means ± SD. I+III2+IVn, SC 
containing CI, CIII, and CIV; III2+IV, SC containing CIII and CIV; III2, CIII dimer; IV, CIV. 
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Figure 22. Assembly kinetics of COX7A2L in CIII- and CIV- containing structures. (A) Densitometric 
profiles representing the assembly progress of COX7A2L in CIII- and CIV- containing structures. (B) Mean 
incorporation rates of COX7A2L into CIII- and CIV- containing structures. The signals from three 
independent experiments were quantified and normalized by CII. Time point values are expressed as 
percentages of the untreated cells (SS) and indicated as means ± SD. I+III2+IVn, SC containing CI, CIII, and 
CIV; III2+IV, SC containing CIII and CIV; III2, CIII dimer; IV, CIV. 
 
5. COX7A2L associates with CIII and SC III2+IV prior to the insertion of the RISP 
catalytic subunit 
In the reported CIII assembly models, incorporation of CORE2 allows the formation of a non-
functional intermediate called pre-CIII, which contains CORE2 and the rest of the CIII subunits 
except RISP and the smallest subunit (Qcr10 in yeast, UQCR11 in mammals), which are 
incorporated at a later assembly stage (Fernández-Vizarra and Zeviani, 2015; Smith et al., 
2012). This late assembly step is promoted by LYRM7/MZM1L, an assembly factor that binds 
RISP to stabilize it prior to its incorporation into CIII. HeLa cells that stably overexpress 
hemagglutinin (HA)- tagged MZM1L showed sequestering of RISP in a small subcomplex, 
thereby preventing CIII maturation (Sánchez et al., 2013).  
 Doxycycline experiments suggested that human COX7A2L could be a component of 
pre-CIII, as this protein gets incorporated into CIII in parallel with the CORE2 subunit but before 
the incorporation of RISP (Figure 21B). To confirm this hypothesis, the COX7A2L distribution 
was analyzed by 1D-BN-PAGE in digitonin-solubilized mitochondria isolated from HeLa cells 
overexpressing MZM1L (Figure 23). As observed by CI in-gel activity (IGA) assay, MZM1L 
overexpression induced a decrease in the levels and activity of the respirasomes (SC I+III2+IVn), 
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as well as an accumulation of CI- containing structures (Figure 23A). The levels of the RISP 
subunit were strongly decreased in the respirasomes, in SC III2+IV, and in CIII2, and there was a 
parallel accumulation of RISP in a small subcomplex that also contains MZM1L-HA (Sánchez et 
al., 2013) (Figure 23B). Upon MZM1L/LYRM7 overexpression, CORE2 and COX7A2L co-
segregated with pre-SC III2+IV and pre-CIII. Altogether, these results confirm that COX7A2L 
associates with pre-CIII before the incorporation of RISP takes place.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. COX7A2L binds to CIII assembly intermediates. (A) Digitonin-solubilized mitochondrial 
extracts (4 g digitonin/1 g protein) from HeLa cells transduced with the MZM1L-HA construct or with the 
empty vector (PuroR) were analyzed by BN-PAGE and CI-IGA assays or, alternatively, by western blot 
and immunodetection. Asterisks indicate unspecific signals that do not appear on 2D BN/SDS-PAGE gels. 
(B) Subsequent 2D-BN/SDS-PAGE and western blot analyses were performed with antibodies against 
RISP and the HA epitope. I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; I*, CI-
containing structure; III2+IV, SC containing CIII and CIV; pre-III2+IV, SC containing pre-CIII and CIV; III2, CIII 
dimer; pre-III2, pre-CIII lacking the RISP subunit; IV, CIV; IV2, CIV dimer; II, CII. Subcomplexes that contain 
CORE2 and COX1 are indicated as subCORE2 and subCOX1, respectively. The association of RISP and 
MZM1L is indicated as RISP+MZM1L. 
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6. COX7A2L downregulation causes SC III2+IV disassembly without altering 
respirasome stability 
In order to investigate if COXA2L exerted a possible role on the biogenesis of the OXPHOS 
structures, transient knockdown (KD) of COX7A2L was carried out using a mix of two small 
interfering RNAs (siRNAs) targeting exons 2 and 3 of COX7A2L mRNA. The COX7A2L-KD 
efficiency was analyzed by SDS-PAGE of whole-cell protein extracts from control 143B cells and 
COX1Δ (CIV-KO) mutant cybrids (Figure 24A). COX7A2L RNAi effectively knocked down the 
COX7A2L protein by 80% in the 143B cells and by 74% in the CIV-KO mutant, compared with 
cells transfected with unspecific scrambled siRNAs (C- in Figure 24A and 24B). Next, the effects 
of COX7A2L silencing on the assembly of the OXPHOS system were analyzed by BN-PAGE in 
combination with CI-IGA and western blot analyses of mitochondrial-enriched fractions from 
143B and CIV-KO cells (Figure 24C). Upon COX7A2L-KD, there was a significant decrease in the 
signals of COX7A2L that co-localized with CIII2, monomeric CIV, and SCs III2+IV, I+III2, and 
I+III2+IVn. Despite the severe drop in COX7A2L levels, only a specific reduction in the levels of 
SC III2+IV was observed in the 143B cells, whereas CI activity and the levels of free OXPHOS 
complexes and the respirasomes were normal.  
To gain deeper insight into the nature of SC III2+IV disruption in 143B cells, 2D-BN/SDS-
PAGE and western blot analyses were carried out with antibodies against CORE2 (CIII), RISP 
(CIII), COX1 (CIV), and COX5B (CIV) (Figure 25A). Densitometric quantification from five 
independent experiments (Figures 25B-E) showed that COX7A2L-KD specifically led to a 
significant decrease in the levels of the four analyzed MRC subunits within SC III2+IV, but not in 
the remainder CIII- and CIV-containing structures. Moreover, COX7A2L silencing did not result 
in a clear accumulation of intermediates smaller than CIII2 and CIV, suggesting that their 
assembly and/or stability are not disturbed.  
 In agreement with these results, COX7A2L-KD in the CIV-KO mutant cybrids produced 
no significant alterations in the levels of CIII2 or SC I+III2 (Figures 26A-C).  
Altogether, our results suggest that COX7A2L has a specific role in the stabilization of 
SC III2+IV.  
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Figure 24. COX7A2L knock-down in human cells specifically decreases the levels of SC III2+IV. (A) To 
characterize the functional role of COX7A2L in the OXPHOS system, silencing assays were performed 
with a mix of two COX7A2L siRNAs in control 143B cells as well as in mutant cybrids lacking complex IV 
(CIV-KO). Upon two rounds of transfection and silencing for 48 hours, cells were collected and whole cell 
extracts were analyzed by SDS-PAGE and western blot using antibodies targeted against COX7A2L and β-
actin as a loading control. (B) The COX7A2L signals from five independent siRNA silencing experiments 
were quantified, normalized by β-actin and expressed as the percentages relative to the cells 
transfected with the scramble siRNA (C-). (C) Mitochondria from untreated (CO), mock-transfected (C), 
and COX7A2L siRNA-transfected (i) 143B cells and CIV-KO mutants were extracted with a 
digitonin:protein ratio of 4 g:1 g and analyzed by BN-PAGE, followed by CI-IGA assays, or alternatively, 
by western blot and immunodetection with the indicated antibodies. Asterisks indicate unspecific 
signals that do not appear on 2D-BN/SDS-PAGE gels. I+III2+IVn, SC containing CI, CIII and CIV; I+III2, SC 
containing CI and CIII; III2+IV, SC containing CIII and CIV; III2, complex III dimer; IV, complex IV; IV2, 
complex IV dimer; II, complex II; CO, cells only treated with the transfection reagent; C-, cells transfected 
with a scrambled siRNA; i, cells transfected with a combination of two specific COX7A2L siRNAs.  
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Figure 25. COX7A2L downregulation in 143B cells specifically decreases the levels of SC III2+IV without 
affecting respirasome biogenesis. (A) Mitochondria from untreated (CO), mock-transfected (C), and 
COX7A2L siRNA-transfected (i) 143B cells were extracted with a digitonin:protein ratio of 4 g:1 g and 
analyzed by 2D-BN/SDS-PAGE followed by western blot analyses and immunodetection with the 
indicated antibodies. To address the relative amounts of (B) CIII2, (C) CIV, (D) SC III2+IV and (E) SC 
I+III2+IVn in 143B cells upon COX7A2L silencing, the optical densities of immunoreactive bands that had 
not reached saturation levels were measured with the ImageLab™ software of the ChemiDoc™ MP 
Image Analyzer (Biorad). The signals from each antibody within the different structures were quantified, 
normalized by CII, and indicated as means ± SD from five independent siRNA experiments. Values are 
expressed as percentages of the cells transfected with scramble RNA (C, horizontal bar). I+III2+IVn, SC 
containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; III2, CIII 
dimer; IV, CIV; IV2, CIV dimer; II, CII. *p < 0.05, Mann-Whitney U test. 
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Figure 26. COX7A2L down regulation in CIV-KO mutant cybrids does not alter the biogenesis of 
OXPHOS structures. (A) Mitochondria from untreated (CO), mock-transfected (C), and COX7A2L siRNA-
transfected (i) CIV-KO cells were extracted with a digitonin:protein ratio of 4 g:1 g and analyzed by 2D-
BN/SDS-PAGE followed by western blot analyses and inmunodetection with CIII subunits CORE2 and 
RISP. To address the relative amounts of (B) CIII2 and (C) SC I+III2 in the CIV-KO mutants upon COX7A2L 
silencing, the signals from each antibody within these structures were quantified, normalized by CII, and 
indicated as means ± SD from three independent siRNA experiments. Numerical values are expressed as 
percentages of the signals obtained for each antibody in cells transfected with the scramble RNA (C-, 
represented as a horizontal bar). I+III2, SC containing CI and CIII; III2, CIII dimer. 
 
7. COX7A2L downregulation does not affect the respiratory chain function 
To further investigate the possible effect of COX7A2L on the MRC function, oxygen 
consumption rates (OCRs) were measured in 143B cells, yielding no significant differences 
between COX7A2L-silenced cells and cells transfected with scrambled siRNAs (Figure 27A). In 
contrast, mitochondrial respiration was drastically reduced in the CI-KD cybrids (used as an 
internal experimental control) that retained SC III2+IV but showed minimal levels of CI and the 
respirasomes, in comparison with 143B cells (Figure 27B). Respiratory chain activities 
measured in COX7A2L-silenced 143B cells were also comparable to the activities in control 
cells (Figure 27C). These results show that a substantial loss of COX7A2L and SC III2+IV has no 
significant impact on MRC function in human cultured cells. 
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Figure 27. COX7A2L down regulation does not affect mitochondrial function. (A) Oxygen consumption 
rates (OCR) measured in 143B cells respiring in 1 g/l glucose-containing medium that were previously 
transfected either with a scrambled siRNA (C-, negative control), or with a combination of two specific 
COX7A2L siRNAs (COX7A2L-). Ten measurements per sample were performed each time in three 
independent experiments. Data are expressed as the mean± standard deviation of the percentages of 
the negative control. (B) Oxygen consumption rates (OCR) measured in control 143B cells and CI-
defective mutant cybrids (CI-KD) respiring in 1 g/l glucose-containing medium. Five measurements per 
sample were performed each time in two independent experiments. Data are expressed as the mean± 
range of the percentages of the control 143B cells. OCR values were calculated in pmol O2.min
-1
.μg 
protein
-1
 in all experiments. (C) Spectrophotometric measurements of the individual activities of MRC 
complexes I to IV (CI-CIV) in 143B cells transfected either with a scrambled siRNA (C-), or with a mix of 
two specific COX7A2L siRNAs (COX7A2L-). Enzyme activities are expressed as cU/U citrate synthase (CS). 
 
 
8. Mouse Cox7a2l is essential for SC III2+IV formation 
Finally, in order to shed light on the contradictory conclusions regarding Cox7a2l function in 
murine models (Ikeda et al., 2013; Lapuente-Brun et al., 2013; Mourier, Matic, et al., 2014; 
Williams et al., 2016), several experiments using isolated heart mitochondria from CD1 and 
C57BL/6 mouse strains were carried out. First, the Cox7a2l levels relative to OXPHOS subunits 
were analyzed by western blot in CD1 mice versus C57BL/6J, C57BL/6N (Lrpprc wt) and Lrpcc 
KO mice (Figure 28A). The CD1 mice express high levels of a 113-amino acids Cox7a2l protein 
isoform (long Cox7a2l), whereas C57BL/6 mice express low levels of a shorter and unstable 
Cox7a2l protein isoform of 111 amino acids (short Cox7a2l). CI, CIII and CIV subunits were 
present at similar levels in all wild-type CD1, C57BL/6J, and C57BL/6N mouse strains. However, 
the levels of Cox7a2l and CIII subunits were slightly increased in the CIV-deficient conditional 
Lrpprc KO mice compared with their wild-type littermates, all of them maintained on the 
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C57BL/6N genetic background (Mourier, Ruzzenente, et al., 2014). These data suggest that 
COX7A2L, as well as CIII, is stabilized in the Lrpprc KO mice possibly as a response to the severe 
CIV deficiency. BN-PAGE followed by IGA assays (Figure 28B) and 2D-BN/SDS-PAGE analysis 
(Figure 28C) of digitonin-solubilized heart mitochondria from CD1, C57BL/6 and Lrppc KO mice 
confirmed similar activities of the respirasomes in all the wild-type strains (Figure 28B) and a 
strong reduction of CIV activity in the Lrppc KO mice compared to littermate controls. Analysis 
of the COX7A2L distribution in CD1 mice (Figure 28C) showed its preferential co-segregation 
with monomeric CIV, SC III2+IV and the respirasomes and, to a minor extent, with CIII2. In the 
wild-type C57BL/6 mice, however, COX7A2L was mostly found in CIII-containing structures 
(Figure 28C). These data suggest that the reduction in COX7A2L levels mostly hampers the 
binding of COX7A2L to CIV, which, nevertheless, only provoked the disappearance of SC III2+IV 
without affecting the levels of monomeric CIV and the respirasomes, or the enzymatic 
activities of the MRC complexes (Figure 28B and 28C). Next, DDM-solubilized mouse heart 
mitochondria was examined, a condition in which respirasomes are disrupted (Figure 28D). 
The co-segregation between COX7A2L and monomeric CIV was totally lost, suggesting that 
their interaction is, indeed, labile. In CD1 mice, both COX7A2L and the CIII subunit CORE2 co-
localized with dimeric CIII and SC III2+IV, whereas in C57BL/6 mice, both proteins only were 
present in CIII2. 
To test whether the respirasome stability depends on COX7A2L levels, heart 
mitochondria from CD1 and C57BL/6J mice were exposed to increasing amounts of the 
detergent digitonin, followed by 1D-BN-PAGE analysis (Figure 29). Respirasome levels and MRC 
organization were comparable between both mouse strains at low digitonin-to-protein ratios. 
Even under the most stringent detergent conditions, respirasomes were still detectable in the 
C57BL/6J mice, albeit at slightly lower levels than those in the CD1 mice. Noteworthy, SCs from 
both mouse strains reorganized in different ways upon increasing digitonin concentrations, 
and some respirasome bands appeared to be more stable in C57BL/6J than in CD1 mice and 
vice versa. Altogether, these data indicate that COX7A2L is essential for SC III2+IV stability but 
dispensable for the respirasomes formation and maintenance. 
 
 
 
 
RESULTS CHAPTER 1 
74 
 
 
 
Figure 28. Mouse Cox7a2l is required for SC III2+IV assembly. (A) Heart mitochondrial extracts from CD1 
and C57BL/6J mouse strains, and from control littermates (Lrpprc wt) and Lrpprc deficient mice (Lrpprc 
KO) with a C57BL/6N genetic background, were analyzed by western blot with antibodies raised against 
COX7A2L and the indicated OXPHOS subunits. (B) Supramolecular organization of the respiratory chain 
in heart mitochondria from wild-type (wt) CD1, C57BL/6J, and C57BL/6N (Lrpprc wt) mouse strains, as 
well as from Lrpprc-deficient (KO) mice. Mitochondria were extracted with a digitonin:protein ratio of 4 
g:1 g and analyzed by 1D-BN-PAGE, followed by CI and CIV-IGA assays, or by (C) 2D-BN/SDS-PAGE 
analyses followed by western blot and immunodetection with antibodies against COX7A2L and the 
indicated OXPHOS subunits. (D) Mitochondrial samples were solubilized with 2% DDM, which disrupts 
respirasomes and CIV oligomers but maintains SC III2+IV and free complexes, and were next analyzed by 
BN-PAGE followed by western blot and immunodetection with the indicated antibodies. I+III2+IVn, SC 
containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; III2, CIII 
dimer; IV, monomeric CIV; IVn, CIV oligomers. 
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Figure 29. The lack of Cox7a2l does not affect the stability of the respirasomes in mice heart 
mitochondria. Heart mitochondria from CD1 and C57BL/6J mouse strains were extracted with 
increasing ratios of digitonin to mitochondrial protein (ranging from 4 to 40 g/g) and analyzed by 1D-BN-
PAGE followed by CI-IGA or CIV-IGA assays. Asterisks indicate the presence of respirasome bands that 
are more stable in the mitochondria from C57BL/6J mice. 
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CHAPTER 2. MITOCHONDRIAL COX7A2L REGULATES THE BIOENERGETIC RATES 
OF DIMERIC COMPLEX III AND OF COMPLEX III-CONTAINING SUPERCOMPLEXES 
TO FINE TUNE SUCCINATE OXIDATION 
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1. TALEN-mediated generation of COX7A2L knockout (KO) cell lines 
All our previous results indicated that COX7A2L preferentially interacts with mitochondrial CIII2 
and, to a minor extent, with monomeric CIV to promote the stabilization of SC III2+IV in both 
mice and humans. However, COX7A2L would have no determinant role in the biogenesis, 
stabilization, or function of the free OXPHOS complexes or in the formation of the 
respirasomes I+III2+IV0-2. The experimental approach used in human cell lines consisted on the 
transient silencing of the expression of COX7A2L mRNA, which still yielded low levels of the 
COX7A2L protein and therefore, results were not fully conclusive.  
To further determine the requirement of human COX7A2L for the formation and function 
of respiratory chain SCs, stable human COX7A2L knockout (KO) HEK293T cell lines were 
created using the TALEN gene editing approach (Christian et al., 2010; Li et al., 2011). A TALEN 
pair was designed to target a region within the first exon of the COX7A2L gene immediately 
downstream the start codon (Figure 30A). HEK293T cells were co-transfected with the TALEN 
pair and subsequently, single clones were isolated by size cell sorting and analyzed for out-of-
frame mutations leading to COX7A2L protein loss. More than 100 clones were screened by 
immunoblotting from cell extracts using a specific anti-COX7A2L antibody. Five promising 
candidates were selected, that completely lacked the COX7A2L protein (Figure 30B). The 
COX7A2L gene was sequenced in two of these clones and found to carry KO mutations. Clone 
KO1 (C2E11) is homozygous and clone KO2 (C1C3) is compound heterozygous, both carrying 
COX7A2L alleles with short deletions involving the start codon and leading to the complete 
absence of COX7A2L (Figure 30C). 
 
2. COX7A2L-KO cells display absence of SC III2+IV with normal respirasome levels and 
increased CIII2 levels and activity 
To analyze the pattern of supramolecular assemblies of MRC complexes resulting from the 
total absence of COX7A2L in human cells, mitochondria-enriched fractions from wild type 
HEK293T (WT), KO1 and KO2 clones were analyzed by BN-PAGE followed by CI-in gel activity 
(IGA) assays and immunoblotting (Figure 31A). Subsequently, 2D-BN/SDS-PAGE was performed 
to analyze in detail the pattern of SCs in COX7A2L-KO cells and the co-localization of COX7A2L 
with all MRC structures in WT cells (Figure 31B). As previously observed in silenced COX7A2L 
cells, the total absence of COX7A2L led to the disappearance of the SC III2+IV, whereas the 
respirasomes were detected in the COX7A2L-KO clones at levels similar to the WT. However 
some SCs larger than the respirasome I+III2+IV1 (indicated with an asterisk), occasionally 
appeared to be at lower levels in some experiments. These observations suggest that these 
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MRC structures assemble in the absence of COX7AL, but might be more labile than in WT 
mitochondria. Although our previous results suggested that COX7A2L associates with pre-CIII2 
before the incorporation of the RISP subunit (Figures 21 and 23), RISP assembly was not 
affected in COX7A2L-KO cells as it was detected in CIII2, and in SCs I+III2 and I+III2+IV1-n. 
However, the accumulation of CIII2 was significantly increased by 2-3-fold in the absence of 
COX7A2L (Figure 31C). In agreement, spectrophotometric measurements of MRC enzyme 
activities showed that CIII activity was specifically enhanced by 20-40% in the KOs (Figure 31D), 
consistent with the accumulation of CIII2 in these cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30. TALEN-mediated generation of COX7A2L-KO clones in HEK293T cells. (A) Schematic 
representation of the first exon of the COX7A2L locus and the sequences of the recognition sites of the 
two TALEN pairs. (B) Immunoblot analysis of the steady state levels of COX7A2L in HEK293T (WT) and 
TALEN-transfected HEK293T cell lines. VDAC was used as a loading control. (C) COX7A2L alleles in TAL-
COX7A2L clones. The DNA numbering refers to the coding sequence (c.) and the protein (p.) number to 
the predicted full polypeptide (den Dunnen and Antonarakis, 2000). C: compound; Mut: mutant; Hetero: 
heterozygous; Homo: homozygous; del: deletion; -: position before starting ATG. 
 
 
 
 
 
A 
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Figure 31. COX7A2L-KO cells display absence of SC III2+IV with normal respirasome levels and altered 
accumulation of CIII2. (A) Mitochondria extracted with a digitonin:protein ratio of 4:1 (g/g) and analyzed 
by 1D-BN-PAGE, followed by CI- and CIV-IGA assays, or alternatively, by immunoblotting using the 
indicated antibodies. Short and long exposures of the immunoblotting are shown. (B) Subsequent 2D-
BN/SDS-PAGE and immunoblot analyses were performed with antibodies against COX7A2L and the 
indicated OXPHOS subunits. (C) To address the relative amount of CIII2 in COX7A2L-KO cells, the signals 
from the CORE2 antibody from four BN-PAGE experiments were quantified by densitometry, normalized 
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by CII and indicated as mean ± SD. (D) Spectrophotometric measurements of the individual activities of 
MRC complexes I to IV (CI-CIV) in WT and COX7A2L-KO cells. Enzyme activities are expressed as cU/U 
citrate synthase (CS). Error bars represent the mean ± SD of four repetitions. *P < 0.05, **P < 0.01. 
I+III2+IVn, SCs containing CI, CIII2 and CIV; I+III2, SC containing CI and CIII2; III2+IV, SC containing CIII2 and 
CIV; III2, complex III dimer (CIII2); IV, complex IV; IV2, complex IV dimer (CIV2); II, complex II. 
Subcomplexes that contain COX1 and COX4 are indicated. Apparent subcomplexes that contain CORE2 
are antibody artifacts that disappear in 2D-BN/SDS-PAGE gels.  
 
3. The absence of COX7A2L does not affect the stability of the respirasomes 
To assess whether the stability of the respirasomes depends on COX7A2L, mitochondria-
enriched fractions from WT and COX7A2L-KO cells were exposed to varying concentrations of 
digitonin and the extracts were analyzed by BN-PAGE followed by CI- and CIV-IGAs or 
immunoblotting (Figures 32 and 33). Stringent SCs extraction conditions using increasing (4-40 
mg/mg) digitonin-to-protein ratios (Figure 32) led to a parallel disintegration of the 
respirasomes (SCs I+III2+IV1-2) and consequent accumulation of SC I+III2 and free CI in both cell 
types. Only when an extremely harsh 40 mg/mg digitonin:protein ratio was used, the 
respirasomes were slightly more unstable in COX7A2L-KO than in WT cells. Milder SCs 
extraction conditions using decreasing (4-1 mg/mg) digitonin-to-protein ratios (Figure 33), 
revealed no differences in the levels of SCs I+III2+IV1-n between COX7A2L-KO and WT cells, but a 
clear decrease in the abundance of larger SCs (indicated with an asterisk) in COX7A2L-KO cells. 
Altogether, these results suggest that COX7A2L may be required for the normal assembly or 
stability of larger megastructures. On the contrary, the abundance and stability of monomeric 
and dimeric CIV were not affected by the absence of COX7A2L (Figures 32 and 33).  
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Figure 32. The absence of COX7A2L does not affect the stability of the respirasomes. Mitochondrial 
were extracted with increasing ratios of digitonin to mitochondrial protein (ranging from 1 to 40 g/g) 
and analyzed by 1D-BN-PAGE followed by CI-IGA and CIV-IGA assays. Subsequent western blot analysis 
was performed with antibodies for subunits NDUFA9 of CI, CORE2 of CIII and COX5B of CIV. Respirasome 
levels and organization are comparable between both control HEK293T (WT) cells and the COX7A2L-KO 
clone 2 (KO2) under the most stringent detergent conditions. I+III2+IVn, SC containing CI, CIII and CIV; 
I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; III2, complex III dimer; IV, complex IV; 
IV2, complex IV dimer; II, complex II.  
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Figure 33. The absence of COX7A2L hampers the accumulation of MRC structures larger than 
respirasomes. Mitochondrial were extracted with decreasing ratios of digitonin to mitochondrial protein 
(ranging from 1 to 40 g/g) and analyzed by 1D-BN-PAGE followed by CI-IGA and CIV-IGA assays. 
Subsequent western blot analysis was performed with antibodies for subunits NDUFA9 of CI, CORE2 of 
CIII and COX5B of CIV. Respirasome levels and organization are comparable between both control 
HEK293T (WT) cells and the COX7A2L-KO clone 2 (KO2) under the low digitonin-to-protein ratios. 
I+III2+IVn, SC containing CI, CIII and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; 
III2, complex III dimer; IV, complex IV; IV2, complex IV dimer; II, complex II.  
 
4. Overexpressed COX7A2L restores the wildtype phenotype in COX7A2L-KO cells 
All the phenotypes described in COX7A2L-KO cells in sections 2, 3 and 4, particularly the 
absence of SC III2+IV and the accumulation of CIII2, were specific since they were restored by 
the overexpression of recombinant COX7A2L-Myc-DDK in both KOs (Figure 34), thus 
eliminating the possibility of off-target effects that could have arisen during the COX7A2L 
gene-disruption. Tagged-COX7A2L incorporated into the same MRC structures as the 
endogenous COX7A2L (Figure 34B), and its mild overexpression (2-3 fold) (Figure 34A) did not 
induce any aberrant phenotype (Figure 34C).  
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Figure 34. Tagged-COX7A2L interacts with MRC complexes and supercomplexes and restores SC 
III2+IV. (A) Immunoblot analysis of the untreated (c-), empty vector (ev) or overexpressed COX7A2L-
Myc-DDK (COX7A2L) constructs in control HEK293T cells (WT) and two COX7A2L-KO clones (KO1 and 
KO2). Membranes were incubated with antibodies raised against the indicated OXPHOS subunits and 
the antibody against COX7A2L to differentiate endogenous COX7A2L (~12.6 kDa) from exogenous 
COX7A2L-Myc-DDK (~16.2 kDa). (B) Digitonin-solubilized mitochondrial extracts (4g digitonin/1 g 
protein) from control HEK293T cells (WT) and COX7A2L-KO clone 2 (KO2) stably transfected with either 
the COX7A2L-Myc-DDK construct or with the empty vector were analyzed by 2D-BN/SDS-PAGE and 
immunoblotting. (C) 1D-BN-PAGE was followed by CI-IGA, CIV-IGA and immunoblotting with the 
indicated antibodies. I+III2+IVn, SCs containing CI, CIII2 and CIV; I+III2, SC containing CI and CIII2; III2+IV, SC 
containing CIII2 and CIV; III2, complex III dimer (CIII2); IV, complex IV (CIV); IV2, complex IV dimer (CIV2); II, 
complex II. Subcomplexes that contain COX1 are indicated as subCOX1. 
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5. COX7A2L-KO cells display a boost in CIII2 biogenesis in parallel with slower 
assembly kinetics of the respirasomes 
The assembly kinetics of MRC complexes and SCs were next analyzed by doxycycline-induced 
reversible inhibition of mitochondrial translation in WT and COX7A2L-KO cells. Doxycycline was 
removed from the cell culture media after 6 days of treatment, and samples were collected at 
different time points (0, 6, 15, 24, 48 and 72 hours). To follow the reappearance of newly-
assembled CIII2, CIV, CIV2 and SCs, digitonin-solubilized mitochondria was separated by 1D-BN-
PAGE and subsequently analyzed by either CI-IGA assays (Figure 35A) or western blot using 
antibodies that recognize CORE2 (CIII) and COX5A (CIV) (Figure 35B). Following 6 days of 
doxycycline treatment (time 0h) only residual levels of CI, CIV and CIII2 (5-10% of untreated 
cells) were detected in either control or KO cells. The treatment did not affect CII levels, as 
expected, since this complex lacks mtDNA-encoded subunits (Figure 35B). Once mitochondrial 
translation resumed (times 6-72 hours), the SC III2+IV formed de novo only in the WT cells 
(Figures 35B and 35C). The levels of CIV and CIV2 increased at similar rates in WT and COX7A2L-
KO cells (Figures 35B and 35C), ruling out a possible role for COX7A2L in the biogenesis of this 
complex. On the contrary, the rate of CIII2 biogenesis, as shown for its steady-state levels in 
Figure 31, was markedly higher in the KOs than in the WT cells (Figures 35B and 35C). These 
data suggest a dysregulation of CIII2 levels in the absence of COX7A2L. Strikingly, the 
reappearance of the respirasomes I+III2+IV1-n was clearly delayed in the COX7A2L-KO cells 
(Figures 35A-C), but it reached levels comparable to the WT at later time-points and in the 
steady-state (previously shown in Figure 31). These results suggest that although the lack of 
COX7A2L does not prevent the formation of the respirasomes, it hampers their assembly 
efficiency. 
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Figure 35. COX7A2L-KO cells have enhanced rate of de novo CIII2 biogenesis and delayed respirasomes 
formation. HEK293T (WT) and COX7A2L-KO clone # 1 (KO1) cells were cultured for 8 days in the 
presence of 15 μg/ml doxycycline and collected at different time points (0, 6, 15, 24, 48, and 72h) after 
doxycycline removal. Mitochondria prepared from these samples were extracted with a 
digitonin:protein ratio of 4 g/g and analyzed by 1D-BN-PAGE in combination with (A) CI-IGA assays or (B) 
immunoblotting with the indicated antibodies. (C) Mean incorporation rates of the subunit CORE2 in 
CIII2, and of COX5A in CIV and CIV2 (upper panels), or their assembly kinetics in the I+III2+IV1-n 
respirasomes (lower panels). The signals from three independent experiments for WT cells, and from 
two independent experiments for the KO1 clone were quantified and normalized by CII. Time point 
values are expressed as percentages of the untreated cells (SS), and indicated as means ± SD. I+III2+IVn, 
SCs containing CI, CIII2 and CIV; III2+IV, SC containing CIII2 and CIV; III2, complex III dimer (CIII2); IV, 
complex IV; IV2, complex IV dimer (CIV2); II, complex II. 
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6. In normal cultured cell physiological conditions, COX7A2L does not have a 
significant impact on mitochondrial respiration 
To shed light onto the functional consequences of COX7A2L and SC III2+IV depletion, 
endogenous coupled cell respiration was polarographically measured in intact cells (Figure 36), 
by studying the co-oxidation of NADH-linked substrates (glutamate-malate) or FADH2-linked 
substrates (succinate). First, no alterations were observed when measuring total cell 
respiration between the WT and COX7A2L-KO1. Similarly, no alterations were observed in the 
oxidation of glutamate-malate measured alone (Figure 36A), succinate measured alone (Figure 
36B) or both substrates measured in combination (Figure 36A and 36B). Moreover, no effect 
on respiration resulted from COX7A2L overexpression. These results suggest that in normal 
cultured cell physiological conditions, neither COX7A2L nor the SC III2+IV have an impactful 
functional effect on electron flow through the MRC. Examples of actual polarographic graphs 
are represented in Figure 37. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. COX7A2L does not affect MRC function in normal cultured cell physiological conditions. 
Oxygen consumption rates were measured in HEK293T (WT) and COX7A2L-KO clone # 1 (KO1) cells 
grown in 4,5 g/l glucose-containing DMEM medium. Endogenous cell respiration was measured 
polarographically in intact cells permeabilized with 0.1% digitonin to measure substrate-driven 
respiration, where (A) glutamate+malate was followed by additional succinate co-oxidation or (B) 
succinate was followed by glutamate+malate co-oxidation. Oxygen consumption rates were calculated 
in nmol O
2
.min
-1
.mg protein
-1
. Three measurements per sample were performed in three biological 
replicates. The left bar graphs represent the average ± SD of all replicates. The right graphs represent 
the ratios of oxygen consumption rates in the presence of one substrate vs the simultaneous presence 
of both substrates.  
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Figure 37. Examples of substrate-driven respiration polarographic graphs. Oxygen consumption rates 
measured in digitonin-permeabilize HEK293T control cells (WT) and COX7A2L-KO clone # 1 (KO1), 
overexpressing the empty vector (ev) or COX7A2L-Myc-DDK (COX7A2L) constructs. On each 
experimental setting, the cells were subsequently used to measure respiratory parameters 
polarographically as explained in the methods section. Endogenous cell respiration was measured in 
intact cells permeabilized with digitonin prior to measuring substrate-driven respiration, in which 
Glutamate+Malate (Glu-Mal) oxidation was followed by succinate (Succ) co-oxidation. The figure 
presents examples of actual polarographic graphs. Oxygen consumption rates were calculated in nmol 
O2.min
-1
.mg protein
-1
.  
 
7. Induction of CI deficiency significantly enhances succinate oxidation in COX7A2L-
KO cells 
Cell respiration resulted to be unaffected in the COX7A2L-KO clones, compared to the WT cells. 
Nevertheless, in human cells more than 90% of CI is present in the respirasomes and the SC 
III2+IV only constitutes ~5% of the total amount of MRC structures (Moreno-Lastres et al., 
2012). Taking this into account, the next step was to limit either the enzymatic activity or the 
amount of CI (and therefore, of the respirasomes) in order to discern whether the absence of 
SC III2+IV and the accumulation of CIII2 in the COX7A2L-KO clones affect substrate competitive 
oxidation. To induce a partial inhibition of CI activity, cells were first treated with either 10nM 
rotenone or the control vehicle (0,05% or 8,5mM ethanol) for 24h. Rotenone treatment did 
not significantly alter the distribution of MRC complexes and SCs in WT or KO cells (Figure 
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38A), but it resulted in a comparable ~40% decrease in glutamate-malate oxidation and a non-
significant 10% decrease in succinate oxidation both in WT and KO digitonin-permeabilized 
cells (Figure 38B). By studying the co-oxidation of NADH (generated by the glutamate-malate 
metabolism) and succinate (an FADH2-linked substrate), succinate oxidation was significantly 
more efficient in rotenone-treated COX7A2L-KO cells than in the WT cells (Figure 38B).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. CI enzymatic inhibition significantly enhances succinate oxidation in COX7A2L-KO cells. 
HEK293T cells (WT) and COX7A2L-KO clone # 1 (KO1) were treated with the CI-inhibitor rotenone, using 
ethanol as a vehicle in the untreated controls. (A) Digitonized cell extracts from the indicated cells were 
analyzed by 1D-BN-PAGE and immunoblotting with the indicated antibodies. (B) Substrate-driven 
respiration was measured polarographically in digitonin-permeabilized cells. Oxidation of 
glutamate+malate was followed by addition of succinate to follow simultaneous oxidation. The top bar 
graph represents respiratory rates average ± SD of all repetitions. The bottom graph represents the ratio 
of oxygen consumption rates in the presence of one substrate vs the simultaneous presence of both 
substrates. Oxygen consumption rates were calculated in nmol O2/min/10
6
 cells. Three measurements 
per sample were performed in three biological replicates. Error bars represent the mean ± SD of all 
repetitions. **P < 0.01. 
 
To further confirm this observation a structural loss of CI, and therefore of the 
respirasomes, was induced by transfecting the WT and KO cells with siRNAs against the CI 
subunit NDUFB8 mRNA, using non-targeting (NT) siRNA as a control (Figure 39B). The 
substantial decrease (>95%) in CI-containing respirasomes (SCs I+III2 and I+III2+IV1-n) was 
accompanied by a slight accumulation of SC III2+IV in WT cells, a mild accumulation of CIV2 in 
the KO cells, and a prominent increase of CIII2 in both cell types (Figure 39A). As in rotenone-
treated cells, NDUFB8 silencing lowered glutamate-malate oxidation by ~45-50% in both WT 
and KO digitonin-permeabilized cells, and induced a simultaneous 10% increase in succinate 
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oxidation in the COX7A2L-KO cells (Figure 39C). Overall, CI depletion resulted in NADH+FADH2 : 
NADH oxidation ratios significantly higher in the COX7A2L-KOs than in WT cells (Figure 39C).  
Altogether, these functional data suggest that in the context of CI deficiency, the 
absence of COX7A2L and SC III2+IV provokes a significant increase in CII-mediated electron 
flow, where electrons would preferentially flow from CII to the accumulated CIII2.  
 
 
Figure 39. Complex I structural defects significantly enhance succinate oxidation in COX7A2L-KO cells. 
HEK293T cells (WT) and COX7A2L-KO clone # 1 (KO1) were transiently transfected with siRNAs targeted 
against the CI subunit NDUFB8 mRNA. Non-targeting siRNA (NT) was used as a negative control. (A) 
Digitonized cell extracts from the indicated cells were analyzed by BN-PAGE and immunoblotting with 
the indicated antibodies. (B) SDS-PAGE followed by immunoblot analysis of NDUFB8 in silenced cells. (C) 
Substrate-driven respiration was measured polarographically in digitonin-permeabilized cells. Oxidation 
of glutamate+malate was followed by addition of succinate to follow simultaneous oxidation. The top 
bar graph represents respiratory rates average ± SD of all repetitions. The bottom graph represents the 
ratio of oxygen consumption rates in the presence of one substrate vs the simultaneous presence of 
both substrates. Oxygen consumption rates were calculated in nmol O2/min/10
6
 cells. Three 
measurements per sample were performed in three biological replicates. Error bars represent the mean 
± SD of all repetitions. **P < 0.01. 
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8. A mutant COX7A2L variant carrying a 6-base-pair deletion present in C57BL/6 mice 
retains the ability to bind CIII2 but does not rescue SC III2+IV assembly, in humans 
To explore the functionality in human cells of the short COX7A2L isoform present in C57BL/6 
and BALB/c mouse strains(Lapuente-Brun et al., 2013; Mourier, Matic, et al., 2014), 
constitutive cell lines were generated expressing either FLAG-tagged COX7A2L (long) or a 
mutant version (short) carrying a deletion of amino acids V72 and P73 of human COX7A2L 
(Lapuente-Brun et al., 2013). Both variants where stably expressed in both WT and COX7A2L-
KO cells, which yielded no major differences in the steady-state levels of respiratory chain 
subunits, as observed in Figure 40A. MRC organization analysis by 2D-BN/SDS-PAGE revealed 
that the short COX7A2L variant was imported into mitochondria, where it colocalized with CIII2 
and SC I+III2, but not with any CIV-containing structure (Figure 40C). In addition, whereas 
expression of the long COX7A2L variant in COX7A2L-KO cells restored normal levels of CIII2 and 
SC III2+IV, the short variant did not (Figure 40C and 40D). Further BN-PAGE analysis disclosed 
that the expression of either the long or the short COX7A2L variants did not affect the steady-
state levels of the respirasomes, as observed in Figures 40B-D. These data suggest that the 2-
amino acids deletion present in the short COX7A2L isoform prevents its association with CIV 
but does not affect its binding to CIII2, an interaction that is not sufficient to promote the 
formation of the SC III2+IV. 
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Figure 40. The short-COX7A2L variant binds to CIII2 and SC I+III2, but does not rescue SC III2+IV 
assembly in COX7A2L-KO cells. Control HEK293T cells (WT) and both COX7A2L-KO (KO1 and KO2) clones 
were transfected with an empty vector (ev) or with constructs to stably overexpress COX7A2L-Myc-DDK 
(long) or short-COX7A2L-Myc-DDK (short). The reconstituted cells were used in the following 
experiments: (A) SDS-PAGE followed by immunoblotting to differentiate endogenous COX7A2L (~12.6 
kDa) from exogenous COX7A2L-Myc-DDK (~16.2 kDa). Membranes were also incubated with antibodies 
that recognize the indicated OXPHOS subunits. (B) 1D-BN-PAGE using digitonin-solubilized mitochondrial 
extracts (detergent:protein ratio 4:1) followed by CI-IGA and CIV-IGA assays, or (C) 2D-BN/SDS-PAGE and 
(D) wester-blot, and immunoblotting with the indicated antibodies. I+III2+IVn, SCs containing CI, CIII2 and 
CIV; I+III2, SC containing CI and CIII2; III2+IV, SC containing CIII2 and CIV; III2, complex III dimer (CIII2); IV, 
complex IV; IV2, complex IV dimer (CIV2); II, complex II. Subcomplexes that contain COX1 are indicated as 
subCOX1. In (D), an unidentified band running a bit faster than the SC III2+IV that cross-reacted with the  
COX5A antibody (but not with CORE2) is indicated with an asterisk. 
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CHAPTER 3. IN THE ABSENCE OF COMPLEX IV, COX7A2L-CONTAINING 
SUPERCOMPLEX I+III2 IS STABILIZED THROUGH THE STEPWISE ASSOCIATION OF 
FREE COX SUBUNITS 
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1. Human cybrids lacking CIV form diverse SC I+III2 species that contain COX7A2L and 
differ in their COX subunit composition 
All the results presented so far suggest that COX7A2L plays a regulatory role on the biogenesis 
of mitochondrial CIII but no functional impact on CIV (COX). As previously observed (Figure 14), 
the levels of COX7A2L within all the structures were significantly decreased in the CIII-KO 
mutant cybrids, and only a minor residual COX7A2L signal co-migrated with free CIV. In 
contrast, in the CIV-KO (COX1Δ) mutant cybrids, COX7A2L clearly colocalized with SC I+III2 and 
CIII2. Interestingly, very small amounts of COX7A2L were bound to CIV in the absence of CIII, 
but COX7A2L appeared at normal levels within the CIII-containing structures present in the 
absence of CIV. To further investigate the influence of COX7A2L on the MRC structural 
organization, and in particular on CIII biogenesis, this study was extended to deeply examine 
two mutant cybrids lacking CIV (CIV-KOs) due to homoplasmic nonsense mutations in the 
mtDNA-encoded COX1 and COX2 subunits. First, the levels of COX7A2L and MRC subunits were 
examined in digitonized mitochondria (Figure 41A) and whole-cell extracts (Figure 41B) from 
control and CIV-KO mutant cybrids. No differences were observed in the steady-state levels of 
CI, CII and CIII subunits between controls and mutants. Regarding the CIV subunits, the levels 
of COX4 and COX5A remained unaltered in both mutants, in agreement with their stabilization 
in common subcomplexes at early assembly stages (McStay et al., 2013; Nijtmans et al., 1998; 
Stiburek et al., 2005; Vidoni et al., 2017; Williams et al., 2004). None of the remainder COX 
subunits were detectable in the mitochondrial fractions from the COX1 deletion mutant 
(COX1Δ) (Figure 41A). However, low levels of the COX5B subunit were observed in whole-cell 
extracts (Figure 41B), suggesting alterations in the mitochondrial import of this protein in the 
COX1Δ cells. In contrast, in the COX2 deletion mutant (COX2Δ) all COX subunits were detected 
at normal levels, except for COX2 that was undetectable, and COX6C, whose levels were 
markedly lower than in control cells. Regarding COX7A2L levels, no differences were observed 
in the absence of CIV, except for a slight increase in the COX2Δ mutant compared to its 
isogenic control (Figure 41A). Interestingly, spectrophotometric measurements of the MRC 
activities showed no functional CIV enzymatic activity in both mutants, and significantly 
reduced activities of complexes I and III (Figure 41C). These data suggest that in our cellular 
models, the absence of CIV induces alterations in the enzymatic activities of complexes I and 
III, despite their steady states levels remained unaltered. 
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Figure 41. Steady states levels of MRC subunits and MRC enzyme activities in CV-KO cybrids. (A) 
Mitochondrial lysates and (B) whole cell extracts from control and mutant cybrids lacking CIV (CIV-KO) 
were analyzed by SDS-PAGE and western blot with the indicated antibodies that target COX7A2L and 
subunits from MRC complexes I, II, III and IV. (C) Spectrophotometric measurements of the enzyme 
activities of MRC complexes I to IV (CI-CIV) in COX1 and COX2 mutant cybrids, as well as in their 
respective isogenic controls and 143B cells, represented as CONTROL (n=3). Enzyme activities are 
expressed as the percentages of cU/U citrate synthase (CS). Error bands represent the mean ± SD of 
four repetitions. * p< 0.05 
 
Subsequently, the accumulation of CI-containing SCs in the CIV-lacking mutants was 
analyzed by 1D-BN-PAGE in combination with CI-IGA assays (Figure 42A). As previously 
observed, in control 143B cells the most prominent structure corresponded to the respirasome 
(band 1) that contains one single copy of CIV (SC I+III2+IV1), followed by the respirasome 
containing two copies of CIV (SC I+III2+IV2). In the mutant cybrids, however, the absence of CIV 
led to the disappearance of both respirasomes, and to a differential accumulation of CI-
containing SCs that displayed NADH dehydrogenase activity. The COX1Δ mutant presented a 
single NADH dehydrogenase-reactive band (band 2), previously demonstrated to correspond 
to fully-assembled SC I+III2, which also contained COX7A2L as a CIII-interacting protein (Figure 
16). The COX2Δ mutant, surprisingly, showed the accumulation of two differentiated NADH 
dehydrogenase-reactive bands of unknown composition (bands 3 and 4). These bands were 
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therefore excised from the blue native gels, and their protein composition was analyzed by 
high-resolution nano-LC/ESI-MS (Table 5, Appendix). The comparative proteomics analysis of 
the respirasome I+III2+IV1 (band 1) in control 143B cells revealed the presence of 93% of the 
total CI subunits, 82% of CIII subunits and 50% of CIV subunits. Parallel proteomics analyses of 
bands 2 to 4 identified ~89-91% of CI subunits in the three bands (including the whole catalytic 
NADH dehydrogenase (N) module and six mitochondrial-encoded ND subunits, except for 
ND4L that was neither detected in the respirasomes), together with all CIII components 
(including its three catalytic subunits, as well as COX7A2L), indicating that these bands 
contained fully-assembled SC I+III2 plus COX7A2L (Figure 42B). Unexpectedly, bands 3 and 4 
differed from band 2 in the presence of specific COX subunits: in band 3 only the liver isoform 
of the COX7A subunit (COX7A2) was detected (Figure 42B), whereas in band 4 subunits COX4, 
COX5B and COX7A2 were identified (Table 5, Appendix).  
Further immunoblotting analyses (Figure 43) confirmed the complete loss of CIV-
containing structures (monomeric and dimeric CIV, SC III2+IV and SC I+III2+IV1-2) in both 
mutants, together with the accumulation of the CIII dimer (CIII2) and the SC I+III2. In agreement 
with the proteomics data, no COX subunits were detected in the SC I+III2 from the COX1Δ 
mutant; however, subunit COX5B clearly colocalized with SC I+III2 in the COX2Δ cybrids, as well 
as a fainter signal corresponding to COX4. Moreover, the COX1 subunit that was not previously 
identified by proteomics, was detected by immunoblotting in the SC I+III2 from the COX2Δ 
cybrids (Figure 43A). In these cells a major proportion of the COX1 subunit colocalized in a 
subcomplex together with COX4, and both subunits accumulated in a second larger 
subcomplex together with COX5B (subIV in Figure 43B). However, subunit COX5A did not 
colocalize with SC I+III2, but accumulated in an independent subcomplex that migrated faster 
than the COX1-containing subcomplex (Figure 43C), which probably corresponds to the stable 
association of COX4-COX5A subunits (McStay et al., 2013; Nijtmans et al., 1998; Stiburek et al., 
2005; Vidoni et al., 2017; Williams et al., 2004). These results indicate that in the absence of 
CIV, different SC I+III2 species can be formed that contain COX7A2L and differ in their COX 
subunit composition. Our data also suggest that the presence of the COX1 subunit is an 
essential requirement for the recruitment or stabilization of additional COX subunits into 
subcomplexes, as well as into SC I+III2. 
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Figure 42. Identification of CI-containing SCs in control and CV-KO cybrids. (A) Digitonin-solubilized 
mitochondria from control (CON) and COX1Δ and COX2Δ mutants were separated by 1D-BN-PAGE. CI-
containing bands b1-b4 were identified by CI-IGA assays, excised from Coomassie-stained gels and 
analyzed by Nano-LC/ESI-MS. (B) MS/MS spectra from the doubly charged COX7A2 (left) and COX7A2L 
(right) peptide unambiguously detected by LC-ESI/MS in two independent experiments per sample. The 
amino acid sequence of the identified unique peptide is highlighted in red. The most intense signals on 
the MS/MS spectra correspond to the main fragmentation series (b-amino and y-carboxy). Doubly 
charged fragments are marked with superscript 2+. b1, control SC I+III2+IVn; b2, COX1Δ SC I+III2; b3, 
COX2Δ SC I+III2; b4, COX2Δ SC I+III2 plus; I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI 
and CIII; III2+IV, SC containing CIII and CIV; III2, CIII dimer. 
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Figure 43. Identification of CIV subunits in the SC I+III2. Mitochondria from control 143B cells and CIV-
KO cybrids were extracted with a digitonin:protein ratio of 4 g:1 g and analyzed by (A and C) 1D-BN-
PAGE, followed by CI in gel activity (IGA) assay and western-blot ,  or alternatively, by (B) 2D BN/SDS-
PAGE. Gels were blotted on nitrocellulose and incubated with antibodies raised against the indicated 
OXPHOS subunits. I+III2+IV1, SC containing CI, CIII and CIV; I+III2, SC containing CI and CIII; III2+IV, SC 
containing CIII and CIV; I*, CI-containing structure; III2, complex III dimer; IV, complex IV; IV2, complex IV 
dimers; II, complex II; subIV, subcomplex containing subunits COX1, COX4 and COX5B. 
 
2. Human cybrids lacking holo-CIV display a differential accumulation of stabilized 
COX subunits 
Our observation that different SC I+III2 species can be formed, all of which contain COX7A2L 
but present a differential arrangement of COX subunits was a surprising finding. Therefore, we 
analyzed the biogenetic dynamics of these COX subunits in SC I+III2, and compared them with 
those of COX7A2L and selected subunits from the remainder MRC complexes in both CIV-KO 
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mutants and control 143B cells. To this aim, cells were cultured for 6 days in the presence of 
doxycycline to reversibly inhibit mitochondrial translation. Whole cell extracts were collected 
at different time-points (0, 6, 15, 24, 48, 72 and 96 hours) after doxycycline removal. The 
reappearance of MRC subunits after the reversible blockage of assembly was analyzed by SDS–
PAGE and immunoblotting with a panel of twelve antibodies raised against MRC subunits and 
COX7A2L (Figure 44). Untreated cells (SS) were included in the panel as a positive control. No 
alterations were observed in the levels of the CII subunit SDHA, as expected since this complex 
lacks mtDNA-encoded subunits. However, there were remarkable differences in the 
reemergence patterns of the MRC subunits from complexes I, III and IV, which were classified 
in three groups. The first group included the mitochondrial-encoded subunits COX1 and COX2 
(subunits colored in red), which were undetectable in the 143B cells after 6 days of doxycycline 
treatment (lane 0). Both subunits appeared 15-24 h after removal of the inhibitor, and 
gradually increased until they reached their steady-state at 96 h. Since these subunits were 
directly targeted by the drug, these data indicate that the inhibition of mitochondrial 
translation worked efficiently and that no pools of preassembled subcomplexes accumulated 
during doxycycline treatment. The COX1 subunit was detected in the COX2Δ mutant following 
a similar reappearance pattern than the control. The second group included the CI NDUFA9, 
the CIII CORE2, and the CIV COX4 and COX5A subunits (subunits colored in green). These 
subunits remained clearly visible upon mitochondrial translation inhibition (lane 0), indicating 
their stabilization in preassembled subcomplexes, and they reached steady-state levels at 6-15 
h after doxycyline removal, in accordance with their early incorporation into their 
corresponding MRC complexes (Stiburek et al., 2006; Vogel et al., 2007; Zara et al., 2009b). The 
third group included the CI NDUFS1, the CIII RISP, and the CIV COX5B and COX6C subunits, as 
well as COX7A2L (subunits colored in blue). There were relatively low levels of these proteins 
upon doxycycline treatment (lane 0), which gradually reached their steady-states at 96 h. This 
result suggests that these proteins might not be fully stabilized in preassembled subcomplexes, 
and it is in agreement with the fact that they all enter the assembly process relatively late 
(Fernandez-Vizarra et al., 2007; Lazarou et al., 2007; Stiburek et al., 2006). No major 
differences were observed in the kinetics of reappearance of most MRC subunits between 
143B cells and the CIV-lacking cybrids, except for the fact that subunits COX1, COX2 and COX6C 
were undetectable in the COX1Δ mutant, while only subunit COX2 was missing in the COX2Δ 
mutant, which also displayed a poor accumulation rate of the COX6C subunit compared with 
the control. These results suggest alterations in the composition and proportion of CIV 
subunit-containing subcomplexes in cybrids lacking holo-COX. 
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Figure 44. Dynamics of reappearance of COX7A2L and MRC subunits in control and CIV-KO cybrids 
reversibly treated with doxycycline. Whole cell extracts from doxycycline-treated 143B cells and COX1Δ 
and COX2Δ cybrids were analyzed by SDS-PAGE and western blot with the indicated antibodies. The 
reappearance kinetic patterns were classified in three groups indicated as red, green and blue. The 
subunits are coloured so that those of the same colour belong to same group. I+III2+IVn, SC containing 
CI, CIII, and CIV; III2+IV, SC containing CIII and CIV; III2, CIII dimer; IV, CIV; the asterisk indicate the 
matching subunit recognized by the antibody. 
 
3. COX7A2L-containing SC I+III2 is fully-assembled prior to the insertion of COX 
subunits 
To investigate how the absence of CIV affects the biogenesis of CI-containing SCs, the assembly 
dynamics of the SC I+III2 species in the CIV-KO mutant cybrids were compared with that of the 
respirasomes (SC I+III2+IV1-2) in control 143B cells. To this aim, the reappearance of NADH 
dehydrogenase-active SCs was first analyzed in digitonized mitochondria from doxycycline-
treated cells by 1D-BN–PAGE in combination with CI-IGA assays (Figure 45A, upper panel). In 
parallel, the incorporation rates of newly-synthesized CI subunits into these structures was 
examined by BN-PAGE and immunoblotting with antibodies that recognize subunits NDUFA9 
and NDUFS1 (Figure 45A, medium and lower panels). This two CI subunits are representative 
of early-intermediate and late CI assembly stages, respectively (Formosa et al., 2017; 
Guerrero-Castillo et al., 2017; Sanchez-Caballero et al., 2016). Signals from at least three 
independent experiments were quantified, normalized to CII, and expressed relative to the 
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steady-levels in untreated cells (SS) (Figure 45B and 45C). Significant differences were neither 
observed in the kinetics of incorporation of CI subunits, nor in the accumulation of active CI 
within the SCs from control and CIV-KO cybrids (Figure 45B). In control 143B cells, the 
incorporation of the NDUFS1 subunit (that belongs to the catalytic N-module) into the 
respirasomes was initially delayed in comparison with the NDUFA9 subunit (Figure 45C), in 
agreement with previous results of our group (Moreno-Lastres et al, 2012). However, in the 
CIV-KO cybrids both subunits first accumulated at the same rates within a  ̴1100 kDa band 
showing NADH dehydrogenase activity, compatible with fully-assembled CI (Figure 45A and 
45C), and then incorporated within SC I+III2. These data suggest that the lack of CIV promotes 
the integration of fully-assembled CI into SC I+III2. 
The same approach was used to subsequently analyzed the assembly kinetics of newly-
synthesized CIII subunits by 2D-BN/SDS-PAGE and western-blot with antibodies that recognize 
CORE2 and RISP (Figure 46), representative of early and late CIII assembly stages, respectively 
(Fernández-Vizarra and Zeviani, 2015; Zara et al., 2009a). Following 6 days of doxycycline 
treatment (time 0h) only residual levels of CORE2 and RISP subunits were detected in co-
localization with the CIII dimer (CIII2) (Figure 46A). Upon doxycycline removal, the amounts of 
both subunits within CIII2 increased gradually and then moved towards the position of SCs 
(Figure 46A). Again, no significant differences were detected in the incorporation rates of CIII 
subunits into SCs I+III2 and I+III2+IV1-2 between the control and COXΔ cybrids (Figure 46B). The 
assembly kinetics of CORE2 within SCs was similar to that of the CI subunit NDUFA9 (Figure 
45A), and significantly faster than that of the RISP subunit both in control and COXΔ cybrids 
(Figure 46A and 46C). These results indicate that a RISP-lacking pre-SC I+III2 is formed at an 
early assembly stage, to which the catalytic RISP subunit is later added to yield fully-assembled 
SC I+III2, in agreement with previous observations (Fernández-Vizarra et al., 2009; Moreno-
Lastres et al., 2012; Sánchez et al., 2013; Wagener et al., 2011). 
 Finally, the assembly kinetics of COX7A2L into SC I+III2 was analyzed in the COX1Δ 
cybrids (Figure 47A). As for CIII subunits, a residual COX7A2L signal was initially detected (time 
0h) only in co-localization with the CIII dimer (CIII2). Upon doxycycline removal, COX7A2L 
accumulated gradually within CIII2 and then moved towards the position of SC I+III2 at similar 
assembly rates than the CORE2 subunit, as previously observed in control 143B cells (Figures 
47B and 21). Altogether, these data indicate that COX7A2L-containing SC I+III2 is normally 
assembled prior to the insertion of COX subunits.  
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Figure 45. Assembly kinetics of CI subunits into COX7A2L-containing SC I+III2. 143B (CON) cells and CIV-
KO (COX1Δ and COX2Δ) cybrids were cultured for 6 days in the presence of 15 μg/ml doxycycline and 
collected at different time points (0, 6, 15, 24, 48, 72 and 96h) after doxycycline removal. (A) 
Mitochondria prepared from these samples were extracted with a digitonin:protein ratio of 4 g/g and 
analyzed by 1D-BN-PAGE in combination with CI-IGA assays and immunoblotting with the indicated 
antibodies. (B) Mean incorporation rates of subunits NDUFA9 and NDUFS1, involved in early and late 
steps of CI assembly respectively, in the SC I+III2+IV1-n in control cells and in SC I+III2 in CIV-KO cybrids. (C) 
The assembly dynamics of the same subunits were compared with each other in the three cell lines. The 
signals from three independent experiments were quantified and normalized by CII. Time point values 
are expressed as percentages of the untreated cells (SS), and indicated as means ± SD. I+III2+IV1, SCs 
containing CI, CIII and CIV; I+III2, SC containing CI and CIII; II, complex II; I, complex I. 
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Figure 46. Assembly kinetics of CIII subunits into COX7A2L-containing SC I+III2. 143B (CON) cells and 
CIV-KO (COX1Δ and COX2Δ) cybrids were cultured for 6 days in the presence of 15 μg/ml doxycycline 
and collected at different time points (0, 6, 15, 24, 48, and 72h) after doxycycline removal. (A) 
Mitochondria prepared from these samples were extracted with a digitonin:protein ratio of 4 g/g and 
analyzed by 2D-BN/SDS-PAGE and immunoblotting with the indicated antibodies. (B) Mean 
incorporation rates of subunits CORE2 and RISP, involved in early and late steps of CIII assembly 
respectively, in the SC I+III2+IV1-n in control cells and in SC I+III2 in CIV-KO cybrids. (C) The assembly 
dynamics of the same subunits were compared with each other in the three cell lines. The signals from 
three independent experiments were quantified and normalized by CII. Time point values are expressed 
as percentages of the untreated cells (SS), and indicated as means ± SD. I+III2+IV1, SCs containing CI, CIII 
and CIV; I+III2, SC containing CI and CIII; III2, dimeric complex III; II, complex II; I, complex I. 
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Figure 47. Assembly kinetics of COX7A2L into SC I+III2 in COX1Δ cybrids. (A) COX1Δ cybrids were 
cultured for 6 days in the presence of 15 μg/ml doxycycline and collected at different time points (0, 6, 
15, 24, 48, 72 and 96h) after doxycycline removal. Mitochondria prepared from these samples were 
extracted with a digitonin:protein ratio of 4 g/g and analyzed by 2D-BN/SDS-PAGE and immunoblotting 
with the COX7A2L antibody. 143B (CON) cells were used as control. (B) Mean incorporation rates of 
COX7A2L and CIII subunit CORE2 in the SC I+III2 from COX1Δ cybrids. I+III2+IV, SC containing CI, CIII and 
CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; III2, complex III dimer; IV, complex 
IV. 
 
4. COX subunits are integrated into fully-assembled SC I+III2 in a stepwise fashion 
The fact that the COX1Δ mutant failed to assemble any COX subunit within SCI+III2, suggests 
that COX1 synthesis is an essential requirement for the integration of CIV into the 
respirasomes. Remarkably, in the COX2Δ cybrids the colocalization of specific CIV subunits 
(namely COX1, COX4, COX5B and COX7A2) with SC I+III2 suggested an unusual biogenetic 
regulatory mechanism for CIV assembly in the respirasomes. To investigate how this process 
takes place, the assembly kinetics of newly-synthesized CIV subunits into SC I+III2 were 
analyzed by 2D-BN/SDS-PAGE and immunoblotting with antibodies that recognize early-
assembly subunits (COX1, COX4 and COX5A) and late-assembly subunits (COX5B and COX6C) 
(Figure 48). Both in control 143B cells and COX2Δ mutants, subunit COX1 got incorporated into 
SCI+III2 with the fastest assembly rates, probably representing the first CIV assembly step 
(Figure 48A and 48B). In control cells, COX1 incorporation was sequentially followed by 
subunits COX4 and COX5A, and later by COX5B and COX6C, an order that resembles the 
canonical CIV assembly pathway (Fontanesi et al., 2008). In the COX2Δ mutants, however, 
COX1 incorporation into SCI+III2 occurred ahead of the incorporation of subunits COX5B and 
COX4. Subunits COX5A and COX6C did not get integrated into SCs despite they remained 
stabilized in small subcomplexes. The assembly kinetics of subunit COX4 in the SC I+III2 was 
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slower than those of the COX1 and COX5B subunits (Figure 48B), observation that agrees with 
its low steady-state levels (see Figure 43) in this supercomplex. Unfortunately, due to the lack 
of an efficient antibody against subunit COX7A2, the assembly dynamics of this subunit was 
not analyzed. However, COX7A2 was the only CIV subunit detected by proteomics in the 
lowest SC I+III2 band from the COX2Δ cybrids (Figure 42 and Table 5, Appendix), providing 
evidence that subunit COX7A2 is probably incorporated prior to the insertion of COX5B and 
COX4. These data therefore suggest that CIV subunits are integrated into fully-assembled SC 
I+III2 in a stepwise fashion that differs between control and COX2Δ cybrids.  
 These observations are consistent with the structural positions of the analyzed COX 
subunits within the human respirasome (Guo et al., 2017). As shown in Figure 49, the COX7A2 
subunit would attach COX1 to the concave surface formed by CIII2 and the distal end of the CI 
membrane arm, an interaction that could be further stabilized by the binding of COX5B to CIII2 
(Letts, Fiedorczuk, et al., 2016; Wu et al., 2016). In contrast, the association of COX4 to this 
partially-assembled SC I+III2+subcomplex [COX1+COX7A2+COX5B] is probably rather unstable, 
which is reflected in the low steady-state levels (Figure 43) and slow assembly kinetics (Figure 
48) of COX4 in this SC. 
 
5. The association of free COX subunits confers stability to SC I+III2 
The accumulation of a partially-assembled SC I+III2 with associated COX subunits is thus an 
intriguing feature of cybrids lacking COX2, but not COX1. Among the possible hypotheses, the 
presence of these free COX subunits may confer stability to SC I+III2. To test this hypothesis, 
radioactive pulse-chase analysis of the 13 mitochondrial translation products was performed, 
in cybrids grown in regular culture medium. The time course of their incorporation into the 
individual MRC complexes and SCs was subsequently analyzed by 2D-BN/SDS-PAGE and 
autoradiography (Figure 50). The relative positions of the labelled mtDNA-encoded subunits 
are indicated according to their molecular weight in control 143B cells (left panel), as well as in 
the COX2Δ (middle panel) and COX1Δ (right panel) mutants. After a 2 hours pulse (T0) and a 
chase period of 4 hours (T4), most of the signals corresponding to newly-synthesized subunits 
of CI (ND1-6) and CIII (cytochrome b, CYTB) were progressing from large subcomplexes (in the 
case of CI proteins) and from free CIII2 (detected from the CYTB signal) to SCs. Between 4-8 
hours after chase initiation (times T4-T8), in the 143B cells the COX1, COX2 and COX3 subunits 
were present in fully-assembled CIV, but not yet integrated in SCs. As expected, no COX 
subunits were detected in the COX1Δ cybrids. In the COX2Δ cybrids, however, the COX1 and 
COX3 subunits accumulated in low molecular weight subcomplexes incapable to reach the CIV 
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position. At 16 hours after chase initiation (T16), in control 143B cells most of the newly-
synthesized CI subunits, >50% of CIII CYTB and ~10-15% of CIV subunits were already residing 
in the fully-assembled respirasomes I+III2+IV1. In the COX1Δ and COX2Δ mutants the SC I+III2 
was also fully-assembled at T16, although there was a larger accumulation of CI subcomplexes 
and SC-unbound CIII2 than in control cells, in agreement with previous observations (Figures 
43A and 46A). Regarding CIV subunits in the COX2Δ cybrids, at T16 the COX1 signal was still 
mostly accumulated in small subcomplexes while the COX3 signal disappeared, suggesting the 
rapid degradation of this subunit when COX2 is not present. After 24-hours chase (T24) the 
respirasomes I+III2+IV1 remained clearly visible in control 143B cells, as well as SC I+III2 in the 
COX2Δ cybrids. However, in the COX1Δ cybrids the radioactive signals for CI and CIII subunits 
declined within SC I+III2, while the relative proportion of subcomplexes increased. Therefore, 
these results point to the rapid turnover of SC I+III2 in the absence of COX1 and strongly 
suggest that this SC could be stabilized in the COX2Δ mutants due to the association of free 
COX subunits. 
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Figure 48. Assembly kinetics of COX subunits in the COX7A2L-containing SC I+III2. (A) Mitochondria 
from doxycycline-treated COX2Δ mutant cybrids were extracted with a digitonin:protein ratio of 4 g:1 g 
and analyzed by 2D-BN/SDS-PAGE and western blot with the indicated antibodies. (B) Densitometric 
profiles representing the incorporation rates of COX subunits into SC I+III2. The signals from three 
independent experiments were quantified and normalized by CII. Time point values are expressed as 
percentages of the untreated cells (SS) and indicated as means ± SD. Control 143B (CON) values were 
obtained from (Moreno-Lastres et al., 2012). SC, supercomplex containing CI, CIII and CIV in the control; 
I+III2, SC containing CI and CIII; III2+IV, SC containing CIII and CIV; IV, complex IV; subCIV, subcomplex IV. 
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Figure 49. Arrangement of the COX subunits detected in association with SC I+III2. The upper 
illustrations depict lateral views of human SC I+III2+IV1, in which CI (aquamarine) and dimeric CIII (CIII2) 
(light green) are positioned along the inner membrane plane (dots). CIV is represented as a smooth 
backbone with the associated COX subunits highlightened to show their positions relative to SC I+III2. 
The COX7A2 (blue) and COX5B (red) subunits attach COX1 (yellow) to the concave surface formed by 
CIII2 and the CI membrane arm. COX4 (magenta) interacts with COX1 on the distal side of the CIV 
monomer. The same structure viewed from the matrix (M) and from the inter membrane space (IMS) is 
depicted in the medium and lower illustrations, respectively. The figure was created in the PDB 
database using the structure 5XTH (Guo et al., 2017). 
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Figure 50. COX subunits-containing SC I+III2 is more stable than COX free-SC I+III2. Mitochondrial 
translation products were pulse-labeled in 143B and CIV-KO cells with [
35
S]-methionine for 2 hours in 
the presence of emetine to inhibit cytosolic translation. In pulse experiments, the cells were then 
washed and incubated with fresh complete culture media for the indicated time points (T0- T24h). The 
radiolabeled mitochondrial proteins were separated by 2D-BN/SDS-PAGE and visualized by 
autoradiography. SC, supercomplex containing CI, CIII and CIV in the control; I+III2, SC containing CI and 
CIII; III2, dimeric CIII; IV, complex IV; V, complex V. 
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1. Functional characterization of human COX7A2L 
The main purpose of this work has been to address how the biogenesis of human 
mitochondrial SCs is regulated and to clarify the role of the COX7A2L assembly factor in this 
process. Studies on COX7A2L function have been surrounded by conflicting results (Davoudi et 
al., 2016; Ikeda et al., 2013; Lapuente-Brun et al., 2013; Mourier, Ruzzenente, et al., 2014; 
Williams et al., 2016), mostly obtained in mouse models, which the present study is now 
helping to clarify. In the first chapter of the results section, we have shown that COX7A2L 
preferentially interacts with mitochondrial CIII and, to a minor extent, with CIV to promote the 
formation and stabilization of SC III2+IV in a respirasome-independent manner in both mice 
and humans. In the second chapter, we have generated TALEN-based COX7A2L knockout 
(COX7A2L-KO) HEK293T cell lines to show that the absence of COX7A2L prevents SC III2+IV 
formation without affecting de novo CIV biogenesis, but it enhances the assembly and 
accumulation of dimeric CIII (CIII2) with a parallel delay in the formation of CIII-containing SCs 
and respirasomes that, nonetheless, are capable to reach control steady-state levels. Despite 
of the structural reorganization of the MRC complexes and SCs, functional substrate 
competition assays showed normal mitochondrial respiration in the COX7A2L-KO cells. 
However, upon enzymatic or structural induction of CI deficiency, COX7A2L-KO cells 
significantly favored electron flux through CII.  
Cox7a2l was originally presented as an exclusive SC assembly factor essential for the 
incorporation of CIV into SCs III2+IV and I+III2+IV1-n in mice (Lapuente-Brun et al., 2013). To 
investigate the functional role of human COX7A2L, we first used a combination of biochemical 
techniques and high-throughput proteomics to demonstrate that COX7A2L co-migrates with 
CIII2, monomeric CIV, SC I+III2, SC I+III2 and the respirasomes (SC I+III2+IV1-n) in both mice and 
humans. Therefore, COX7A2L is not exclusively present in SCs, as previously reported 
(Lapuente-Brun et al., 2013; Müller et al., 2016). Moreover, the co-localization patterns of 
COX7A2L in control and mutant cybrids lacking one MRC complex, and the fact that the 
stability of COX7A2L depends on the presence of CIII suggest that COX7A2L behaves as a CIII 
structural component. In agreement, COX7A2L remained associated with CIII2 and CIII-
containing SCs in the absence of CI and CIV, and COX7A2L pull-down showed its preferential 
binding to CIII subunits. Furthermore, analyses of the SCs assembly rates upon reversible 
treatment with doxycycline showed that COX7A2L bound first to a reported CIII assembly 
intermediate that lacks the catalytic RISP subunit (pre-CIII2) before it interacts with free CIV, SC 
III2+IV or the respirasomes. In agreement with this observation, COX7A2L remained associated 
with pre-CIII2 in HeLa cells with an impaired incorporation of RISP. In contrast, the lack of the 
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central CIII subunit cytochrome b precluded the formation of pre-CIII2 and led to the 
disassociation of COX7A2L from CIV. Overall, our data dissent from the proposed role of 
COX7A2L as an assembly factor exclusive to CIV-containing SCs (Lapuente-Brun et al., 2013).  
In C57BL/6 and BALB/c mouse strains, the lack of residues V72-P73 in a naturally-
occurring short Cox7a2l variant was found to impact Cox7a2l stability and its role in the 
assembly of SC III2+IV, the respirasomes, as well as on mitochondrial respiration (Ikeda et al., 
2013; Lapuente-Brun et al., 2013). In contrast, our present results in heart mitochondria from 
different mice strains confirmed the specific loss of SC III2+IV in the C57BL/6 mice with normal 
levels of respirasomes and MRC enzymatic activities. Moreover the respirasomes, but not SC 
III2+IV, remained stabilized in heart mitochondria from C57BL/6 mice solubilized with 
increasing detergent concentrations. These data indicate that the respirasomes are stable 
structures that do not dependent on the Cox7a2l allelic variations, in accordance with previous 
studies (Mourier et al., 2014). Also at variance with the previous studies in fibroblasts from 
Cox7a2l-deprived mice (Lapuente-Brun et al., 2013), COX7A2L mRNA silencing in human cells 
led to significantly reduced levels of the COX7A2L protein, with a specific loss of SC III2+IV but 
without apparent alterations in the amounts of CIII2, monomeric CIV and the respirasomes, nor 
in the mitochondrial function. Therefore, our data contradict the hypothesis that COX7A2L is 
an assembly factor that regulates the respirasome formation and, on the contrary, points out a 
specific role in the biogenesis and stabilization of SC III2+IV in a respirasome-independent 
manner. It is important to note that transient COX7A2L overexpression in human cell lines did 
not cause a significant increase in the levels of individual complexes III and IV, or in the SCs 
(including SC III2+IV). These data suggested that COX7A2L is probably essential for the 
formation and stabilization of SC III2+IV, but nonetheless it does not regulate its maximum 
levels. 
All our previous results pointed towards the preferential interaction of COX7A2L with 
mitochondrial CIII2 and, to a minor extent, with monomeric CIV to specifically promote SC 
III2+IV biogenesis in both mice and humans. However, according to our experimental approach 
based on the transient silencing of COX7A2L mRNA expression in human cell lines, COX7A2L 
would neither play a determinant role in the biogenesis, stabilization and function of the free 
OXPHOS complexes, nor in the formation of the respirasomes I+III2+IV1-n. Since this 
experimental strategy still yielded low levels of the COX7A2L protein, results were not fully 
conclusive. Consequently, the biochemical and functional characterization of TALEN-generated 
COX7A2L-KO human cell lines presented in the second chapter of the results section aimed to 
provide unambiguous insights into the regulation of the MRC structural organization and 
respiratory metabolism by human COX7A2L. Our results showed that whereas the SC III2+IV is 
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not formed in human COX7A2L-KO cells, the respirasomes I+III2+IV1-n are assembled at slower 
rates but eventually accumulate to control steady-state levels. These data are in agreement 
with our former observation in COX7A2L-silenced cells, as well as with previous studies that 
clearly showed the presence of respirasomes in different tissues from C57BL/6 mice, including 
the heart, liver, and skeletal muscle (Davoudi et al., 2014; Hatle et al., 2013; Ikeda et al., 2013; 
Jha et al., 2016; Milenkovic et al., 2013; Mourier et al., 2014; Williams et al., 2016), in contrast 
with the initial report (Lapuente-Brun et al., 2013). It is thus conceivable that in vivo, the effect 
of mouse Cox7a2l in the SCs assembly rates may vary from tissue to tissue, which could be a 
contributing factor to explain why respirasomes containing more than one CIV unit (I+III2+IV2-n) 
seem to be less abundant in liver than in heart from C57BL/6 mice (Williams et al., 2016). 
However, it is important to acknowledge that the observed changes in mice samples may not 
necessarily be a consequence of genetic Cox7a2l variation, but could well be explained by 
other types of genetic differences among mouse strains. Based on our data, we cannot exclude 
the possibility that the mechanisms of SC assembly are regulated in a tissue-dependent 
manner, as recently proposed (Jha et al., 2016; Williams et al., 2016), and that the previously 
reported absence of respirasomes in mouse strains with the truncated Cox7a2l allele 
(Lapuente-Brun et al., 2013) was a result from differences in the methodologies or reagents 
used for membrane protein solubilization. In fact, we observed variations in the intensities of 
different SC bands between C57BL/6J and CD1 mice strains at high detergent concentrations; 
however, the pattern was not constant, as specific SCs were stabilized in C57BL/6J mice but 
not in CD1 mice, and vice versa. On the same line, milder SCs extraction conditions (using 
digitonin at a detergent-to-protein ratio of 1-2:1) revealed no differences in the steady-state 
levels of SCs I+III2+IV1-n between COX7A2L-KO and WT cells, but a decrease in the abundance of 
larger SCs (I+III2+IV2-n) in COX7A2L-KO cells.  
Regarding the functional impact of the short COX7A2L variant in human cell lines, 
overexpression of a short COX7A2L did not support SC III2+IV assembly in COX7A2L-KO cells, as 
previously seen in C57BL/6 mice (Lapuente-Brun et al., 2013); but in contrast with the former 
report, it neither affected the steady-state levels of SCs I+III2+IV1-n. As we had observed in 
heart mitochondria from C57BL/6 mice, the human version of short COX7A2L retained the 
ability to bind both CIII2 and SC I+III2, but it did not interact with CIV or CIV-containing 
respirasomes. In contrast, WT (long) COX7A2L preferentially co-segregated with CIII2, 
monomeric CIV, as well as with SCs III2+IV and the respirasomes in human HEK293T cells, as it 
occurs in our mouse heart mitochondria from CD1 mice and in human 143B osteosarcoma 
cells. Altogether these data are consistent with our view that the formation and stabilization of 
SC III2+IV relies on the association of COX7A2L with CIII2 and CIV through independent protein 
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domains. This is in agreement with recent observations where COX7A2L binding to CIV 
requires the correct orientation of a histidine residue at position 73 (Cogliati et al., 2016). 
These results suggest that COX7A2L promotes specific interactions between CIII2 and CIV that 
are essential for their association into SC III2+IV, which are probably different to their 
interactions in the respirasomes, where CI is recruited into the macrostructure (Gu et al., 2016; 
Guo et al., 2017; Letts, Fiedorczuk, et al., 2016; Sousa et al., 2016; Wu et al., 2016). In this 
regard, it is tempting to speculate that different pathways may operate to assemble the 
different SCs. The fact that mammalian COX7A2L is essential to maintain SC III2+IV stability, but 
it plays no critical role in the assembly or stabilization of SC I+III2+IV1-n strongly suggests that 
there must be independent regulatory mechanisms for the biogenesis and turnover of SC 
III2+IV and the respirasomes. SC III2+IV could be assembled by the coming-together of the 
individual complexes, which requires the earlier insertion of COX7A2L in the pre-CIII2 (Figure 
51). In contrast, SC I+III2+IV1 would be assembled in a COX7A2L-independent manner, 
compatible with the incorporation of newly-synthesized subunits/subassemblies from CIII2 and 
CIV that accumulate once these fully-assembled complexes have reached their steady-state 
levels, into larger structures containing CI intermediates, as previously proposed (Moreno-
Lastres et al., 2012) (Figure 51).  
The total absence of COX7A2L in our COX7A2L-KO cells led to an unexpected significant 
accumulation of CIII2 levels, which were restored to normal by complementation with the long-
COX7A2L variant, but not with the short variant despite it retained the ability to bind the 
complex. Along this line, we previously mentioned that in cybrid cell lines lacking CIII2, 
COX7A2L stability was largely compromised. Furthermore, de novo assembly studies in control 
143B cells showed that whereas COX7A2L assembles into a pre-CIII2 before the incorporation 
of the catalytic RISP subunit, COX7A2L only joins CIV once this complex is fully assembled. 
These negative genetic interactions indicate a regulatory role for COX7A2L in CIII2 biogenesis, 
rather than an adaptation to the inability to form and utilize the SC III2+IV. As a hypothesis, 
COX7A2L could establish a CIII2 quality control checkpoint before the complex becomes 
functionally active by the incorporation of RISP, which would be reminiscent to the role played 
by MITRAC7 on regulating the turnover of COX1-containing intermediates during CIV assembly 
(Dennerlein et al., 2015). Based on our data so far, there seems to be a relationship between 
the deregulation in the CIII2 steady-state levels provoked by the absence of COX7A2L and the 
delay the formation of the I+III2+IV1 respirasomes (Figure 52), as well as on the further 
incorporation of additional fully-assembled CIV units to generate I+III2+IV2-n respirasomes. Our 
results argue that whereas COX7A2L would be permanently associated with CIII, it would exist 
in association/dissociation equilibrium with CIV, which could define the fate of CIV depending 
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on whether COX7A2L is bound to it or not. This would provide a mechanism whereby 
COX7A2L-bound CIV is guided to the proximity of CIII to form and stabilize SC III2+IV. In this 
aspect, COX7A2L would resemble HIG2A, the human orthologue of the yeast Rcf1 SC factor. In 
yeast, Rcf1 preferentially associates with CIV to mediate SCIII2+IV1–2 stability (Chen et al., 2012; 
Strogolova et al., 2012; Vukotic et al., 2012). Several human homologs of Rcf1 have been 
reported, whereof HIG2A is involved in the stabilization of a portion of CIV-containing SCs 
(Chen et al., 2012). C11ORF83 or UQCC3A, a cardiolipin-binding protein involved in the early 
stages of human CIII assembly, has also been reported to act as a SC III2+IV-stabilizing factor 
(Desmurs et al., 2015). The similarities in modes of action between these proteins and 
COX7A2L make it conceivable that they could act in conjunction, having a respiratory chain 
‘‘stabilizing’’ or ‘‘gluing’’ function, although further studies are required to demonstrate such 
functional interactions.  
The impact of the MRC structural remodeling promoted by COX7A2L on mitochondrial 
physiology has also been a source of controversy. The fact that the formation and stabilization 
of a less abundant structure such as SCIII2+IV is regulated by a specific protein like COX7A2L in 
a respirasome-independent manner may be indicative of the, yet not well-understood, 
physiological importance of SC III2+IV. Originally, it was proposed that COX7A2L-dependent SCs 
organization remodeling would provide a mechanism for the physiological regulation of energy 
metabolism in mammals by providing alternate paths for electrons derived from the 
catabolism of specific substrates (Lapuente-Brun et al., 2013). In this model, electron flux from 
CI to CIII2 (carried by NADH) would proceed essentially within the CI-containing SCs, whereas 
electron flow from CII (carried by FAD) would preferentially occur through free CIII2 and SC 
III2+IV (Lapuente-Brun et al., 2013). ATP production and respiration rates were found higher in 
mouse liver mitochondria and permeabilized fibroblasts with the unstable short-COX7A2L 
variant, both in the presence of pyruvate + malate (NADH-linked substrates) or succinate (FAD-
linked substrate), whereas maximal respiration and ATP production in cells expressing long-
COX7A2L required substrates for both electron transfer paths (Lapuente-Brun et al., 2013). 
However, other groups reported lower mitochondrial respiration and ATP synthesis in muscle 
(Ikeda et al., 2013) and liver (Shiba et al., 2017) from COX7A2L-KO mice, or no effect of short-
COX7A2L on mouse heart mitochondrial respiration (Mourier et al., 2014). Our human 
COX7A2L-KO cellular models displayed no differences with WT cells in coupled endogenous cell 
respiration, or in single and combined substrate (glutamate-malate or succinate) oxidation, 
indicating a minor functional role of COX7A2L in normal cultured cell physiological conditions. 
However, the induction of CI deficiency in COX7A2L-KO cells had a significant effect on the 
simultaneous oxidation of glutamate-malate and succinate, which proceeded at rates 
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significantly higher than in WT cells. These data would support the idea that when CI (and 
hence, the respirasome) is compromised, electron flow from CII preferentially occurs through 
free CIII2 rather than by SC III2+IV that is absent in COX7A2L-KO cells. By dynamically regulating 
CIII2 levels, the formation of SC III2+IV, and the kinetics of respirasome assembly, COX7A2L 
would adjust the rate of electron flow from CII to SC-unbound CIII2, which would limit FADH2 
oxidation when the catalytic function of CI and NADH oxidation are compromised (Figure 53). 
This could be a way to facilitate adaptation to varying carbon sources, as previously proposed 
(Lapuente-Brun et al., 2013). Alternatively, COX7A2L could be part of a metabolic response to 
accelerate CIII-containing SCs assembly when needed. How metabolism may compensate for 
CI deficiency in patients suffering from mitochondrial disorders remains intriguing (Zielinski et 
al., 2016), but the reported compensatory increase in CII activity is not sufficient to overcome 
the cellular respiratory defect (Esteitie et al., 2005). The value of this compensatory response is 
highlighted by the recent report that cell-permeable succinate prodrugs can bypass 
mitochondrial CI deficiency in cultured cells (Ehinger et al., 2016). Our data suggest that 
COX7A2L could be a key regulator of this adaptive process, which has vast clinical implications 
and could pave the way for novel COX7A2L-targeted gene therapy interventions.  
The experimental evidence of independent regulatory mechanisms and proteins for 
the biogenesis of intermediate SCs and the respirasomes opens new doors for exciting future 
investigations of the role for these supramolecular structures in the regulation of cellular 
energy supply. 
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Figure 51. Human COX7A2L-mediated SC III2+IV biogenesis is independent of respirasome assembly. 
COX7A2L is bound to pre-CIII2 and CIV binds to COX7A2L-containing pre-III2 prior to the incorporation of 
RISP (UQCRFS1). The assembly pathways of individual CIII2 (green) and CIV (red), CI (blue) within the 
respirasome are depicted according to stablished models (Bottani et al., 2017; Moreno-Lastres et al., 
2012; Vidoni et al., 2017), where SC III2+IV is formed independently of the respirasome. 
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Figure 52. Structural rearrangements of the respiratory chain in the absence of COX7A2L. Fully-
assembled CIII2 and CIV accumulate until they reach a threshold that ignites SC III2+IV and respirasome 
assembly at rates arbitrarily indicated by arrows. In the absence of COX7A2L, CIII2 levels are ~3-fold, SC 
III2+IV is not formed and the assembly kinetics of CIII-containing SCs is slower. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53. Functional rearrangements of the respiratory chain in the absence of COX7A2L. In 
physiological conditions, individual and simultaneous oxidation of NADH- and FAD-linked substrates is 
similar in wild-type and COX7A2L-KO cells. However, when CI activity in respirasomes is inhibited, 
succinate oxidation is enhanced in the absence of COX7A2L presumably due to the larger accumulation 
of CIII2 and/or absence of SC III2+IV in the KO cells. Mitochondrial CI, CIII2 and CIV are represented in 
blue, green and red, respectively. COX7A2L is represented as a black stick. 
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2.  COX7A2L and the structural organization of the respiratory chain in human 
cybrids lacking complex IV 
In cellular and animal models of mitochondrial disease, mutations that generate failures in the 
assembly or stability of MRC complexes I, III and IV may also affect the formation, stability and 
activity of other OXPHOS complexes. This will probably lead to a specific accumulation of 
assembly intermediates that may allow us not only to elaborate a more detailed map of the 
biosynthetic pathway of the MRC complexes and SCs, but also to better determine the role of 
COX7A2L as well as of other assembly factors involved in the process. The results presented so 
far in this study suggest that, besides being essential for the formation and stabilization of SC 
III2+IV, COX7A2L plays a regulatory role on the biogenesis of mitochondrial CIII2, but has no 
functional impact on CIV. In the third chapter of the results section, we have further 
investigated the influence of COX7A2L on the structural organization of the respiratory chain, 
and in particular on the biogenesis of CIII-containing structures, in human cellular models of 
CIV deficiency. In particular, we have analyzed two mutant cybrids lacking CIV (CIV-KOs) due to 
homoplasmic nonsense mutations that lead to the complete loss of the mtDNA-encoded COX1 
and COX2 subunits (COX1Δ and COX2Δ, respectively). As we had previously demonstrated in 
chapter 1, in the COX1Δ cybrids there was an accumulation of CIII2 and SC I+III2 that clearly 
colocalized with COX7A2L (Figure 14). Interestingly, very small amounts of COX7A2L were 
bound to CIV in the absence of CIII, but COX7A2L appeared at normal levels within the CIII-
containing structures present in the absence of CIV. We next extended our experimental 
strategy to BN-PAGE in combination with proteomics, and time-course analysis of OXPHOS 
subunits incorporation into SCs, to show that both CIV-KO mutants lack respirasomes (SC 
I+III2+IV1-n), but accumulate different SC I+III2 species that contain COX7A2L and specific COX 
subunits involved in both early and late steps of the canonical CIV assembly pathway. The 
association of individual CIV subunits takes place in a stepwise fashion once the SC I+III2 is fully 
formed. This process yields a partially-assembled respirasome that remains more stable than 
the canonical (COX-free) SC I+III2, indicating that COX7A2L binding is not sufficient to stabilize 
SC I+III2. Our data point towards a molecular mechanism through which the binding of free CIV 
subunits to COX7A2L-containing SC I+III2 is essential to stabilize CI within the respirasome.  
Preceding this work, our research group reported the comigration of CIV subunits 
COX1 and COX4 in the SC I+III2 from the COX2Δ mutant (Moreno-Lastres et al., 2012), and 
suggested that specific free COX subunits or subassemblies could bind directly to SC 
intermediates in the absence of holo-COX. Here we have confirmed that the absence of CIV 
leads to the accumulation of different SC I+III2 species that contain COX7A2L, but surprisingly 
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these species differ in the presence of specific COX subunits. The fact that the COX1Δ mutant 
failed to assemble any of the analyzed COX subunits within SC I+III2, suggests that either COX1 
is the first CIV subunit to get incorporated into this structure in order to complete the 
formation of the respirasome I+III2+IV1, or alternatively, that its incorporation is essential to 
stabilize the association of COX subunits previously bound to SC I+III2. Although the specific 
early steps of mammalian CIV biogenesis remains unconcluded (Timón-Gómez et al., 2017), 
subunit COX1 is traditionally considered as the seed around which monomeric CIV is 
assembled (Nijtmans et al., 1998; Stiburek et al., 2005; Vidoni et al., 2017; Williams et al., 
2004). In agreement, the incorporation of nuclear-encoded COX subunits into SC I+III2 occurred 
only in the COX2Δ mutant, which expressed the COX1 subunit at normal levels. Interestingly, 
COX1 was mainly stabilized in a number of subcomplexes in colocalization with the COX4 and 
COX5B subunits, but not with COX5A. Based on our observations and partially agreeing with 
the canonical CIV biosynthetic pathway (Dennerlein and Rehling, 2015; Fernández-Vizarra et 
al., 2009; Nijtmans et al., 1998; Soto et al., 2012; Stiburek et al., 2005, 2006; Vidoni et al., 
2017), subunits COX4 and COX5A would form an independent submodule. In the absence of 
COX2, only COX4 (and not COX5A) would bind subunit COX1 in a second COX1-COX4 
submodule at an early assembly step, to which subunit COX5B would be further incorporated. 
In addition, we cannot exclude the presence of subunit COX7A2 (also detected by proteomics) 
in any of these subcomplexes. Our findings partially disagree with the COX1-COX4-COX5A 
subassembly that is usually observed in other COX-defective cell lines, as well as in fibroblasts 
from patients with CIV-deficiency (Bourens and Barrientos, 2017a; Kovářová et al., 2012; 
Stiburek et al., 2005; Williams et al., 2004). For example, human SURF1-depleted cells 
accumulated the canonical COX1-COX4-COX5A subassembly (Williams et al., 2004), which was 
also accumulated in heart, skeletal muscle and brain of SCO2 patients (Leary et al., 2004; 
Stiburek et al., 2005). Both SCO2 and SURF1 play a role in COX2 maturation or assembly, either 
in the copper transfer to the CuA centre of COX2 (SCO2) (Richter-Dennerlein et al., 2016) or in 
the association of COX2 with the COX assembly intermediate composed of COX1, COX4 and 
COX5A (SURF1) (Williams et al., 2004). However, in none of these cases there is a full 
destabilization of the newly-synthesized COX2, which remains present albeit at reduced levels. 
Importantly, TALEN-generated COX18-KO and COX20-KO HEK293T cells, which displayed an 
isolated CIV deficiency due to the direct breakdown of COX2 synthesis (Bourens et al., 2014; 
Bourens and Barrientos, 2017a) accumulated several CIV subcomplexes that contained at least 
subunits COX1 and COX4. Although the authors argued that COX5A was probably present in 
this COX1-COX4 subassembly, this statement was based solely on the stabilization of COX5A in 
western-blots on SDS-PAGE gels, which is in agreement with our observations in the COX2Δ 
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cybrids. Furthermore, one could expect the presence of chaperones or assembly factors 
attending these COX1- subassemblies, in agreement with the proposed modular assembly 
mechanism for the cytochrome c oxidase in humans (Bourens et al., 2014; Bourens and 
Barrientos, 2017a, 2017b; Mick et al., 2012; Vidoni et al., 2017) and yeast (McStay et al., 2013), 
where the biogenesis of each of the three catalytic core subunits (COX1-3) proceeds by a 
relatively independent process with the participation of subunit-specific chaperones (McStay 
et al., 2013). In this regard, the well-studied biogenesis of COX1 in yeast shows a rigorous 
checkpoint through the so-called MITRAC (mitochondrial translation regulation assembly 
intermediate of COX) complex, which reduces the rate of COX1 translation under unusual 
conditions, e.g., a limited flux of imported subunits (Barrientos et al., 2004; Mick et al., 2007). 
In human, a similar regulatory cycle that links COX1 assembly to the translation of its mRNA 
through MITRAC has been proposed (Dennerlein and Rehling, 2015; Mick et al., 2012), 
indicating the importance of the evolutionarily-conserved COX1 translation regulatory 
mechanisms. The binding of the COX1 nascent polypeptide to COA3 (MITRAC12), COA1 
(MITRAC15), COX14, CMC1 and SURF1 seems essential to promote COX1 stability, maturation 
and structural conformation (Bourens and Barrientos, 2017b; Dennerlein and Rehling, 2015; 
Mick et al., 2012). This MITRAC complex then receives newly-imported nuclear CIV subunits 
from the mitochondrial pre-sequence translocase (Mick et al., 2012), thus allowing COX1 to 
progress in the canonical assembly pathway through its interaction with the COX4-COX5A sub-
module (Vidoni et al., 2017). Interestingly, an alternative MITRAC constituent, the MITRAC7 
chaperone, has been identified to be dispensable for early stages of COX1 assembly but 
essential for the stabilization of specific COX1 submodules in human, such as COX1-COX4-
COX6C (Dennerlein et al., 2015). The fact that COX6C is traditionally considered as a late-
assembly subunit opens the possibility of multiple ways of COX1 stabilization in MITRAC 
complexes of different protein composition. Altogether, these observations suggest that, 
depending on the CIV subunit holding a specific pathogenic mutation, different CIV 
subcomplexes might be assembled to stabilize subunit COX1, which is indispensable to ignite 
CIV biogenesis. It is thus conceivable that in the absence of subunits COX2 and COX3 there 
could be a rearrangement of COX1-containinig submodules formed by specific CIV subunits, 
and possibly some of them in a competent state for their direct incorporation into SCs. Overall, 
our data indicate the accumulation of COX1-containing subassemblies in the COX2Δ cells that, 
due to the impossibility to form holo-CIV, would be directly integrated into SCI+III2. Our results 
thus suggest different mechanisms of CIV assembly depending on whether the fate of this 
complex is to get associated or not with SCs.  
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The presence of specific COX subunits within the SC I+III2 in the absence of fully-
assembled CIV is a good indication that free COX subunits or subassemblies may associate 
gradually in SCs, in contrast with alternative models proposing that the respirasomes are 
formed by the association of fully-assembled complexes I, III and IV (Acín-Pérez et al., 2008; 
Guerrero-Castillo et al., 2017). Our results are in agreement with previous studies in yeast 
(Mick et al., 2007), where a partially assembled CIV was already competent to associate with 
CIII2, as well as with the finding that in skin fibroblasts mitochondria from patients with severe 
CIV deficiency and unstable CIV, COX nuclear-encoded subunits (including COX4) were 
preferentially incorporated into SC I+III2 (Lazarou et al., 2009). Moreover, in the proposed 
human respirasome assembly model (Moreno-Lastres et al., 2012), newly-synthesized COX 
subunits and subassemblies incorporated sequentially into larger structures that already 
contained CI and CIII assembly intermediates, therefore giving support for CIV subunits to 
assemble individually into the SCs in patients’ mitochondria. In contrast, an extensive study on 
patients’ fibroblasts with mutations in the assembly factor SURF1, characterized by a 
pronounced COX deficiency and the accumulation of CIV subcomplexes, showed that fully-
assembled CIV rather than its subassemblies was preferentially associated with CI and CIII2 to 
form SCs (Kovářová et al., 2012). Our results do not necessarily contradict previous statements 
(Acín-Pérez et al., 2008; Guerrero-Castillo et al., 2017; Kovářová et al., 2012), since alternative 
pathways for SCs biogenesis might exist in different cell lines or tissues to adjust respiratory 
chain function to the availability of specific MRC structural components.  
Our results are consistent with the recent highly-resolved structures for the 
mammalian respirasomes (Gu et al., 2016; Guo et al., 2017; Letts, Fiedorczuk, et al., 2016; 
Sousa et al., 2016; Wu et al., 2016), except for the presence of the COX7A2L assembly factor in 
these structures. Noteworthy, the described respirasome structures point out an interaction 
between CIII2 and CIV that is defined by an uncertain COX7A isoform and CIII subunits 
(UQCR11, UQCRC1 and UQCRB). Analysis of the loose structure of the ovine respirasome, 
showed that this COX7A isoform may switch contacts from CIII2 to the CI subunit ND5 (Letts, 
Fiedorczuk, et al., 2016). Consistently, an interaction between COX7A and the CI subunit 
NDUFB8, which structurally is part of the ND5 module, was also observed in the porcine 
respirasome (Wu et al., 2016). In none of the recently described mammalian respirasomes, 
including the human one (Guo et al., 2017), the precise identity of the COX7A isoform 
responsible for these interactions has been resolved yet. Our proteomics analyses 
unambiguously detected both COX7A2L and the liver-isoform of COX7A (subunit COX7A2) co-
existing in the respirasomes (SC I+III2+IV) from control 143B cells, as well as in the two SC I+III2 
species from the COX2Δ mutant. According to our data, in the COX2Δ cybrids, besides 
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COX7A2L and subunit COX7A2, CIV subunits COX1, COX4 and COX5B were additionally 
incorporated into SC I+III2. However, in the COX1Δ mutant, COX7A2L was present in SCI+III2 
without any detectable COX subunit, probably through interactions with CIII2. These 
observations suggest that subunit COX7A2 would anchor COX1 to the COX7A2L-containing SC 
I+III2, an interaction that could be further stabilized by the binding of COX5B and the formation 
of a partially-assembled respirasome, composed of SC I+III2+subcomplex 
[COX1+COX7A2+COX5B]. The association of COX4 to the partially-assembled SC 
I+III2+subcomplex [COX1+COX7A2+COX5B] is probably unstable due to the absence of subunit 
COX5A in the SC I+III2 in the COX2∆ mutant. A striking observation is the coexistence of 
subunits COX5B and COX7A2 together with COX1 in the SC I+III2, since these two subunits form 
part of independent CIV submodules that get incorporated in intermediate- or late-assembly 
steps in CV biogenesis. These observations again suggest the coexistence of alternative 
assembly pathways for the synthesis of free- versus SC-associated CIV, but how this is 
regulated at the molecular level remains unknown.  
The well-known existence of CIV tissue-specific isoforms in mammalian cells and 
tissues, such as the liver/heart-type pairs of CIV subunits COX7A2/ COX7A1 (among others) 
could be an adaptation to tissue-specific metabolic demands. Heart (or muscle) isoforms are 
expressed in tissues that have high aerobic capacity and abundant mitochondria, whereas liver 
(or non-muscle) isoforms are found in tissues like brain and kidney that contain fewer 
mitochondria (Timón-Gómez et al., 2017). It was recently proposed in mice that the relative 
abundance of tissue-specific CIV subunit isoforms could vary among MRC structures in 
different tissues and mice strains (Cogliati et al., 2016). For instance, in liver and heart from 
CD1 mice expressing the long COX7A2L/SCAFI variant, the COX7A2 subunit was reported to be 
present almost exclusively in monomeric CIV (also slightly detected in heart respirasome), and 
would be preferentially replaced by COX7A2L/SCAFI in SCs that contain CIV associated with 
CIII2 (the I+III2+IV respirasomes and SC III2+IV), and by COX7A1 in CIV dimers. In C57BL/6 mice, 
the COX7A2 subunit distribution appeared to be similar to that in CD1 mice; however, this 
subunit would be replaced by the short COX7A2L/SCAFI variant, uncapable to bind CIV and to 
promote associations between complexes III and IV. Therefore, the absence of functional 
COX7A2L/SCAFI would lead to the absence of SC III2+IV and to looser (probably unstable) 
respirasomes exclusively containing subunit COX7A2 (Cogliati et al., 2016). The proteomics 
detection of subunit COX7A2 along with COX7A2L/SCAFI within the SC I+III2 in our cellular 
models, as well as within monomeric CIV in HEK293T cells (Vidoni et al., 2017) partially 
disagrees with the interchange-hypothesis of COX7A subunits isoforms in different CIV-
containing structures. Instead, our results support the co-existence of different CIV species, 
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either with COX7A2L or COX7A2 alone, or even with both proteins co-existing together within 
the same structure, in agreement with yeast studies showing a heterogeneous population of 
CIV variants with regards to their subunit composition and SCs assembly (Vukotic et al., 2012).  
The presence of tissue-specific isoforms of nuclear-encoded COX subunits (Timón-
Gómez et al., 2017), the heterogeneity of CIV species in both mammalian (Cogliati et al., 2016) 
and yeast (Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012), and the fact that 
mutations in CIV assembly factors may result in tissue-specific variations in CIV assembly into 
SCs (Kovářová et al., 2012; Stiburek et al., 2005) give evidence that CIV biogenesis is a 
heterogeneous process that remains to be fully-understood. According to our data, the binding 
of four specific COX subunits to SC I+III2 yields a partially-assembled respirasome that is more 
stable than the canonical (COX-free) SC I+III2. These findings gain intrigue due to the 
circumstance that the precise roles of the SCs and respirasomes remain unclear, and they 
could point out an unexpected mechanism for CI stabilization in the respirasomes. In fact, the 
possible role of the SCs in the stabilization of individual MRC complexes, most particularly on 
CI, is currently a field of intense debate. CI functional alterations are relatively infrequent to 
most patients presenting with CIII2 or CIV enzyme deficiencies (Fernández-Vizarra and Zeviani, 
2015; Rak et al., 2016), indicating that only severe structural alterations of these two 
complexes induce a parallel CI dysfunction. Our kinetics analyses in COX-KO cells suggest that 
the lack of CIV promotes the association of CI with a CIII2 assembly intermediate that lacks the 
RISP subunit (pre-CIII2), to form a partially-assembled SC (pre-SC I+III2) that awaits RISP 
incorporation to complete SC I+III2 formation (Figure 54). CI could be stabilized through its 
interaction with either pre-CIII2 or fully-assembled CIII2, consistent with experimental evidence 
on respiratory chain disease models, where CI is unstable if not associated with CIII2 (Acín-
Pérez et al., 2004; Schägger et al., 2004). Analyses in Ndufs4-KO mice showed that a partially-
assembled CI lacking its functional NADH-binding (N) module tends to associate with CIII2 in an 
incomplete SC (Calvaruso et al., 2012), providing further evidence that CIII2 aids CI stabilization. 
In contrast, CI stability is mainly affected by the absence of CIV in rapidly dividing cells, as 
evidenced in Cox10-KO mouse fibroblasts (Diaz et al., 2006), in human cybrid cells (D’Aurelio et 
al., 2006) or in mouse cells with limited expression of subunit Cox4 (Li et al., 2007). Studies in 
heteroplasmic COX1 mutant cybrids also showed that small levels of fully-assembled CIV are 
sufficient to stabilize CI and the SCs (D’Aurelio et al., 2006), leading to the proposal that a CIV 
defect may only lead to combined OXPHOS deficiencies when it has surpassed a certain 
threshold. This is a way to reconcile different observations between patients and cellular 
models of CIV deficiency that showed close to normal CI activity (Tiranti et al., 2000; Valente et 
al., 2009). In accordance with these studies, our results argue in favour of a stabilizing role for 
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individual COX subunits on SC I+III2. Alternatively, our findings may suggest the existence of a 
regulatory checkpoint at the level of SCs, for instance, through a mechanism for COX1 subunit 
stabilization within the SCs when CIV biogenesis is compromised. A previous study in cybrids 
with homoplasmic nonsense mutations in subunit COX1 showed that the truncated COX1 
species were translated and successfully assembled into SC I+III2, yet this SC was unstable and 
degraded rapidly (Hornig-Do et al. 2012). This study, as ours, suggests that the association of CI 
with CIII2 is not sufficient to stabilize the SC I+III2 and that CIV would function as a stabilizer.  
 
 
 
 
 
 
 
 
 
 
 
Figure 54. Biogenesis of COX7A2L-containing SC I+III2 in CIV-deficient cybrids. COX7A2L binds a CIII2 
assembly intermediate that lacks the RISP subunit (pre-CIII2 + COX7A2L), which joins CI to form a 
partially-assembled SC (pre-SC I+III2) that awaits RISP incorporation to complete SC I+III2 formation. The 
subsequent association of specific COX subunits adds stability to SC I+III2. The assembly pathway of 
individual CIII2 is depicted according to reported models (Bottani et al., 2017).  
As a final remark, the impact of COX7A2L on the biogenesis of CIII2 and SC I+III2 
remains to be clarified in cells lacking CIV. COX7A2L protein levels have been described to 
increase upon cellular stress conditions that stimulate energy metabolism (Zhang et al., 2016), 
which would enhance its binding to CIII2 and CIV, and SCs formation. In agreement, our data 
show that COX7A2L may accelerate di novo SCs formation and therefore, upon COX7A2L 
silencing one would expect a delay in the SC I+III2 assembly rates. However, since CIII2 levels 
are already increased in CIV-KO cells, the effect of a hypothetical COX7A2L silencing on the 
structural reorganization of the MRC is unclear. The future perspectives should include the 
generation of a COX7A2L-KO in COX-deficient cell lines to detail the role of this protein when 
CIV is structurally and functionally compromised. Since COX7A2L could be part of a metabolic 
response to accelerate CIII2-containing SCs assembly when needed, functional assays with 
different carbon sources and stress conditions, e.g., during hypoxia, may give exciting 
outcomes of the accurate metabolic role of COX7A2L.   
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1. COX7A2L is a mitochondrial protein that colocalizes with the respiratory chain complex 
III dimer, with monomeric complex IV, and with supercomplexes III2+IV, I+III2 and I+III2 
+IV1. 
 
2. COX7A2L preferentially associates to complex III, and with a lower affinity to complex 
IV. COX7A2L initially binds to a complex III assembly intermediate (named pre-complex 
III) prior to the incorporation of the RISP subunit, and later to fully assembled CIV. 
 
3. Silencing of COX7A2L mRNA expression in human control cells displays a significant 
reduction of the supercomplex III2+IV levels, without affecting the levels of the 
respirasomes or individual complexes III and IV. 
 
4. Using the TALEN technology we have generated COX7A2L-knockout HEK293T cells 
(COX7A2L-KO). These cells exhibit a total absence of supercomplex III2+IV, a significant 
increase in complex III biogenesis and a delay in the respirasome assembly rates, 
which nonetheless reach control steady-state levels. 
 
5. COX7A2L-mutant HEK293T cells generated in vitro that carry an in-frame 6-base-pair 
deletion in the COX7A2L gene exhibit a total absence of supercomplex III2+IV and 
control respirasome levels. In this human model the short version of COX7A2L 
colocalizes with respiratory chain complex III dimer and with supercomplex I+III2, as in 
mouse C57BL/6 heart mitochondria. 
 
6. Functional substrate competition assays show no significant differences in 
mitochondrial respiration between control and COX7A2L-KO cells. However, upon 
induction of CI deficiency, the absence of COX7A2L significantly favours succinate 
oxidation and electron transfer from complex II to complex III. 
 
7. Human cybrids with homoplasmic nonsense mutations in the MT-CO1 and MT-CO2 
genes lack mitochondrial complex IV, and accumulate different COX7A2L- containing 
supercomplex I+III2 species that differ in their COX subunit composition.  
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8. The supercomplexes I+III2 from mutant cybrids lacking COX2 contain subunits COX1, 
COX4, COX5B and COX7A2, and are more stable than the COX-free supercomplex I+III2 
present in mutant cybrids lacking COX1.  
 
9. COX7A2 is the COX7A subunit isoform present in the respirasomes from human 
cybrids. 
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1. COX7A2L es una proteína mitocondrial que colocaliza con los complejos III y IV 
individuales de la cadena respiratoria mitocondrial, y con los supercomplejos III2+IV, 
I+III2 and I+III2 +IV1. 
 
2. COX7A2L se asocia preferentemente al complejo III y con menor afinidad al complejo 
IV. Inicialmente, COX7A2L se une a un intermediario del complejo III (denominado pre-
complejo III) antes de la incorporación de la subunidad RISP, y posteriormente al CIV 
totalmente ensamblado. 
 
3. El silenciamiento de la expresión del mRNA de COX7A2L en células control de origen 
humano produce una reducción significativa de los niveles del supercomplejo III2+IV, 
sin afectar a los niveles del respirasoma ni a los de los complejos III y IV individuales. 
 
4. Usando la tecnología TALEN, se han generado células HEK293T carentes de COX7A2L 
(COX7A2L-KO). Estas células muestran una ausencia total del supercomplejo III2+IV, un 
incremento significativo de la biogénesis del complejo III y un retraso en las cinéticas 
de formación del respirasoma, el cual alcanza niveles estacionarios comparables a los 
de células control. 
 
5. Células HEK293T mutantes generadas in vitro portadoras de una delección de 6 pares 
de bases en el gen de COX7A2L muestran una ausencia total del supercomplejo III2+IV 
y niveles de respirasoma comparables a los de células control. En este modelo celular 
humano la versión corta de COX7A2L colocaliza con el complejo III dimérico y con el 
supercomplejo I+III2, como ocurre en mitocondrias de corazón del ratón C57BL/6. 
 
6. Ensayos funcionales de competición de sustratos no muestran diferencias significativas 
en la respiración mitocondrial entre células HEK293T control y células COX7A2L-KO. Sin 
embargo, en ausencia de COX7A2L, la inducción de un déficit enzimático del complejo I 
favorece significativamente la oxidación de succinato y el flujo de electrones entre el 
complejo II y el complejo III. 
 
7. Cíbridos humanos portadores de mutaciones sin sentido en los genes MT-CO1 y MT-
CO2 carecen de CIV mitocondrial, pero acumulan diferentes especies de 
supercomplejo I+III2, las cuales contienen a COX7A2L y difieren en su contenido de 
subunidades COX.  
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8. Los supercomplejos I+III2 del cíbrido mutante carente de COX2 contienen a las 
subunidades del complejo IV COX1, COX4, COX5B y COX7A2. Estos supercomplejos son 
más estables que el supercomplejo I+III2 (libre de subunidades COX) del cíbrido 
mutante carente de COX1.  
 
9. La subunidad COX7A2 es la isoforma de COX7A presente en el respirasoma de cíbridos 
humanos. 
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Over  the  past  sixty  years,  researchers  have  made  outmost  efforts  to  clarify  the  structural  organization  and
functional  regulation  of the  complexes  that  conﬁgure  the  mitochondrial  respiratory  chain.  As  a  result,
the  entire  composition  of  each  individual  complex  is practically  known  and,  aided  by notable  struc-
tural  advances  in  mammals,  it is now  widely  accepted  that these  complexes  stablish  interactions  to  form
higher-order  supramolecular  structures  called  supercomplexes  and  respirasomes.  The  mechanistic  mod-
els  and  players  that  regulate  the  function  and  biogenesis  of  such  superstructures  are  still under  intense
debate,  and  represent  one  of the  hottest  topics  of  the  mitochondrial  research  ﬁeld  at  present.  Noteworthy,
understanding  the  pathways  involved  in  the assembly  and  organization  of  respiratory  chain  complexes
and  supercomplexes  is of  high  biomedical  relevance  because  molecular  alterations  in these  pathways
frequently  result  in severe  mitochondrial  disorders.  The  purpose  of  this  review  is to  update  the struc-
tural,  biogenetic  and  functional  knowledge  about  the  respiratory  chain  supercomplexes  and  assembly
factors  involved  in their formation,  with  special  emphasis  on  their  implications  in  mitochondrial  disease.
Thanks  to  the  integrated  data  resulting  from  recent  structural,  biochemical  and  genetic  approaches  in
diverse  biological  systems,  the  regulation  of the  respiratory  chain  function  arises  at  multiple  levels  of
complexity.
©  2017  Elsevier  Ltd. All  rights  reserved.
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1. Introduction
Recent investigations have shed light into the sophistica-
tion surrounding the biogenesis of the oxidative phosphorylation
(OXPHOS) system. In mammals, the OXPHOS system is formed by
ﬁve multiprotein enzyme complexes and two mobile electron carri-
ers embedded in the inner mitochondrial membrane. The ﬁrst four
enzyme complexes (CI-CIV) comprise the mitochondrial respira-
tory chain (MRC), which facilitates electron transfer from reducing
equivalents to molecular oxygen coupled to the generation of a
proton gradient across the inner membrane that will be used by
the ATP synthase (complex V) to drive ATP synthesis. In addition
to their structural subunits, the biogenesis of these ﬁve hetero-
oligomeric enzymatic complexes requires an extensive number
of ancillary factors to coordinate subunits maturation, incorpora-
tion of prosthetic groups and assembly into the holoenzymes. The
discovery that some MRC  enzymes physically interact to form a
variety of supramolecular structures called supercomplexes (SCs)
and respirasomes, and the existence of SC-speciﬁc assembly factors
involved in their assembly, has put the spotlight on the structural
and functional properties of the SCs, and on the regulatory path-
ways involved in their biogenesis. It is currently debated whether
SCs play a relevant functional role in cellular bioenergetics, in
the formation of reactive intermediates, or in the stabilization of
the individual MRC  complexes. Since genetic alterations in MRC
subunits and assembly factors often lead to severe encephalomy-
opathies and neurodegenerative disorders, a full understanding of
the structural organization and biosynthetic regulation of the MRC
is essential to understand the molecular mechanisms underlying
mitochondrial pathology. In this review we will explore the cur-
rent knowledge on mammalian respiratory SCs, integrating the
historical perspective with the most recent structural ﬁndings, and
putting this information in the context of mitochondrial disease.
2. Mitochondrial respiratory chain, a long-lasting journey
2.1. Composition and function of the respiratory chain
The production of adenosine 5′-triphosphate (ATP), the key
energy source of the cell, through aerobic substrate oxidation
is the main function of the mitochondrial metabolism. In the
late 50s, several redox enzymes and prosthetic groups respon-
sible for the classic mitochondrial electron transfer chain were
deﬁned [1] followed by their reconstitution in the early 60 s [2].
The overall respiratory chain activity was postulated as a sequen-
tial transfer of electrons between four major multi-enzymatic
complexes dispersed in the inner mitochondrial membrane
(IMM): NADH dehydrogenase:ubiquinone oxidoreductase (com-
plex I, CI), succinate:ubiquinone oxidoreductase (complex II, CII),
ubiquinol:cytochrome c oxidoreductase or cytochrome bc1 com-
plex (complex III, CIII), and cytochrome c oxidase (complex IV,
CIV). In addition, the electron transfer was ensured by the diffusion
of two mobile components acting as co-substrates: the lipophilic
ubiquinone, also designated as coenzyme Q (CoQ), embedded in
the membrane lipid bilayer, and the hydrophilic heme protein
cytochrome c (cytc) located on the external surface of the IMM [3,4].
Altogether, these components form the mitochondrial respiratory
chain (MRC) where cellular respiration takes place. Organic nutri-
ents are catabolized into small electron donor molecules, NADH2
and FADH2, which transfer the electrons to CI and CII, respectively.
CoQ uptakes the electrons from both sources, transferring them to
dimeric CIII (CIII2), then to cytc and ﬁnally to CIV, that yields the
electrons to molecular oxygen. This electron ﬂux is coupled to a
proton pump from the matrix to the intermembrane space through
complexes I, III and IV, which generates an electrochemical gra-
dient across the IMM  that provides the necessary free energy for
the ATP synthase (complex V, CV) to synthesize ATP through the
mechanism known as oxidative phosphorylation [5].
2.2. Models for the structural organization of the respiratory
chain
Despite the well-known functional relevance of the respira-
tory chain, the structural organization of its components remains
unclear.
2.2.1. Solid-state model
The pioneering spectrophotometric studies of Chance and
Williams represented the MRC  as a solid state assembly of pros-
thetic groups that carry out sequential redox reactions in a protein
matrix [1]. The evidences in favour of this “rigid” or “solid-state
model” were based on the isolation of CI-CIII and CII-CIII active units
in a stoichiometric molar ratio of 1:1 during intermediate puriﬁ-
cation steps of the individual enzymes, that were interpreted as
secondary enzymatically active complexes [6]; and on the reconsti-
tution of a “repeating unit of electron transfer” containing all MRC
complexes from bovine heart mitochondria [7]. This model implied
the notion of permanently-bound CoQ to the MRC  units. Accord-
ingly, vesicle reconstitution experiments showed stoichiometric
associations between CI and CIII2 at high protein concentrations
with no exchange between free and bound ubiquinone, i.e., no
‘CoQ-pool’ behaviour [8]. Only when sufﬁcient lipid was added the
CoQ-pool behaviour was  restored, but this was interpreted as the
movement of complex-associated CoQ rather than of free CoQ [9].
Later studies in Saccharomyces cerevisiae provided evidence that
CoQ and cytc only diffused freely along the membrane upon the
addition of chaotropic agents, suggesting that the respiratory chain
in yeast also behaves as one functional unit that at least comprises
complexes III and IV with bound CoQ and cytc [10].
2.2.2. Liquid-state model
The general vision gradually evolved into a “random colli-
sion”, “ﬂuid” or “liquid-state” model, proposed by Hackenbrock and
co-workers, that pictured all membrane proteins and redox compo-
nents that catalyse electron transport and ATP synthesis in constant
and independent diffusional motion, where electron transfer to
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place through diffusion-based collisions among the redox part-
ners [11]. Evidence in favour of the “liquid-state model” arose from
kinetic analyses proposing not only that electron transfer in the CoQ
and cytc regions obeyed a pool behaviour in mammalian mitochon-
dria, but also that it followed saturation kinetics with regards to CoQ
and cytc  concentrations [3,12]. Furthermore, enzymatic activities
were retained upon isolation of the individual OXPHOS complexes
[2] and the use of ﬂuorescent antibodies against CIII2 and CIV caused
independent aggregation of these complexes, suggesting that they
diffuse laterally in the membrane plane independent of one another
[13].
2.2.3. Dynamic aggregate or plasticity model
The two previous models were proposed for the way  in which
MRC  components interact to accomplish a maximal-efﬁcient elec-
tron transfer, representing extreme examples where intermediate
modes of operation are feasible. Alternative studies by Ferguson-
Miller and collaborators that analysed the role of lateral diffusion
of cytc in electron transfer within native mitochondrial mem-
branes, gave rise to the “dynamic aggregate” model [14]. In this
model, a dynamic equilibrium exists between freely diffusing
and associated-forms of the MRC  components, all active in elec-
tron transfer. This new representation of the respiratory chain
reconciled the two classical models, as it incorporated transient
aggregates as well as free lateral diffusion of redox components to
account for the electron transport rates. The reversible formation
of speciﬁc MRC  aggregates additionally offered a mechanism for
localized proton ﬂow and the possibility of regulating the direction
and efﬁciency of electron transfer [15,16].
This idea was disregarded in favour of the “ﬂuid” model until
new data from two groups, based on the use of blue native poly-
acrylamide gel electrophoresis (BN-PAGE) developed by Schägger
and collaborators, showed the co-existence of individual MRC
complexes together with their inter-associations in supramolec-
ular assemblies that were termed supercomplexes (SCs) [17,18].
Experimental evidences demonstrated that SCs are evolutionarily
conserved stable structures in both prokaryotes and eukaryotes,
and not random associations of MRC  complexes [19,20], and
recent high-resolution cryo-electron microscopy (cryo-EM) anal-
yses showed the detailed structural architecture of mammalian
respiratory SCs (Fig. 1) [21–23]. The coexistence of individual MRC
complexes and SCs thus supports the principles of the “dynamic
aggregate” model, which was lately renamed as the “plasticity”
model by Enríquez and co-workers [24,25]. In its current form,
this model proposes that the switch between freely moving MRC
complexes to ﬁxed SCs would optimize electron ﬂux from differ-
ent substrates (NADH and FADH2), adapting the efﬁciency of the
respiratory chain to changes in cellular metabolism via partitioned
CoQ and cytc pools [26]. The catalytic relevance of this hypothe-
sis, based on BN-PAGE and oxygen consumption analyses in mouse
cells depleted of MRC  complexes, was however questioned by more
direct spectroscopic and kinetic experiments in yeast and bovine
submitochondrial particles showing that: a) the metabolic path-
ways for NADH and succinate oxidation occur through a single
and universally accessible CoQ-pool [27], and b) that cytc does not
encounter major barriers to its free diffusion [28]. Moreover, this
model was proposed on the basis of differences in the steady-state
levels of respiratory chain structures on BN-PAGE gels, and there-
fore, the reversible and dynamic association/dissociation events
−the so-called “plasticity”- between the individual complexes and
the SCs remains to be proven. The prospective evolution of the
“plasticity” model will thus rely on the extensive characterization
of the structural, functional and kinetic properties of the SCs upon
variations in physiological conditions [29,30].
3. Structural architecture of respiratory chain
supercomplexes
3.1. Types of respiratory chain supercomplexes
The notion of “supercomplexes” ﬁrst appeared upon the
observations of preferential associations between bacterial MRC
complexes [31,32]. Respiratory chain SCs of different compositions
and stoichiometries were later reported by means of BN-PAGE
analyses of mitochondrial fractions solubilized with the mild
detergent digitonin. This method allows the retention of labile
supramolecular assemblies of membrane protein complexes that
would otherwise be dissociated (Fig. 2A). The solubilization of
OXPHOS complexes from yeast and bovine heart mitochondria
using varying digitonin-to-protein ratios and subsequent BN-PAGE
allowed to separate assorted types of stoichiometric associations of
complexes I, III and IV within the molecular mass range from ∼750
to ∼2100 kDa, in an overall 1:3:6 stoichiometry [33]. Additional BN-
PAGE, single-particle electron microscopy (EM) and cryo-electron
tomography studies, consistently reported speciﬁc associations
between CI, CIII2 and CIV in a wide range of organisms [19]. It is
worth mentioning that for a long time, many researchers attributed
the appearance of SCs on BN-PAGE gels to protein aggregation as a
consequence of detergent solubilisation. However, the migrations
of these bands in the gels are consistently reproducible, as shown
by many different laboratories in the last 17 years, and well-deﬁned
structures from these bands extracted from the gels are now avail-
able.
The composition and abundance of the respiratory chain SCs
may  vary among organisms and tissues depending on the metabolic
and physiological conditions [17,26,34–40], as well as on the lipid
content of the mitochondrial inner membrane [41–44]. In most CI-
containing eukaryotes, CI primarily interacts with CIII2 and CIV to
form the most abundant SC, I + III2 + IV1, to which additional CIV
monomers are added to form SCs I + III2 + IV2-4. These structures are
known as the respirasomes [17], since they contain all the com-
ponents required to transfer electrons from NADH to molecular
oxygen. Additionally, CI associates with CIII2 to form SC I + III2; and
CIII2 binds one to two  CIV monomers to assemble SCs III2 + IV1-2. In
mammals, most CI, ∼40-50% of CIII2 and ∼20-30% of CIV are local-
ized in the largest SCs I + III2 and I + III2 + IV1-4 (Fig. 2B). CIII2 and CIV
may  also interact to form SC III2 + IV1 that scarcely represents 5–10%
of the total MRC  structures [33,45]. In higher plants mitochondria,
CIV-containing SCs are barely detectable, and SC I + III2 is the pre-
dominant macrostructure [46]. In S. cerevisiae, which lacks CI, two
bands of ∼750 and ∼1000 kDa corresponding to SCs III2 + IV1 and
III2 + IV2, respectively, are predominant [17,18]. These variations in
the relative abundance of SCs may  reﬂect different stoichiometries
of CI, CIII2 and CIV among organisms. Regarding CII and CV, these
enzymes form oligomers that do not interact with complexes I, III
and IV under normal physiological conditions [17,33,45,47–50].
Based on the differential solubilisation of MRC complexes and
SCs on BN-PAGE, a higher organization level of SCs in “respiratory
strings” was  proposed for mammals and yeast [51], where res-
pirasomes would be interconnected by CIV tetramers at regular
intervals, thus generating linear assemblies of respiratory SCs. The
observation of CI dimers (CI2) in Yarrowia lipolytica [52] redeﬁned
this model as “respiratory patches” generated by the interactions
between two  CI monomers within adjacent respiratory strings. An
alternative model for plants based on single-particle EM,  proposed
the repetition of I2III2IV2 units into a respiratory string mediated by
the interaction of two  neighbouring CIV through a dimeric inter-
face [53], which differed from the previous model by the lower
abundance of CIV copies. The structural and functional character-
ization of SCs among different species would beneﬁt very much
from in situ studies without disrupting the mitochondrial mem-
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Fig. 1. Architectures of the mammalian respirasomes. Side views along the membrane from (A) Supercomplex I + III2, (B) the tight respirasome, and (C) the loose respirasome,
according to the structures proposed by Letts et al. [22]. Images were obtained from the RCSB Protein Data Bank in combination with the NGL viewer. The structural models
of  CI, CIII2, and CIV are colored in red, turquoise, and navy blue, respectively. The transmembrane region is indicated by two dashed lines. M,  matrix; IM,  mitochondrial inner
membrane; IMS, intermembrane space.
branes with detergents; for example, using ﬂuorescence life-time
imaging, as recently published [54].
3.2. Structural properties of respiratory chain supercomplexes
3.2.1. Supercomplexes I + III2 and III2 + IV1-2
The ﬁrst structure of SC I + III2 from Arabidopsis thaliana mito-
chondria was determined at 18 Å resolution [46], revealing the
lateral association of CIII2 to the membrane-embedded distal part
of CI. However, the lack of an atomic CI structure failed to deci-
pher the precise subunit interactions within this SC. Recently, the
architectures of the mammalian SC I + III2 were resolved at high res-
olution in ovine (Fig. 1A) [22] and bovine [55]. In these structures,
contacts between CI and CIII2 were similar to the ones detected for
SC I + III2 + IV1 (described in Section 3.2.2.).
A pseudo-atomic model at 15 Å resolution of yeast SCs III2 + IV1-2
[56] revealed that CIII2 is attached to the convex side of two CIV
monomers, leaving the opposite interfaces open for CIV dimer-
ization. Cardiolipin and phosphatidylethanolamine lipids were
identiﬁed at the CIII2-CIV interface. This structure also revealed
cytc bound to CIII2, which moves and rotates within a distance of
40 Å (∼4 nm)  to mediate electron transfer between CIII2 and CIV.
Later studies based on 3D-cryo-EM maps speciﬁed the distance
between the cytc binding sites of CIII2 and CIV as ∼6 nm,  considered
to be sufﬁciently short to enable the channelling of cytc between
these complexes [57], although this was  previously refuted [28].
The yeast CIII2 subunits cytochrome b, cytochrome c1, Qcr6 (Hinge
protein), Qcr7, Qcr8 and Qcr9 were identiﬁed at the CIII2-CIV inter-
face, as well as the CIV subunits CoxI, CoxII, CoxIII, CoxIV, CoxVIc,
CoxVIIa and CoxVIIc [56]. However, direct evidence supporting
precise subunit interactions was missing. Due to its low relative
abundance, SCs III2 + IV1-2 from higher organisms await structural
characterization.
3.2.2. Respirasome or supercomplex I + III2 + IV1
In mammalian mitochondria, I + III2 + IV1 is the most abun-
dant SC. The ﬁrst 3D maps of the bovine heart SC I + III2 + IV1
[47,50,58,59] revealed the lateral binding of CIII2 to the middle
part of the CI membrane arm, with CIV positioned in the dis-
tal tip of CI while laterally interacting with CIII2, and cardiolipin
molecules ﬁlling the gaps between the transmembrane domains
at the interfaces between the individual complexes [47,59]. The
recent characterization of the atomic structure of mammalian CI by
cryo-EM [60,61] represented a major step forward that enabled to
obtain high-resolution projection maps of the mammalian respira-
somes [21–23,55]. Yang and collaborators solved the conformation
of porcine SC I + III2 + IV1 [21,23], where CIV would loosely bind
CI and CIII2. In addition, Letts et al. [22] distinguished two archi-
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Fig. 2. Distribution of human respiratory chain complexes and supercomplexes. (A) Mitochondria isolated from cultured 143B TK- cells (1) and cybrids (2) were analysed
by  BN-PAGE in combination with CI in-gel activity (IGA) assay and western blot with antibodies against the indicated MRC  subunits. (B) Most CI (blue), ∼half of CIII2 (green)
and  ∼20-30% of CIV (red) are localized in the respirasome (I + III2 + IV0-1). SC III2 + IV1 represents ∼5% of the total amount of MRC  structures, as well as CIV dimers (IV2). CII
(II)  is not present in SCs. Free CI (light blue) requires to be associated in supercomplexes to minimize destabilization and ROS generation [29].
tectures for the ovine respirasome, a major “tight” and a minor
“loose” conformations, where CIV would contact both CI and CIII2
within the tight form, but only CI within the loose form (Fig. 1B–C).
Sousa et al. also resolved two classes of SC I + III2 + IV1 in bovine [55].
The tight form of the ovine respirasome was essentially identical
to the bovine respirasome class 1. However, the bovine respira-
some class 2 differed in the conformational ﬂexibility of CIII2, as
this rotates by 25◦ relative to CI while CIV remains unchanged. The
bovine respirasome additionally showed clear density in one of the
two membrane extrinsic iron-sulphur domains of CIII2, suggesting
that only one CIII monomer would be active [55]. The heterogene-
ity among these structures deserves further consideration [30], as
it could reﬂect the existence of independent structural entities
resulting from the differential association and dissociation of the
MRC  complexes in response to, e.g., tissue-speciﬁc phospholipid
environments or ROS levels.
The respirasome-bound CI is more compact than free CI due to
its associations with CIII2 and CIV [60,61]. Although several inter-
action points exist between CI, CIII2 and CIV, the most extensive
and stable interactions take place between CI supernumerary sub-
units (absent in bacteria) and CIII2 at two  major points: CI subunits
NDUFA11 (B14.7 in bovine) and NDUFB4 (B15) directly interact
with CIII2 subunit UQCRQ at the matrix and inner membrane inter-
face, and CI subunits NDUFB4 and NDUFB9 (B22) bind CIII2 subunits
UQCRC1 and UQCRFS1 in the matrix [22,23]. Another important
interaction occurs between CI subunit NDUFB7 (B18) and subunit
UQCRH on CIII2. Both subunits contain disulphide bonds, suggest-
ing that redox regulation might modulate the interactions between
MRC  complexes [22]. Since the long helix of NDUFB7 is poised at
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the interface of the three complexes, it may  also interact with CIV
through the COX7A and COX8 B subunits at the intermembrane
space and inner membrane interface [22,23]. CIV is less tightly
bound to the respirasomes and major contacts differ among struc-
tures, reﬂecting its varying location. There is a close association
of CIV subunit COX7C and ND5 on CI, as well as an interaction of
COX7A on CIV with CIII2 subunits UQCR11, UQCRC1 and UQCRB at
the matrix and inner membrane interface [22,23]. This interaction
between CIII2 and CIV seems to swing away in the loose respira-
some form, where only COX7A would contact CI through subunit
ND5 [22]. It must be noted that the differences that exist between
the structural models presented from ovine/bovine/porcine prob-
ably rely on the species-speciﬁc protein sequences of the MRC
subunits. Therefore, structural variations in the SCs and respira-
somes from other species, such as rodents and human, appear well
possible depending on the degree of conservation of the speciﬁc
protein domains and residues that promote the interactions within
these structures.
3.3. Effect of cardiolipin on the stabilization of supercomplexes
Supporting the idea that phospholipids mediate
protein–protein interactions in the inner mitochondrial mem-
brane, cardiolipin molecules were detected within yeast SCs
III2 + IV1-2 [57], where they stabilize these structures [41,42].
Moreover, studies in lymphocytes from patients with Barth syn-
drome, a mitochondrial disorder in which cardiolipin levels are
drastically reduced due to mutations affecting Tafazzin (an enzyme
involved in cardiolipin maturation), revealed the speciﬁc destabi-
lization of SC I + III2 + IV1 [62]. A pluripotent stem cell model system
of this disorder later conﬁrmed the role of cardiolipin content
for SCs stabilization [63]. Consistent with these observations, the
atomic structure of the respirasome revealed clear gaps between
CI, CIII2 and CIV that were occupied by cardiolipin molecules to
further stabilize the respirasome [23,59]. Although cardiolipin is
considered to stabilize SCs, phosphatidylethanolamine, another
phospholipid of the inner membrane, seems to exert the opposite
effect [43]. Therefore, differences in the balance between phos-
pholipid species may  contribute to the speciﬁc reorganization of
the MRC  complexes and SCs.
4. Functional roles of the supercomplexes
The discovery of SCs represents a great progress in the study
of the functional and structural properties of the MRC, and their
existence should provide functional advantages that remain far to
be fully-understood.
4.1. Catalytic enhancement of the electron ﬂux through substrate
channelling
The arrangement into SCs was initially proposed to maximize
the efﬁciency of the electron ﬂux across the MRC  [17]. Indeed,
spectrophotometric assays of the MRC  activities of isolated SCs
from bovine heart mitochondria showed that CI in SC I + III2 dis-
plays about half the activity of that in SC I + III2 + IV1, suggesting
that the full respirasome was the most active unit [50]. Substrate
channelling was proposed as a possible mechanism to explain the
increased rates of electron transfer within SCs based on ﬂux con-
trol analyses of the MRC  complexes in bovine heart mitochondria
[64]. The authors suggested that CI and CIII2 behave as a single
enzymatic unit, where electron transfer through CoQ is accom-
plished by channelling between the two redox enzymes without
following a pool behaviour, in agreement with other reports in
yeast [10] and bovine mitochondria [8]. Following studies that ana-
lysed the roles of CoQ and cytc in the attenuation of CIII2 and CIV
pharmacological inhibition on the respiratory ﬂux supported the
dynamic compartmentalization of the respiratory substrates [65],
as well as studies based in the competition of substrates for NADH
and succinate oxidation [26]. The proposal that SCs may  provide
distinct electron translocation pathways through the partition of
CoQ into different pools to mediate metabolic adaptation [26], was
questioned by kinetic and ﬂux control studies showing that the
metabolic pathways for NADH and succinate oxidation comprise
different CoQ redox steady states, but communicate and converge
on a single non-partitioned CoQ pool [27,30]. It has also been argued
that the cytc pool is equally compartmentalized [26], but stud-
ies monitoring the reduction potential of CIII upon addition of
NADH, succinate or both [27], evidenced against cytc  partitioning.
In agreement, time-resolved spectroscopic analysis of cytc oxida-
tion in intact yeast cells showed that cytc is not trapped within
SCs and, therefore, there are no restrictions that limit its diffusion
[28]. Moreover, the respirasome structures showed no evidence of
a protein-mediated substrate channel connecting the CoQ binding
sites of CI and CIII2 [22], since both active sites are open to the
membrane and separated by 10 nm,  as also evidenced for cytc, in
agreement with previous studies that questioned substrate chan-
nelling based on the distances between the substrates binding sites
on SCs [47]. Therefore, the function of a direct catalytic role for
mitochondrial SCs remains questionable [30].
4.2. Assembly and stability of complex I
Experimental evidence accumulated on respiratory chain dis-
ease models, suggests that the formation of mammalian SCs confers
stability to their individual components, and most particularly to
CI. The ﬁrst description of a patient with progressive exercise intol-
erance due to a nonsense mutation in the CIII2 subunit gene MT-CYB
associated with a combined enzyme deﬁciency of complexes I and
III [66], was followed by a more extensive study showing that
genetic alterations leading to a loss of CIII2 prevented respirasome
formation and led to the secondary loss of CI [67]. Further studies
conﬁrmed that not only the structural integrity of CIII2 [68], but
also that of CIV [69–71], were essential to maintain the stability
of mammalian CI. Despite these evidences, ostensible CI functional
alterations are relatively infrequent to most patients presenting
with CIII2 or CIV enzyme deﬁciencies [72,73], indicating that only
severe structural alterations of these two complexes induce a paral-
lel CI dysfunction. On the contrary, a dramatic decrease in CI levels
do not generally lead to CIII2 and CIV functional defects in mam-
mals [67]. In agreement, the depletion of 28 different CI accessory
subunits in human HEK293T cells showed a loss of SCs I + III2 and
I + III2 + IV1 with no alterations in the steady-state levels of CIII2 or
CIV [74].
The speciﬁc dependence of CI stability on the respirasome
biosynthesis has important repercussions for our understanding of
the respiratory chain disorders. In this regard, two main hypotheses
are currently debated to explain the integration and stabilization
of CI into SCs (Figs. 3 and 4, see Section 5.1.). However, the fact
that CI is puriﬁed and remains active in its free form adds to the
debate whether CI stability may  rely on additional molecular mech-
anisms, like alterations in the mitochondrial membrane potential
[49] or ROS levels (see Section 4.3.). In accordance, the absence
of respirasomes due to the lack of cytc [75], CIII2 or CIV induced
reverse electron transport from reduced CoQ to CI, triggering local
superoxide generation and CI degradation [76].
4.3. Modulation of ROS production
Because CI and CIII2 constitute the main redox centres respon-
sible for oxygen reduction to superoxide [77,78], it has been
hypothesized that their arrangement into SCs could minimize ROS
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Fig. 3. Respirasome biogenesis through the direct association of fully-assembled respiratory chain complexes. This model [24,86] proposes that the mammalian respirasome
(I  + III2 + IV1) originates by the direct association of single pre-assembled CI (blue), CIII2 (green) and CIV (red). The assembly pathways of the individual MRC  complexes
are  depicted according to stablished models [72,86,108], and SC III2 + IV1 is formed independently of the respirasomes [98]. Supercomplex assembly factors COX7A2L and
HIGD2A are marked in green/red.
production. Measurements in bovine heart mitochondria provided
the ﬁrst demonstration that the disruption of SC I + III2 enhanced
the generation of superoxide from CI [79], and a direct correlation
between ROS levels and CI dissociated from SCs was  established
in neurons and astrocytes [80]. According to the ovine respirasome
structure [22], the two CoQ binding cavities on CIII2 are arranged in
such way that the symmetry of CIII2 is broken, and this asymmetry
could limit ROS production at the expense of maximal activity.
Although decreased ROS production may  be a functional con-
sequence of SCs, oxygen levels can also modulate the assembly of
these superstructures and the efﬁciency of mitochondrial respira-
tion. For instance, during prolonged hypoxia, potato mitochondria
showed a rearrangement of CI from SC I + III2 to its free form [36].
Other studies in mouse ﬁbroblasts lacking the Rieske Fe-S protein
of CIII2 showed that enhanced ROS disrupted SCs and produced a
deleterious effect on the stability of complexes I and IV [81]. One
way the cells adapt to hypoxic conditions is by building a more
efﬁcient respiratory chain through CIV, a key enzyme composed of
oxygen-regulated subunit isoforms in yeast and mammals [82–84].
Variations in oxygen levels may  thus affect the assembly state of
CIV and its incorporation into respirasomes. Aging, a fundamen-
tal biological process that affects all eukaryotic lives, is generally
attributed to increased oxidative damage induced by ROS, and this
is usually accompanied by a decay of SCs levels [85]. Therefore, the
interplay between oxygen levels, superoxide production, synthe-
sis and turnover of SCs and impaired respiration, arises as a crucial
regulatory mechanism in health, disease and ageing.
5. Biogenesis of respiratory chain supercomplexes
5.1. The respirasome assembly pathway
The precise mechanisms that regulate the biosynthesis of mam-
malian mitochondrial SCs remain unsolved. Two models have
been proposed to explain the association of CI with complexes III
and IV to form the respirasome [45,86]. The ﬁrst model (Fig. 3)
proposes that CI gets fully-assembled prior to its binding to
SCs [86]. Time-course incorporation analyses of the 13 radiola-
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Fig. 4. Respirasome biogenesis through the stepwise association of partially- assembled respiratory chain complexes and submodules. This model [45] proposes the sequential
and  coordinated association of submodules and free subunits from CIII2 (green) and CIV (red) to a CI-scaffold (blue) that lacks the N catalytic module, which is incorporated at
the  latest assembly stage to ensure respirasome activation in the presence of all the necessary structural components. The assembly pathways of individual CIII2 and CIV are
depicted according to stablished models [72,108], and SC III2 + IV1 is formed independently of the respirasomes [98]. Supercomplex assembly factors COX7A2L and HIGD2A
are  marked in green/red.
belled mitochondrial-encoded polypeptides into complexes and
SCs showed the existence of a temporal gap between the forma-
tion of the complexes and their co-localization in SCs, suggesting
that SCs originate by the direct association of single preassem-
bled complexes [24]. Recent proteomics studies based on BN-PAGE
and complexome proﬁling of CI intermediates upon mitochon-
drial translation inhibition with chloramphenicol, agreed that CI
was independently assembled before SC formation [86]. In con-
trast, previous studies from the same group in Ndufs4-KO mice
had shown that CI lacking its functional NADH-binding (N) module
is associated with CIII2 in a partially-assembled SC [87], suggest-
ing that the biogenesis of SCs does not necessarily require the
preassembly of individual complexes. The possibility that the for-
mation of the respirasome could be achieved instead through a
coordinated association of submodules and free subunits was sup-
ported by the observation in Neurospora crassa that the assembly of
SC I + III2 occurs before the individual CI is formed [88], and by stud-
ies showing that, in mitochondria from patients with chronically
reduced CIV levels, newly-imported COX subunits preferentially
integrate into SCs [89,90]. In accordance with this idea, we analysed
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the formation of SC assembly intermediates by reversibly deplet-
ing control cell lines of OXPHOS complexes by long treatment with
doxycycline, a reversible inhibitor of mitochondrial translation.
Results led us to propose a second model (Fig. 4) that involves the
sequential binding of subcomplexes from CIII2 and CIV to an almost
complete CI scaffold that lacks the N catalytic module, which would
be incorporated at the end of the assembly process to ensure the
activation of the respirasome once all the essential structural com-
ponents are present [45]. This model implies that the SCs constitute
the structural units where CI gets fully-assembled and activated,
providing a basis to explain the relevance of the respirasomes for
CI stability [67] and why  certain mutations in CIII2 or CIV-associated
genes lead to a combined enzyme deﬁciency of CI [45]. The differ-
ences between both CI assembly models [45,86] could be attributed
to technical differences related to the use of two  different mito-
chondrial translation inhibitors, the length of the inhibition periods,
or the time gaps between the collected samples, which probably
affect the balances between the synthesis of individual MRC  sub-
units and their kinetics of incorporation into the different MRC
structures. Although the ﬁrst model [86] supports the dynamic
exchange of CI between its free form and a SC-associated form, the
fact that “free CI” is underrepresented in mammalian tissues under
mild puriﬁcation conditions [33] mainly agrees with our statement
that SCs provide a scaffold for the full-assembly and stability of
CI. Additionally, our model supports the idea that, when “unable
to associate to/or once dissociated from” SCs, free CI is prone to
degradation by, i.e. locally-produced superoxide [76,79]; moreover,
it does not exclude the dynamic exchange of CIII2 and CIV once the
respirasome assembly has been completed (being compatible with
the variable stoichiometry of CIV within SCs), and it allows for the
dynamic replacement on site of speciﬁc CI reassembled modules
to avoid futile continuous cycles of turnover and de novo synthesis
of this large complex. In this regard, we agree with the previous
reports where a CI intermediate lacking the N catalytic module is
stably associated in SCs [55,87,91]. Extensive structural studies in
cellular and animal models of respiratory chain disease are neces-
sary to clarify the intriguing mechanisms that govern the stepwise
biogenesis of the mitochondrial respirasome.
5.2. Supercomplex assembly factors
An important issue is the regulatory function that chaperones
or assembly factors play on the assembly of SCs and respirasomes.
Here we will discuss the roles of the two best-studied protein types
currently deﬁned as SC assembly factors: COX7A2L and the RCFs.
5.2.1. COX7A2L/COX7RP/SCAFI
An interesting debate concerns the regulatory role of the protein
COX7A2L/COX7RP in the formation and stabilization of mito-
chondrial SCs. COX7A2L was ﬁrst reported to be present in the
respirasomes and SC III2 + IV1 but not in CIII2 or free CIV, there-
fore constituting the ﬁrst SC-speciﬁc assembly factor that was
renamed SCAFI [26]. Enríquez and co-workers discovered that cer-
tain wild-type mouse strains widely used in biological research,
e.g. C57BL/6J and BALB/c, were homozygous for a 6 bp deletion
in the Cox7a2 l gene and expressed a short, unstable COX7A2L
isoform that failed to support CIV association into SCs, thereby
promoting differences in mitochondrial respiration rates and ATP
production. The authors proposed that COX7A2L is a SC-speciﬁc
assembly factor that adapts respirasomes formation and mito-
chondrial function to metabolic variations [26,29]. This hypothesis
was challenged by Larsson and co-workers, who demonstrated
normal respirasome formation and respiratory chain function in
liver and heart mitochondria from mice strains bearing the trun-
cated COX7A2L isoform [92], which was conclusively supported by
other studies [93–97]. A recent work from our laboratory showed
that COX7A2L is neither essential for respirasome formation in
human cell lines [98]. This protein is not uniquely found associ-
ated in SCs, since it independently interacts with both CIII2 and
free CIV to promote the stabilization of SC III2 + IV1, results later
supported by other groups [84,96,99]. In the absence of CI and CIV,
COX7A2L remains associated with CIII2-containing SCs, thereby
showing a preferential association for CIII2 [98]. The fact that the
formation/stabilization of mammalian SC III2 + IV1 is regulated by a
speciﬁc protein in a respirasome-independent manner implies the
co-existence of independent regulatory mechanisms for the bio-
genesis and turnover of different SC structures that deserve further
attention.
Variations were observed among tissues in the relative dis-
tribution of BN-PAGE bands above the canonical respirasome
(corresponding to SC I + III2 + IV2-4) in mice strains bearing the short
COX7A2L isoform [94–96]. This opened the possibility that the
assembly of speciﬁc SCs could be regulated in a tissue-speciﬁc
manner. The high sequence similarity between COX7A2L and
tissue-speciﬁc isoforms of the CIV subunit COX7A, led to speculate
that COX7A2L may  replace COX7A within SCs, acting as a bridge to
stabilize the interaction between CIII2 and CIV [22]. Mass spectro-
metric analyses of SCs from CD1 mice mitochondria (that express
the long COX7A2L isoform), revealed that COX7A2 was present
almost exclusively in CIV1-2, whereas COX7A2L was  present in SCs
III2 + IV and I + III2 + IV1-4 [84]. These observations suggested that
the homologous region of COX7A2L could displace COX7A from CIV
to form a tight CIII2-CIV interface within SCs, while in the absence
of COX7A2L, respirasomes would form with a weaker CIII2-CIV
interface solely stabilized by interactions with CI. This possibil-
ity remains to be conﬁrmed by higher resolution cryo-EM density
maps of the “tight” and “loose” respirasome structures that allow
identiﬁcation of the individual residues [22].
5.2.2. Rcf 1–3
Three independent groups identiﬁed two  respiratory complex
factors (Rcf1 and Rcf2) that control the formation and stabilization
of yeast SC III2 + IV1-2 [100–102]. Rcf1 and Rcf2 belong to the con-
served hypoxia induced gene 1 (Hig1) protein family, and both are
CIV-binding proteins that may  also interact with CIII2. Regarding
Rcf1, deletion mutants (Rcf1) showed an impaired incorpora-
tion of Rcf2, and subunits Cox13 and Cox12 (Cox6a and Cox6b in
mammals, respectively) into CIV [101,102], resulting in defective
CIV activity, decreased SC III2 + IV1-2 levels and increased ROS pro-
duction [100,102]. Remarkably, SC III2 + IV was  detectable in the
Rcf1/Rcf2 double mutants, indicating that the core of CIV could
still bind CIII2 in the absence of these proteins [101]. These results,
as well as recent kinetic and spectroscopic studies in Rcf1 and
Rcf2 mutants [103], revealed the presence of at least two differ-
ent enzymatically-active CIV forms, which differ in their protein
composition and are independently incorporated into SCs, maybe
to adapt the respiratory function to different physiological con-
ditions. Rcf1 interacts with the Aac2 protein [101], a member of
the ADP/ATP carrier protein family that facilitates the equimolar
exchange of ATP for ADP across the inner membrane [104]; there-
fore, changes on the conformational state of the Aac2 protein could
inﬂuence the binding of Rcf1 to CIV and the regulation of its activity
[101]. Latest studies showed that Rcf1 interacts with CIV to regulate
late stages of its assembly process [105], suggesting that it functions
in the assembly of individual CIV rather than playing a direct role
in SC III2 + IV1-2. Rcf1 eukaryotic homologs include two variants,
HIGD1A and HIGD2A, that display the broadest expression pattern
in mammals [100]. Silencing of HIGD1A in mice C2C12 cells did not
induce structural alterations on mammalian SCs [100]; instead, this
protein was  shown to bind CIV in early assembly stages [107], and
to upregulate CIV activity under hypoxic cellular stress [106]. How-
ever, HIGD2A knockdown caused the depletion of SC III2 + IV1 and
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of CIV-containing bands above the SC I + III2 + IV1 without altering
free CIV levels [100], suggestive of a true SC stabilizing role. Rcf2 is
found in yeast species, and it is speciﬁcally required for CIV assem-
bly [101,102]. Recent studies showed that Rcf2 is processed into a
stable C-terminal fragment that remains associated with CIV and
SCs, and a labile N-terminal fragment that displays high sequence
similarity with another mitochondrial protein, Rcf3 [107]. Rcf2 and
Rcf3 associate predominantly with CIV and CIV-containing SCs in
the inner membrane, and in the absence of any of these proteins,
CIV activity is increased. However, Rcf2/Rcf3 double mutants
displayed a decrease in CIV activity that resulted in the loss of yeast
respiratory growth, indicating an overlapping function of both pro-
teins. Whether the Rcf proteins are truly SC assembly factors is a
matter of discussion, as they primarily assist CIV assembly rather
than the biogenesis of SCs. However, the fact that all three Rcfs
remain associated with CIII2 in the absence of a functional CIV [107],
open new prospects regarding their functional implications, as well
as those of their human orthologues, in the assembly of SCs.
6. Conclusions and perspectives
The structural and functional organization of the respiratory
chain has been long debated. Although the existence of speciﬁc
associations of complexes I, III and IV into higher-order structures
(i.e., respirasomes and intermediate SCs I + III2 and III2 + IV1-2) is
generally accepted, their functional relevance remain unsolved.
Recent structural advances in the composition and organization
of the mammalian respirasomes represent a signiﬁcant step for-
ward to understand the functional consequences of the dynamic
rearrangements between individual MRC  complexes and SCs, as
well as their implications in the regulation of the respiratory chain
function in different physiological conditions. This is of particular
importance for the understanding of the molecular mechanisms
underlying respiratory chain disorders and ageing, where a gen-
eral deterioration of SCs formation is commonly observed. The
following research excitingly points towards the decryption of the
speciﬁc interactions that govern the bindings among the individ-
ual complexes in a variety of superstructures, and to unravelling the
molecular mechanisms and players that regulate SCs formation.
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SUMMARY
Mitochondrial respiratory chain (MRC) complexes I,
III, and IV associate into a variety of supramolecular
structures known as supercomplexes and respira-
somes. While COX7A2L was originally described as
a supercomplex-specific factor responsible for the
dynamic association of complex IV into these struc-
tures to adapt MRC function to metabolic variations,
this role has been disputed. Here, we further examine
the functional significance of COX7A2L in the struc-
tural organization of themammalian respiratory chain.
As in the mouse, human COX7A2L binds primarily to
free mitochondrial complex III and, to a minor extent,
to complex IV to specifically promote the stabilization
of the III2+IV supercomplex without affecting respira-
some formation. Furthermore, COX7A2L does not
affect the biogenesis, stabilization, and function of
the individual oxidative phosphorylation complexes.
These data show that independent regulatorymecha-
nisms for the biogenesis and turnover of different
MRC supercomplex structures co-exist.
INTRODUCTION
Theoxidative phosphorylation (OXPHOS) system is embedded in
the lipid bilayer of the inner mitochondrial membrane and is
composed of five multiprotein enzyme complexes as well as
the two mobile electron carriers coenzyme Q (or Q) and cyto-
chrome c (cyt c). The first four enzyme complexes (CI–CIV)
make up the mitochondrial respiratory chain (MRC), which facili-
tates electron transfer from reducing equivalents tomolecular ox-
ygen. The electron translocation through the MRC is coupled to
the creation of a proton gradient across the inner mitochondrial
membrane that will be used by the ATP synthase (complex V)
to driveATP synthesis. In recent years, it has beenwidely demon-
strated that MRC complexes I, III, and IV (CI, CIII, and CIV,
respectively) may associate to form a diversity of supramolecular
assemblies known as supercomplexes (SCs) or respirasomes
(Cruciat et al., 2000; Scha¨gger and Pfeiffer, 2000). However, the
functional relevance of mitochondrial SCs is a matter of intense
debate, even though theyare conserved across species. Inmam-
mals, the respirasome is often referred to as SC I+III2+IV1–4.
Biochemical analyses support the idea that the respirasome con-
tains the MRC and the electron carriers and, thus, is a structural
entity that can carry out respiration on its own (Acı´n-Pe´rez et al.,
2008). Some authors have proposed that SCs function to confer
stability toCI (Moreno-Lastres et al., 2012; Scha¨gger et al., 2004),
to reduce reactive oxygen species (ROS) production (Maranzana
et al., 2013), to facilitate electron channeling (Bianchi et al., 2004),
and to mediate metabolic adaptation through the partition of Q
into two different pools (Lapuente-Brun et al., 2013). However,
the view that SC assemblies provide distinct electron transloca-
tion pathways is currently disputed. Kinetic and spectroscopic
studies have challenged the substrate channeling model by
concluding that (1) cyt c is not trappedwithin the SCs, and, there-
fore, it does not encounter any restriction of its diffusion (Trouil-
lard et al., 2011); and (2) the metabolic pathways for NADH and
succinate oxidation impose different coenzyme Q redox steady
state but communicate and converge on a single non-partitioned
coenzyme Q pool (Blaza et al., 2014; Rigoulet et al., 2010). More-
over, cryo-electron microscopy analyses of the mammalian SC
I+III2+IV1 does not support the substrate channeling model,
because the distance between the binding sites for coenzyme
QonCI andCIII, aswell as the distance between the binding sites
for cyt c onCIII andCIV, is sufficiently far enough to allow free ex-
change (Althoff et al., 2011; Dudkina et al., 2011). Instead, it has
been suggested that the relatively weak interactions between
Cell Reports 16, 1–12, August 30, 2016 ª 2016 The Author(s). 1
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Pe´rez-Pe´rez et al., COX7A2L Is a Mitochondrial Complex III Binding Protein that Stabilizes the III2+IV Supercomplex
without Affecting Respirasome Formation, Cell Reports (2016), http://dx.doi.org/10.1016/j.celrep.2016.07.081
the MRC complexes that lead to SCs formation could prevent
deleterious protein aggregation in the densely packed innermito-
chondrial membrane (Blaza et al., 2014). According to this latter
idea, SC formation would have no direct bioenergetic role but
rather be a protectivemechanism that prevents tight interactions
between the individual OXPHOS complexes.
In budding yeast lacking CI, the formation and stabilization of
the mitochondrial SC III2+IV1–2 is controlled by specific regula-
tory proteins called the respiratory SC factors 1 and 2 (Rcf1
and Rcf2) (Chen et al., 2012; Strogolova et al., 2012; Vukotic
et al., 2012). While both proteins are preferentially associated
with CIV, only Rcf1 seems to play a crucial role in SC stability,
as its human ortholog HIG2A does (Chen et al., 2012). A highly
controversial issue involves the potential regulatory role of the
protein COX7A2L/COX7RP in the formation and stabilization of
mitochondrial SCs.Mouse COX7A2Lwas reported to be present
in SC III2+IV and the respirasomes but not in free CIII or CIV (La-
puente-Brun et al., 2013; M€uller et al., 2016), and was, therefore,
renamed the SC-specific assembly factor I (SCAFI). Certain wild-
type mouse strains, e.g., C57BL/6J and BALB/c, are homozy-
gous for a 6-bp deletion in the Cox7a2l gene and, therefore,
express a short, unstable COX7A2L variant that was reported
to lead to a failure to form SC III2+IV and respirasomes (La-
puente-Brun et al., 2013). Remarkably, the respiration rates
and ATP production from CI- and CII-linked substrates were re-
ported to be higher in tissues from mice bearing the short
COX7A2L isoform. The authors suggested that COX7A2L could
mediate the binding of CIV to SCs to physiologically regulate en-
ergy metabolism by providing alternate paths for electrons from
different metabolic sources (NADH, FAD, or both), thus allowing
optimization of respiration to substrate availability (for discus-
sion, see Barrientos and Ugalde, 2013). Another study used
Cox7a2l knockout (KO) mice (Ikeda et al., 2013) and reported
that COX7A2L is a SC-specific factor that, in contrast to the pre-
vious model (Lapuente-Brun et al., 2013), would promote respi-
rasome stability to gain full activity of the MRC. The KO study
showed that respirasomes were present in mitochondria from
skeletal muscle of C57BL/6J mice (Ikeda et al., 2013), despite
previous claims that this mouse strain lacks respirasomes (La-
puente-Brun et al., 2013). In agreement, an in-depth character-
ization of isolated heart and liver mitochondria from control
mouse strains that contained either the full-length Cox7a2l
gene (i.e., CD1 mice) or the variant with the 6-bp deletion (i.e.,
C57BL/6J, C57BL/6N, and BALB/c mice) demonstrated that all
mice had normal formation of respirasomes and normal respira-
tory chain function, thus showing that the truncated version of
the Cox7a2l gene does not impact the bioenergetic capacity
in vivo (Mourier et al., 2014a). A recent report conclusively sup-
ports the presence of respirasomes in different tissues of
C57BL/6 mice (Williams et al., 2016).
The aim of the present work was to elucidate the functional
importance of COX7A2L in the structural organization of the
mammalian OXPHOS system. Our study demonstrates that
COX7A2L preferentially interacts with mitochondrial CIII and, to
a minor extent, with CIV to promote the stabilization of SC III2+IV
in both mice and humans. However, COX7A2L has no role in the
biogenesis, stabilization, or function of the free OXPHOS com-
plexes, and it has no role in the formation of the respirasomes.
These data show the co-existence of alternative regulatory
mechanisms for the biogenesis and turnover of different respira-
tory chain SC structures.
RESULTS
Mouse COX7A2L Is Essential for SC III2+IV Formation in
a Respirasome-Independent Manner
In order to shed light on these contradictory conclusions
regarding COX7A2L function in murine models (Ikeda et al.,
2013; Lapuente-Brun et al., 2013; Mourier et al., 2014a; Williams
et al., 2016), we first analyzed the COX7A2L levels relative to
OXPHOS subunits by western blots in isolated heart mitochon-
dria fromCD1 versus C57BL/6mice (Figure S1A). The allelic vari-
ation of the Cox7a2l gene in nuclear DNA was previously
described (Mourier et al., 2014a). The CD1 mice express high
levels of a 113-amino-acid COX7A2L protein isoform, whereas
C57BL/6 mice express low levels of a slightly shorter and unsta-
ble COX7A2L protein isoform of 111 amino acids. CI and CIV
subunits were present at similar levels in the wild-type CD1,
C57BL/6J, and C57BL/6N mouse strains. However, the levels
of COX7A2L and CIII subunits were slightly increased in the
CIV-deficient conditional Lrpprc KO mice compared with their
wild-type littermates that all were maintained on the C57BL/6N
background (Mourier et al., 2014b). These data suggest that
COX7A2L, as well as CIII, is stabilized in the Lrpprc KO mice
as a response to the severe CIV deficiency.
In agreement with a previous report (Mourier et al., 2014a),
BN-PAGE analysis of digitonin-solubilized heart mitochondria
from CD1 and C57BL/6 mice confirmed similar levels and activ-
ities of the respirasomes in all wild-type strains (Figures 1A and
1B). Analysis of COX7A2L distribution in CD1 mice (Figure 1C)
showed its preferential co-segregation with free CIV, with SC
III2+IV and respirasomes, and, to a minor extent, with the CIII
dimer. In the C57BL/6 mice, however, COX7A2L was mostly
found in CIII-containing structures (Figure 1C). These data sug-
gest that the two-amino-acid deletion and consequent reduction
in COX7A2L levels mostly hampers the binding of COX7A2L to
CIV, which, nevertheless, only provoked the disappearance of
SC III2+IV (Figures 1B and 1C) without affecting free CIV or
respirasome levels and activities (Figures 1A–1C). Thus, the
severely reduced COX7A2L levels in C57BL/6 mice do not
hamper the association of CIV with the respirasomes, as previ-
ously proposed (Lapuente-Brun et al., 2013). To test whether
the respirasome stability depends on COX7A2L levels, we
exposed heart mitochondria from CD1 and C57BL/6J mice to
increasing amounts of the detergent digitonin, followed by BN-
PAGE analysis (Figure S1B). Respirasome levels and organiza-
tion were comparable between both mouse strains at the low
digitonin-to-protein ratios. Also, under the most stringent deter-
gent conditions, respirasomes were still clearly detectable in the
C57BL/6J mice, albeit at slightly lower levels than those in the
CD1 mice. Noteworthy, SCs from both mouse strains reorgan-
ized in different ways upon increasing digitonin treatment, and
some respirasome bands appeared to be more stable in
C57BL/6J than in CD1 mice and vice versa. Next, we analyzed
DDM-solubilized mouse heart mitochondria, a condition in
which respirasomes are disrupted (Figure S1C), and found that
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the co-segregation between COX7A2L and free CIV was totally
lost, suggesting that their interaction is, indeed, labile. In CD1
mice, both COX7A2L and the CIII subunit CORE2 co-localized
with the CIII dimer and SC III2+IV, whereas in C57BL/6 mice,
both proteins only were present in the CIII dimer. Altogether,
these data show that COX7A2L is essential for SC III2+IV stabil-
ity, whereas it is dispensable for the respirasome formation.
Next, we assessed import and assembly of the radiolabeled
113-amino-acid COX7A2L isoform into isolated heart mitochon-
dria from CD1, C57BL/6J, and C57BL/6Nmice by BN-PAGE an-
alyses (Figures 1D, S1D, and S1E). We used mitochondria with
dissipated membrane potential as controls to ensure that the
protein import and assembly depend on the membrane potential
across the inner mitochondrial membrane (Figure S1D). The
comparison of migration patterns and the kinetics of formed as-
sembly intermediates after import of COX7A2L or the CIII subunit
RISP showed that the long COX7A2L isoform was incorporated
into CIII-containing structures in all mice strains. We observed a
preferential co-segregation of the newly imported COX7A2Lwith
the CIII dimer at early time points after import (Figure 1D),
whereas COX7A2L was present in higher molecular-weight
structures, such as SC III2+V and respirasomes, at later time
points. These data demonstrate that COX7A2L preferentially in-
teracts with CIII prior to SC formation. Additional analyses of the
import of COX7A2L into isolated mitochondria from Lrpprc wild-
type and KO hearts (Figure S1E) revealed that COX7A2L associ-
ates with CIII independently of the presence of CIV.
Human COX7A2L Co-localizes with Respiratory Chain
CIII and CIV and CIII-Containing SCs
In humans, only one COX7A2L protein of 114 amino acids has
been reported in the NCBI Gene database ([Gene ID: 9167]
http://www.ncbi.nlm.nih.gov/gene/9167) To clarify the func-
tional role of the human COX7A2L protein, we first analyzed its
distribution pattern in relation to free MRC complexes and SCs
by performing BN-PAGE, followed by western blot analyses.
We analyzed digitonin-solubilized mitochondria from control
143B cells and cybrids with a severe CI assembly defect (CI-
KD [knockdown]), total lack of CIII (CIII-KO) or total lack of CIV
(CIV-KO) (Figure 2A; Figure S2A). In controls, COX7A2L co-local-
ized not only with SC III2+IV and the respirasomes (SC I+III2+IVn),
as previously described in murine models (Lapuente-Brun et al.,
Figure 1. Mouse COX7A2L Behaves as a
CIII-Binding Protein Specifically Required
for SC III2+IV Assembly
(A) Supramolecular organization of the respiratory
chain in heart mitochondria from wild-type (wt)
CD1, C57BL/6J, and C57BL/6N (Lrpprcwt) mouse
strains, as well as from Lrpprc-deficient (KO) mice
with a C57BL/6N genetic background. Mitochon-
dria were extracted with a digitonin:protein ratio
of 4 g:1 g and analyzed by BN-PAGE, followed by
CI and CIV-IGA assays.
(B) Heart mitochondria were extracted with a
digitonin:protein ratio of 6 g:1 g and analyzed by
BN-PAGE, followed by western blot with double-
fluorescent detection of CIII and CIV (anti-CORE2
or anti-COX1, green) and COX7A2L-containing
complexes (anti-COX7A2L, red). White asterisks
show the localization of SC III2+IV.
(C) Heart mitochondria were extracted with a
digitonin:protein ratio of 4 g:1 g and analyzed by
2D BN/SDS-PAGE, followed by western blot and
immunodetection with antibodies against
COX7A2L and the indicated OXPHOS subunits.
(D) Import of radiolabeled RISP and COX7A2L
precursors and subsequent incorporation into CIII
and SCs in intact heart mitochondria from C57BL/
6J and CD1 mouse strains. After the indicated in-
cubation times (in minutes), mitochondria were
solubilized in 6 g:1 g digitonin per protein and
analyzed by BN-PAGE.
I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC
containing CI and CIII; III2+IV, SC containing CIII
and CIV; III2, CIII dimer; IV, free CIV; IVn, CIV
oligomers.
See also Figure S1.
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2013; Williams et al., 2016), but also with SC I+III2, the CIII dimer
(CIII2), and free CIV. The CI-KD cybrids, which harbored a >90%
heteroplasmic mutation in the MT-ND2 subunit gene of mtDNA
(Ugalde et al., 2007), showed a strong reduction in the levels of
SC I+III2+IVn, SC III2+IV, and free CIV. Consistently, the amounts
of COX7A2L within those structures were also reduced in the CI-
defective cells compared with the controls. The CIII-KO cybrids
lacked CIII due to a homoplasmic 4-bp deletion in the MT-CYB
gene that encodes cytochrome b (Rana et al., 2000). Lack of
CIII caused the complete disruption of SC I+III2+IVn and SC III2+-
IV, accompanied by increased levels of free CIV and CIV oligo-
mers. In addition, a dramatic reduction in COX7A2L levels, com-
parable to that of the CIII structural subunits, was observed
(Figure 2B). Only a minor residual COX7A2L signal co-migrating
with free CIV was seen at the longest exposures (Figure S2B),
indicating that the lack of CIII profoundly affects the stability of
COX7A2L and its binding to CIV. The CIV-KO cybrids harbor a
homoplasmic nonsense mutation in MT-CO1 (Bruno et al.,
1999), leading to the disappearance of free CIV, SC III2+IV, and
SC I+III2+IVn, accompanied by an accumulation of SC I+III2
and CIII2. Interestingly, COX7A2L could bind SC I+III2 and CIII2
in the absence of CIV, whereas very small amounts were bound
to CIV in the absence of CIII. Thus, in human cells, COX7A2L
preferentially associates with CIII2 and CIII-containing struc-
tures, and only to a minor extent with free CIV, showing that
COX7A2L principally behaves as a CIII interactor rather than an
assembly factor exclusive to CIV-containing SCs (Lapuente-
Brun et al., 2013). The presence of COX7A2L in CIII2, SC I+III2,
and I+III2+IVn was further confirmed by high-resolution nano-
LC/ESI-MS (nano-liquid chromatography/electrospray ioniza-
tion-mass spectrometry) proteomic analysis of the blue native
(BN) gel bands corresponding to SC I+III2+IVn in 143B cells
and to SCs I+III2 and CIII2 in the CIV-KO mutant cybrids (Figures
2C and 2D; Table S1).
Overexpressed COX7A2L Is Imported into Mitochondria
and Binds CIII and CIV without Significantly Enhancing
SC Formation
Next, we investigated the cellular localization of human COX7A2L
by transfecting control 143B cells with a construct expressing
COX7A2L with a C-terminal GFP-tag, yielding a product of
39.3 kDa (Figure S3A). Confocal microscopy showed co-locali-
zation of COX7A2L-GFP with the ATP synthase (complex V),
thus confirming mitochondrial localization of the fusion protein
(Figure 3A). Next, we analyzed by BN-PAGE the mitochondrial
distribution of exogenous COX7A2L and the effect of COX7A2L
overexpression on the assembly of the OXPHOS system. To this
end, we initially used 143B cells transfected either with the GFP-
tagged COX7A2L construct or with a vector that expressed
COX7A2L with a C-terminal MYC-DDK tag, yielding a product of
16.2 kDa (Figures 3B and S3B). In 143B cells, COX7A2L-GFP
was effectively overexpressed by 15-fold relative to the endog-
enous COX7A2L (Figure S3A), while COX7A2L-MYC-DDK was
overexpressed by 2-fold (Figure S3B). BN-PAGE analyses
confirmed the co-migration of exogenous COX7A2L with the CIII
dimer, free CIV, SC III2+IV, and the respirasomes in digitonin-sol-
ubilized mitochondria (Figures 3B and S3C), thus showing that
COX7A2L, with both tags, is efficiently incorporated into MRC
complexes and SCs. Densitometric analyses of OXPHOS subunit
distribution showed that the overexpression of tagged COX7A2L
induced no significant increase in the amounts of CIII- and CIV-
containing structures (Figure 3C). We extended this analysis to
HEK293 cells transfected with either the MYC-DDK-tagged
COX7A2L construct or the MYC-DDK tag alone. In HEK293 cells,
COX7A2L-MYC-DDKwas effectively overexpressedby10-fold,
relative to endogenous COX7A2L (Figure S3B), and co-migrated
with the CIII dimer, free CIV, SC III2+IV, and the respirasomes
Figure 2. Human COX7A2L Co-migrates with Respiratory Chain SCs
and Free CIII and CIV
(A) Mitochondria from control 143B cells and mutant cybrids defective in CI
(CI-KD), CIII (CIII-KO), andCIV (CIV-KO) were extractedwith a digitonin:protein
ratio of 4 g:1 g and analyzed by 2D BN/SDS-PAGE and western blot with
antibodies raised against COX7A2L, CORE2, and COX1.
(B) Mitochondrial lysates from control and mutant cybrids were analyzed by
SDS-PAGE and western blot with the indicated antibodies.
(C) BN-PAGE and CI-IGA analysis of control 143B cells and CIV-KO mutant
cybrids. After Coomassie staining, the SC I+III2+IV1 bandwas excised from the
control lane, and the bands corresponding to SC I+III2 and CIII were excised
from the CIV-KO lane. Bands were subsequently analyzed by LC coupled to
tandem MS (MS/MS). MW, molecular weight.
(D) MS/MS spectra from the doubly charged COX7A2L tryptic peptide
unambiguously detected by LC-ESI/MS in two independent experiments per
sample. The amino acid sequence of the identified COX7A2L unique peptide is
highlighted in red. Themost intense signals on theMS/MS spectra correspond
to the main fragmentation series (b-amino and y-carboxy). Doubly charged
fragments are marked with superscript 2+.
I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI and CIII;
III2+IV, SC containing CIII and CIV; III2, CIII dimer; IV, CIV; IV2, CIV dimer.
See also Figure S2 and Table S1.
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(Figure S3D). Tagged COX7A2L overexpression in HEK293 cells
altered the levels of neither MRC complexes nor SCs.
Next, we tested whether the COX7A2L co-localization with
MRC CIII and CIV was due to a direct physical interaction. We
performed co-immunoprecipitation assays of digitonin-solubi-
lized mitochondrial lysates from HEK293 cells transfected with
either the COX7A2L-MYC-DDK construct or the empty vector
(Figure 4A). Immunoprecipitation with an anti-DDK antibody
specifically pulled down the tagged-COX7A2L protein in cells
overexpressing COX7A2L-MYC-DDK. In addition, the CIII sub-
units CORE1, CORE2, CYC1, RISP, and UQCRQ and the CIV
subunits COX1, COX4, COX5B, and COX6C were detected in
the co-immunoprecipitate (coIP). The CI subunits NDUFA9 and
NDUFS1 were barely detectable, and CII was not detected in
the coIP samples. When reverse immunoprecipitation assays
were performed using antibodies against CORE2 or COX1 pro-
teins, both the tagged and the endogenous COX7A2L proteins
Figure 3. Overexpressed COX7A2L Local-
izes to Mitochondria with Minor Effects on
the Respiratory Chain Complexes and SCs
(A) Confocal microscopy of 143B cells transiently
transfected with the COX7A2L-GFP construct and
with the empty-GFP vector as a control. Upper
images show the GFP signal. Middle images show
the mitochondrial network using an antibody
against the ATPase a subunit. Lower images show
the overlay between the two signals.
(B) BN-PAGE and western blot analyses of con-
trol 143B cells transiently transfected both with
the COX7A2L-GFP or COX7A2L-MYC-DDK con-
structs and with their corresponding empty
vectors. Membranes were incubated with anti-
bodies raised against COX7A2L and the indicated
OXPHOS subunits.
(C) Densitometric analysis of the MRC complexes
and SCs in 143B cells transfected with both
COX7A2L-tagged constructs. The optical den-
sities of immunoreactive bands that had not
reached saturation levels were measured with the
ChemiDoc MP Image Analyzer software package
(Biorad). The antibody signals within the same
structures were quantified; the mean values were
normalized by CII and expressed as percentages
of the cells transfected with the empty vectors
(horizontal bar). Values represent the means ± SD
from four independent experiments.
I+III2+IVn, SC containing CI, CIII, and CIV; III2+IV,
SC containing CIII and CIV; III2, CIII dimer; IV, CIV;
IV2, CIV dimer; II, CII.
See also Figure S3.
were successfully pulled down (Figures
4B and 4C). Importantly, immunoprecipi-
tation with CORE2 (but not with COX1)
pulled down the endogenous COX7A2L
protein in cells transfected with the empty
vector. These data show that COX7A2L
physically interacts with CIII and CIV
but presents a higher affinity for CIII. Ac-
cording to the TOPCONS prediction soft-
ware (http://topcons.cbr.su.se/), human COX7A2L contains one
transmembrane domain that spans amino acids 86 to 107, leav-
ing most of the N-terminal part of the protein exposed to the
mitochondrial matrix, and a short C-terminal stretch of seven
amino acids facing the inter membrane space. The direct asso-
ciation of COX7A2L with mitochondrial CIII and CIV is, therefore,
compatible with its predicted topology.
Endogenous COX7A2L Associates with Respiratory
Chain CIII and CIV and with SCs during Their Assembly
Process
Next, we analyzed the assembly kinetics of COX7A2L into MRC
complexes and SCs by doxycycline-induced reversible inhibition
of mitochondrial translation in control 143B cells (Moreno-
Lastres et al., 2012). Doxycycline was removed from cell-culture
media after 6 days of treatment, and samples were collected at
different time points (0, 6, 15, 24, 48, 72, and 96 hr). To follow the
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integration of endogenous COX7A2L into newly assembled CIII,
CIV, and SCs, digitonin-solubilized mitochondria were sepa-
rated by 2DBN/SDS-PAGE and subsequently analyzed bywest-
ern blot using antibodies that recognize COX7A2L, CORE2 (CIII),
RISP (CIII), and COX5A (CIV) (Figure 5A). Signals from at least
three independent experiments were quantified by densitometry
and normalized to CII levels, and values were expressed relative
to levels in untreated cells (SS in Figures 5B and 5C; Figures
S4A–S4D). After 6 days of doxycycline treatment (time, 0 hr),
there was a drastic decrease (80%–95%) in the levels of the
CIII dimer (CIII2), CIV, SC III2+IV, and SC I+III2+IVn, as well as
in the levels of COX7A2L that co-localizes with these structures.
The CII levels remained normal after doxycycline treatment (data
not shown) as expected, because this complex lacks mtDNA-
encoded subunits. Once mitochondrial translation resumed
(times, 6–96 hr; Figures 5B and 5C), we observed a gradual in-
crease of the levels of COX7A2L protein that co-localized with
CIII2, in agreement with our previous results showing the co-
localization of newly imported COX7A2L and the CIII dimer in
mouse heart mitochondria (Figure 1D). The incorporation of
COX7A2L into CIII occurred in parallel to the insertion of the
CORE2 subunit, which gets assembled into CIII prior to the
incorporation of RISP (Figure S4A). In contrast, the CIV levels
increased prior to the binding of COX7A2L (Figure S4B), sug-
gesting that COX7A2L only binds fully assembled CIV. Once
COX7A2L had bound to CIV, there was a simultaneous increase
of the levels of COX7A2L in CIV and SC III2+IV (Figures 5B and
5C).Moreover, COX7A2Lwas incorporated into SC III2+IV in par-
allel with the CORE2 and COX5A subunits but prior to the inte-
gration of RISP in this structure (Figure S4C). The incorporation
of COX7A2L into respirasomes occurred concomitantly with
the integration of CORE2 and COX5A, and earlier than the inte-
gration of RISP (Figure S4D), which indicates that COX7A2L is
incorporated before the respirasome formation is completed.
COX7A2L Associates with CIII and SC III2+IV prior to the
Insertion of the RISP Catalytic Subunit
In the reported CIII assembly models, incorporation of CORE2
allows the formation of a non-functional intermediate called
pre-CIII, which contains CORE2 and the rest of the CIII subunits
except RISP and the smallest subunit (Qcr10 in yeast, UQCR11
in mammals), which are incorporated at a later assembly stage
(Ferna´ndez-Vizarra and Zeviani, 2015; Smith et al., 2012). This
late assembly step is promoted by LYRM7/MZM1L, an assembly
factor that binds RISP to stabilize it prior to its incorporation into
CIII. HeLa cells that stably overexpress hemagglutinin (HA)-
taggedMZM1L showed sequestering of RISP in a small subcom-
plex, thereby preventing CIII maturation (Sa´nchez et al., 2013).
Doxycycline experiments suggested that humanCOX7A2Lcould
be a component of pre-CIII, as this protein gets incorporated into
CIII in parallel with the CORE2 subunit but before the incorpora-
tionofRISP (FigureS4A). Toconfirm this hypothesis,weanalyzed
COX7A2L distribution by BN-PAGE of digitonin-solubilized mito-
chondria isolated from HeLa cells overexpressing MZM1L-HA
(Figure 6). As observed by CI in-gel activity (IGA), MZM1L over-
expression induced a decrease in the levels and activity of the
respirasomes (SC I+III2+IV), as well as an accumulation of CI-
containing structures (Figure 6A). As expected, the levels of the
RISP subunit were strongly decreased in the respirasomes, in
SC III2+IV, and in the CIII dimer, and there was a parallel accu-
mulation of RISP in a small subcomplex that also contains
MZM1L-HA (Sa´nchez et al., 2013) (Figure 6B). The amount of
RISP remained relatively high in SC I+III2+IV, compared with
Figure 4. COX7A2L Physically Binds CIII and CIV
(A) COX7A2L co-immunoprecipitation assay. Digitonin-solubilized mitochon-
drial extracts (4 g digitonin/1 g protein) from HEK293 cells transiently trans-
fected with COX7A2L-MYC-DDK (+) or the empty MYC-DDK construct ()
were immunoprecipitated using an anti-DDK antibody. IP, immunoprecipitate.
(B and C) The same digitonin-solubilized mitochondrial extracts were immu-
noprecipitated using antibodies against (B) CORE2 or (C) COX1. Samples
were subsequently analyzed by SDS-PAGE and western blot with the indi-
cated antibodies.
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other structures, suggesting that this subunit is stably bound
to the respirasomes. Upon MZM1L/LYRM7 overexpression,
CORE2 and COX7A2L co-segregated with pre-SC III2+IV and
pre-CIII (Figure 6B), further supporting that COX7A2L associates
with pre-CIII before the incorporation of RISP takes place (Fig-
ure S4E). All in all, our data demonstrate that, in human cells,
the interaction of COX7A2L with CIV depends on the presence
of pre-CIII, the formation of which is not affected by the lack of
RISP (Figure 6) but is dependent on cytochrome b (Figure 2B).
COX7A2L Downregulation Causes SC III2+IV
Disassembly without Altering Respirasome Stability or
Respiratory Chain Function
We further investigated the effect of COX7A2L KD on mitochon-
drial functionbyusing amix of two small interferingRNAs (siRNAs)
targeting exons 2 and 3 ofCOX7A2LmRNA. TheCOX7A2LKDef-
ficiencywasanalyzedbySDS-PAGEofwhole-cell proteinextracts
from control 143B cells and CIV-KO mutant cybrids (Figures S5A
Figure 5. Assembly Kinetics of COX7A2L in
Free Complexes and SCs
(A) Mitochondria from doxycycline-treated 143B
cells were extractedwith a digitonin:protein ratio of
4 g:1 g and analyzed by 2D BN/SDS-PAGE and
western blot with the indicated antibodies.
(B) Densitometric profiles representing the as-
sembly progress of COX7A2L in CIII- and CIV-
containing structures.
(C) Mean incorporation rates of COX7A2L into CIII-
and CIV-containing structures. The signals from
three independent experiments were quantified
and normalized by CII. Time point values are ex-
pressed as percentages of the untreated cells (SS)
and indicated as means ± SD.
I+III2+IVn, SC containing CI, CIII, and CIV; III2+IV,
SC containing CIII and CIV; III2, CIII dimer; IV, CIV;
a.d.u., arbitrary densitometric units.
See also Figure S4.
and S5B). COX7A2L RNAi effectively
knocked down the COX7A2L protein by
80% in the 143B cells and by 74% in the
CIV-KO mutants, compared with cells
transfected with unspecific scrambled
siRNAs (C- in Figures S5A and S5B).
Next, we analyzed the effects ofCOX7A2L
silencingonOXPHOSsystemassemblyby
BN-PAGE in combination with CI-IGA and
westernblot analysesofmitochondrial-en-
riched fractions from 143B and CIV-KO
cells (Figure7A). UponCOX7A2LKD, there
was a significant decrease in the signals of
COX7A2L that co-localized with the CIII
dimer, free CIV, and SCs III2+IV, I+III2,
and I+III2+IVn. Despite the severe drop in
COX7A2L levels, we only observed a spe-
cific reduction in the levels of SC III2+IV in
the 143B cells, whereas the CI activity
and the levels of freeOXPHOScomplexes,
other SCs, and respirasomeswere normal.
To gain deeper insight into the nature of SC III2+IV disruption in
143B cells, we performed 2D BN/SDS-PAGE and western blot
analyses with antibodies against CORE2 (CIII), RISP (CIII),
COX1 (CIV), and COX5B (CIV) (Figure 7B). Quantification of re-
sults from five independent experiments (Figure 7C; Figures
S5C and S5D) showed thatCOX7A2LKD specifically led to a sig-
nificant decrease in the levels of the four analyzed subunits
within SC III2+IV but not in the other CIII- and CIV-containing
structures. These data indicate that COX7A2L has a specific
role in the stabilization of SC III2+IV but not in the respirasome
maintenance. Moreover, COX7A2L silencing did not result in a
clear accumulation of intermediates smaller than CIII and CIV,
indicating that their assembly and/or stability are not disturbed.
In agreement with these results, COX7A2L KD in the CIV-KO
mutant cybrids produced no significant alterations in the levels
of the CIII dimer or SC I+III2 (Figures S6A and S6B). Altogether,
our results show that the stabilization of SC III2+IV relies on the
association of COX7A2L with MRC CIII and CIV.
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Finally, we measured oxygen consumption rates (OCRs) in
143B cells and found no significant differences between
COX7A2L-silenced cells and cells transfected with scrambled
siRNA (Figure S6C). In contrast, mitochondrial respiration was
drastically reduced in the CI-KD cybrids that retained SC III2+IV
but showed minimal levels of CI and respirasomes (Figure S6D).
Respiratory chain activities measured in COX7A2L-silenced
143B cells were also comparable to the activities in control cells
(Figure S6E). These results show that a substantial loss of
COX7A2L and SC III2+IV has no significant impact onMRC func-
tion in human cell lines.
DISCUSSION
We have investigated the role of COX7A2L/COX7RP in the struc-
tural organizationof themammalianOXPHOSsystemandclarified
theapparentcontradictionsabout the roleof thisprotein in the liter-
ature (Ikeda et al., 2013; Lapuente-Brun et al., 2013;Mourier et al.,
2014a;Williams et al., 2016). Our data demonstrate that COX7A2L
acts as a CIII-binding protein in mitochondria from mouse heart
and human cell lines. Furthermore, COX7A2L is specifically
required for SC III2+IV maintenance, and this finding strongly ar-
gues against its previously proposed function as a SC-specific
assembly factor that mediates respirasome formation.
We used a combination of COX7A2L immunodetection, high-
throughput proteomics, and mitochondrial in vitro import assays
to demonstrate that COX7A2L co-migrates with the CIII dimer,
free CIV, SC I+III2+IVn, SC I+III2, and SC III2+IV in both mice
and humans. Thus, the COX7A2L protein is not exclusively pre-
sent in SCs, as previously reported (Lapuente-Brun et al., 2013;
M€uller et al., 2016); instead, it predominantly associates with
different CIII-containing structures. In mice, the long COX7A2L
isoform preferentially interacts with CIII prior to SC formation.
The small amount of COX7A2L that co-segregates with free
CIV in the CD1 strain could reflect continuous turnover and ex-
change cycles between the SC-bound and free CIV states, or,
alternatively, a fraction of the COX7A2L-bound CIV could be
dissociated from SCs upon detergent extraction. Such dissocia-
tion cannot be observed in the C57BL/6 mice, because they
have already lost the association between COX7A2L and CIV.
Our data in human control and mutant cybrids lacking one
MRC complex suggest that COX7A2L behaves as a structural
component of CIII, because COX7A2L preferentially binds this
complex, and the stability of COX7A2L depends on the presence
of CIII. Accordingly, COX7A2L remains associated with the CIII
dimer and CIII-containing SCs in the absence of CI and CIV.
Furthermore, COX7A2L binds to a reported CIII assembly inter-
mediate that lacks the RISP subunit (pre-CIII) before it interacts
with free CIV, SC III2+IV, or the respirasomes. In agreement
with this observation, COX7A2L remained associated with pre-
CIII in HeLa cells with an impaired incorporation of RISP. In
contrast, lack of cytochrome b precludes the formation of pre-
CIII and led to the disappearance of CIV-associated COX7A2L.
At variance with previous studies in fibroblasts from COX7A2L-
deprived mice (Lapuente-Brun et al., 2013), COX7A2L overex-
pression in human cell lines did not cause a significant increase
in the levels of MRC CIII, CIV, or SCs. However, reduced
COX7A2L levels led to a specific loss of SC III2+IV but did not
affect the amounts of free CIII and CIV, respirasomes, or mito-
chondrial function. Similar to the situation in cultured human cells,
the mouse COX7A2L variant of 113 amino acids is imported into
mitochondria, where it preferentially associates with CIII-contain-
ing structures and plays an essential role inSC III2+IV stabilization.
These results show that mammalian COX7A2L is essential to
maintain SC III2+IV stability, but it plays no critical role in the as-
sembly or stabilization of SC I+III2+IVn. These findings strongly
suggest that there are independent regulatory mechanisms for
the biogenesis and turnover of SC III2+IV and the respirasomes.
This is in accordance with previous observations suggesting
that SC III2+IV gets fully assembled after the completion of
Figure 6. COX7A2L Binds to CIII Assembly Intermediates
(A) Digitonin-solubilized mitochondrial extracts (4 g digitonin/1 g protein) from
HeLa cells transduced with the MZM1L-HA construct or with the empty vector
(PuroR) were analyzed by BN-PAGE and CI-IGA assays or, alternatively, by
western blot and immunodetection. Asterisks indicate unspecific signals that
do not appear on 2D BN/SDS-PAGE gels.
(B) Subsequent 2D BN/SDS-PAGE and western blot analyses were performed
with antibodies against COX7A2L, the indicated OXPHOS subunits, and the
HA epitope.
I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; I*,
CI-containing structure; III2+IV, SC containing CIII and CIV; Pre-III2+IV, SC
containing pre-CIII and CIV; III2, CIII dimer; Pre-III2, pre-CIII lacking the RISP
subunit; IV, CIV; IV2, CIV dimer; II, CII. SCs that contain CORE2 and COX1 are
indicated as subCORE2 and subCOX1, respectively. The association of RISP
and MZM1L is indicated as RISP+MZM1L.
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respirasome formation (Moreno-Lastres et al., 2012). Our present
results also confirm that the levels of respirasomes and MRC ac-
tivities in mitochondria from mouse hearts are not dependent on
the allelic variations of Cox7a2l (Mourier et al., 2014a), and they
contradict the hypothesis that COX7A2L is an assembly factor
that regulates respirasome formation to modulate respiration.
The fact that respirasomes (but not SC III2+IV) are present in
C57BL/6J mitochondria solubilized with a variety of detergent
concentrations provides additional support for a role for
COX7A2L to stabilize SC III2+IV. These data are in agreement
with other reports that show the presence of respirasomes in
different tissues, including the heart, liver, and skeletal muscle,
of C57BL/6 mice (Hatle et al., 2013; Ikeda et al., 2013; Jha
et al., 2016; Milenkovic et al., 2013; Williams et al., 2016). In this
regard, the previously reported absence of respirasomes in
mouse strains with the truncated Cox7a2l allele (Lapuente-Brun
et al., 2013) could have resulted from differences in the method-
ologies or reagents used for membrane solubilization. Indeed,
we observed some variations in the intensity of SC isoforms be-
tweenC57BL/6J and CD1mice at high detergent concentrations;
however, the pattern was not constant, as specific SCs were sta-
bilized in C57BL/6J mice but not in CD1 mice, and vice versa.
Based on our data, we cannot exclude the possibility that the
mechanisms of SC assembly are regulated in a tissue-dependent
manner, as recently proposed (Jha et al., 2016; Williams et al.,
2016). However, it is important to acknowledge that the observed
changes may not necessarily be a consequence of genetic
COX7A2L variation but could well be explained by other types
of genetic differences among mouse strains.
Our results argue that COX7A2L is permanently associated
with CIII and that it exists in an association/dissociation equilib-
rium with CIV, which can define the fate of CIV depending on
whether COX7A2L is bound or not. This could provide a mecha-
nism whereby COX7A2L-bound CIV is guided to the proximity of
CIII to form and stabilize SC III2+IVn. The functional role of
COX7A2L may resemble that described of HIG2A, the human
ortholog of the yeast Rcf1 SC factor. In yeast, Rcf1 and Rcf2
preferentially associate with CIV to mediate SC III2+IV1–2 stability
(Chen et al., 2012; Strogolova et al., 2012; Vukotic et al., 2012).
Whereas Rcf2 is yeast specific, several human homologs of
Rcf1 have been reported, whereof HIG2A is involved in the sta-
bilization of a proportion of CIV-containing SCs (Chen et al.,
Figure 7. COX7A2L Downregulation Specifically Decreases the Levels of SC III2+IV without Affecting Respirasome Biogenesis
The effect of COX7A2L KD on MRC complex assembly was investigated in untreated (CO), mock-transfected (C), and COX7A2L siRNA-transfected (i) 143B
cells and in the CIV-KO mutants.
(A) Mitochondria were extracted with a digitonin:protein ratio of 4 g:1 g and analyzed by BN-PAGE, followed by CI-IGA assays, or alternatively, by western blot
and immunodetection with the indicated antibodies. Asterisks indicate unspecific signals that do not appear on 2D BN/SDS-PAGE gels.
(B) 2D BN/SDS-PAGE and western blot analyses of 143B cells upon COX7A2L silencing.
(C) The optical densities of immunoreactive bands that had not reached saturation levels were measured. The signals within SC III2+IV were quantified,
normalized by CII, and shown as means ± SD from five independent siRNA experiments. Values are expressed as percentages of the cells transfected with
scramble RNA (C, horizontal bar).
I+III2+IVn, SC containing CI, CIII, and CIV; I+III2, SC containing CI and CIII; III2+IV, SC containing CIII andCIV; III2, CIII dimer; IV, CIV; IV2, CIV dimer; II, CII. *p < 0.05,
Mann-Whitney U test.
See also Figures S5 and S6.
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2012). C11ORF83 or UQCC3A, a cardiolipin-binding protein in-
volved in the early stages of human CIII assembly, has also
been reported to act as a SC III2+IV-stabilizing factor (Desmurs
et al., 2015). The similarities in modes of action between these
proteins and COX7A2L make it conceivable that they could
act in conjunction, having a respiratory chain ‘‘stabilizing’’ or
‘‘gluing’’ function, although further studies are required to
demonstrate such functional interactions.
Interestingly, the COX7A2L-mediated absence of SC III2+IVn
does not affect respirasome formation or maintenance. In
addition, the fact that the formationandstabilizationofa lessabun-
dant structure such as SC III2+IVn is regulated by specific proteins
in a respirasome-independent manner supports the existence of
alternative assembly pathways for SC III2+IVn and the respira-
somes. It may also be indicative of a specific, yet not well-under-
stood,physiological importanceofSC III2+IVn.Results fromothers
havesuggested thatSC III2+IVn could provide anMRCstructure to
receive electrons from CII (Lapuente-Brun et al., 2013). However,
given current evidence that puts in doubt the catalytic roles for
mitochondrial SCs (Blaza et al., 2014; Trouillard et al., 2011), alter-
native non-catalytic functions should also be considered. These
would include the regulation of MRC complex distribution in
specific cardiolipin microdomains within the densely protein-
packed mitochondrial inner membrane or a role in storage or
preservation of excess MRC components to avoid futile contin-
uous cycles of turnover and de novo synthesis. The experimental
evidence of independent regulatory mechanisms and proteins
for the biogenesis of intermediate SCs and the respirasomes
opens new doors for exciting future investigations of the role for
these supramolecular structures in the regulationof cellular energy
supply.
EXPERIMENTAL PROCEDURES
Cell Cultures
The CI-deficient (CI-KD) cell line harbors a homoplasmic m.4681T > C muta-
tion in the MT-ND2 subunit gene that leads to a severe CI assembly defect
due to a p.L71P substitution (Ugalde et al., 2007). The CIII mutant (CIII-KO)
cell line contains a homoplasmic 4-bp deletion in the MT-CYB gene affecting
the de novo synthesis of cytochrome b (Rana et al., 2000). The CIV mutant cell
line (CIV-KO) lacks holo-COX due to the homoplasmic m.6930G > A transition
in the MT-COI gene, which creates a stop codon that results in a predicted
loss of the last 170 amino acids of the COX1 polypeptide (Bruno et al.,
1999). HeLa cells, either transduced with the empty pWPXLd-ires-PuroR vec-
tor or overexpressing LYRM7-001-HA (MZM1L-HA), were generated as previ-
ously described (Sa´nchez et al., 2013).
Cells were cultured in high-glucose DMEM (Life Technologies), supple-
mented with 10% fetal calf serum (FCS), 2 mM L-glutamine, 1 mM sodium
pyruvate, and antibiotics. To blockmitochondrial translation, 15 mg/ml doxycy-
cline was added for 6 days to the culture medium. Cells were grown in expo-
nential conditions and harvested at the indicated time points.
In Vitro Import
Radiolabeled COX7A2L, COX6A, and RISP proteins were obtained by coupled
transcription and translation in the presence of 35S-methionine (PerkinElmer),
using the TNT SP6 Quick Coupled System (Promega). Import experiments
were performed on freshly isolated mitochondria from heart tissue, as
described previously (Mourier et al., 2014a).
Immunoprecipitation
Mitochondrial protein (1 mg) from HEK293-transduced cells was solubilized in
600 ml of 4 g/g digitonin-to-protein buffer, as for BN electrophoresis (BNE) an-
alyses. After centrifugation for 30 min at 13,000 rpm at 4C, 50 mg supernatant
was separated as the input fraction. The remaining supernatant was co-immu-
noprecipitated in resin spin columns (Pierce CoIP Kit, Thermo Scientific), in
which 15 mg antibodies against DDK-tag (Oncogene), CORE2, or COX1 had
been previously immobilized. The mixture was gently incubated overnight at
4C in a rotating shaker and centrifuged at 1,000 3 g for 1 min to separate
the flowthrough fraction. The column was washed three times with lysis buffer
containing 1% NP-40, and proteins were eluted. The immunoprecipitate was
divided into three aliquots, treated with 53 loading sample buffer, and heated
at 95C for 5 min prior to loading.
BNE and IGA Assays
Isolation of mitochondrial pellets and BN analyses were performed as
described previously (Moreno-Lastres et al., 2012; Mourier et al., 2014a).
Native PAGE Novex 3%–12% Bis-Tris Protein Gels (Life Technologies) or
self-made 4%–10% polyacrylamide gradient gels were loaded with
60–80 mg mitochondrial protein. After electrophoresis, proteins were trans-
ferred to nitrocellulose or PVDF (polyvinylidene fluoride) membranes at 40 V
overnight and probed with specific antibodies.
Antibodies
Western blot was performed using primary antibodies raised against
COX7A2L (ProteinTech), Myc (Origene), turbo-GFP (Origene), HA (Roche),
b-actin (Sigma), and the following human OXPHOS subunits: NDUFS1 (Gene-
Tex); NDUFA9, NDUFB8, CORE2, RISP, CYC1, UQCRB, UQCRQ, COX1,
COX4, COX5A, COX6C, SDHA, and SDHB (Mitosciences); and COX5B (Santa
Cruz Biotechnology). Peroxidase-conjugated anti-mouse and anti-rabbit
immunoglobulin Gs (IgGs) were used as secondary antibodies (Molecular
Probes). Immunoreactive bands were detected with the ECL Prime Western
Blotting Detection Reagent (Amersham) in a ChemiDoc MP Imager (Biorad).
Optical densities of the immunoreactive bands were measured using the Im-
ageLab (Biorad) and ImageJ analysis softwares.
Indirect Immunofluorescence
Cells were fixed with 4% paraformaldehyde for 15 min, permeabilized for
15 min with 0.1% Triton X-100, and incubated in blocking buffer containing
10% goat serum for 1 hr. Coverslips were incubated with an antibody against
monoclonal complex V a subunit and a Texas Red-conjugated anti-mouse
secondary antibody (Abcam). Coverslips were rinsed andmounted in ProLong
Gold antifade reagent (Molecular Probes) on glass slides, and cells were
viewed with a Zeiss LSM 510 Meta confocal microscope and a 633 planapo-
chromat oil inmersion objective (NA, 1.42). Sequential scanning of green and
red channels was performed to avoid bleed-through effect. Cells were imaged
randomly with 0.5- to 1.0-mm slices and 1,024- 3 1,024-pixel resolution. For
colocalization analysis, the ‘‘Merge channels’’ plugin from the ImageJ 1.48v
software was used.
Statistical Data Analysis
All experiments were performed at least in triplicate, and results were
presented as means ± SD. Statistical p values were obtained by applica-
tion of the Friedman and Mann-Whitney U tests using the SPSS v21.0
program.
Ethics Statement
This study was performed in accordance with the guidelines of the Federation
of European Laboratory Animal Science Associations. The protocol was
approved by the Landesamt f€ur Natur, Umwelt und Verbraucherschutz in
Nordrhein-Westfalen in Germany.
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Table S1. Proteomic features of COX7A2L and complex III subunits identified by 
nano LC-ESI-MS analysis in mitochondrial complex III-containing structures. 
CIII SUBUNITS IN CIII2 Accessiona Coverage (%)b # PSMsc # Peptidesd Scoree 
Cytochrome b P00156 2,37 2 1 49,72 
UQCRC1 - CORE1 P31930 35,83 50 13 1339,01 
UQCRC2 - CORE2 P22695 48,34 52 14 1442,20 
CYC1 - Cytochrome c1 P08574 20,62 52 5 710,57 
UQCRFS1 - Rieske FeS* P47985 23,36 15 5 469,24 
UQCRH - Subunit 6 P07919 19,78 2 1 61,11 
UQCRB - Subunit 7 P14927 30,63 19 4 518,81 
UQCRQ - Subunit 8 O14949 12,20 4 2 77,07 
UQCR10 - Subunit 9 Q9UDW1 65,08 9 3 189,97 
UQCR11 - Subunit 10 O14957 21,43 3 1 64,81 
COX7A2L O14548 11,40 4 1 149,43 
      
      CIII SUBUNITS IN SCI+III2 Accessiona Coverage (%)b # PSMsc # Peptidesd Scoree 
Cytochrome b P00156 2,37 1 1 45,50 
UQCRC1 - CORE1 P31930 19,58 26 9 551,53 
UQCRC2 - CORE2 P22695 31,13 29 8 780,09 
CYC1 - Cytochrome c1 P08574 15,69 9 4 159,24 
UQCRFS1 - Rieske FeS* P47985 13,87 3 3 68,83 
UQCRH - Subunit 6 P07919 7,69 1 1 26,45 
UQCRB - Subunit 7 P14927 30,63 12 4 298,03 
UQCRQ - Subunit 8 O14949 12,20 4 2 57,61 
UQCR10 - Subunit 9 Q9UDW1 38,10 5 2 171,68 
UQCR11 - Subunit 10 O14957 21,43 1 1 32,11 
COX7A2L O14548 11,40 2 1 106,86 
      
      
CIII SUBUNITS IN SCI+III2+IVn Accessiona Coverage (%)b # PSMsc # Peptidesd Scoree 
Cytochrome b P00156 2,37 4 1 56,95 
UQCRC1 - CORE1 P31930 50,21 74 18 1692,75 
UQCRC2 - CORE2 P22695 41,28 70 14 1891,05 
CYC1 - Cytochrome c1 P08574 27,08 21 6 448,78 
UQCRFS1 - Rieske FeS* P47985 32,85 21 6 546,23 
UQCRH - Subunit 6 P07919 n.d. n.d. n.d. n.d. 
UQCRB - Subunit 7 P14927 43,24 21 6 451,96 
UQCRQ - Subunit 8 O14949 15,85 2 1 68,39 
UQCR10 - Subunit 9 Q9UDW1 38,10 6 2 99,73 
UQCR11 - Subunit 10 O14957 n.d. n.d. n.d. n.d. 
COX7A2L O14548 19,30 4 2 140,64 
 
aProtein accession numbers according to the Uniprot/Swiss-Prot/TrEMBL database. 
bAmino acid sequence coverage for the matched peptides in identified proteins. 
c Number of peptide spectrum matches. 
dNumber of distinct peptide sequences identified in MS/MS MASCOT results. The confidence 
ion was high (>95%) for all matches. 
eMascot protein score, obtained from LTQ-OrbiTRAP MS/MS spectra. In all cases, a probability 
score <0.05 was obtained. 
n.d., not detected.  
 
  
SUPPLEMENTAL FIGURES AND LEGENDS 
 
       Figure S1 
Figure S1. Mouse COX7A2L behaves as a complex III-binding protein specifically 
required for supercomplex III2+IV assembly. (A) Heart mitochondrial extracts from 
CD1 and C57BL/6J mouse strains, and from control littermates (Lrpprc wt) and Lrpprc 
deficient mice with a C57BL/6N genetic background, were analyzed by western blot 
with antibodies raised against COX7A2L and the indicated OXPHOS subunits. (B) 
Heart mitochondria from CD1 and C57BL/6J mouse strains were extracted with 
increasing ratios of digitonin to mitochondrial protein (ranging from 4 to 40 g/g) and 
analyzed by BN-PAGE followed by CI-IGA or CIV-IGA assays. Asterisks indicate the 
presence of respirasome bands that are more stable in mitochondria from the 
C57BL/6J mice. (C) Mitochondrial samples were solubilized with 2% DDM, which 
disrupts respirasomes and CIV oligomers but maintains SC III2+IV and free complexes, 
and were next analyzed by BN-PAGE followed by western blot and immunodetection 
with the indicated antibodies. (D) Import of radiolabeled COX6A, RISP and COX7A2L 
precursors and subsequent incorporation into complexes III, IV and SC in intact heart 
mitochondria from wild type mice with C57BL/6N genetic background. After 60 minutes 
of incubation, mitochondria were solubilized in 6 g/g digitonin per protein and analyzed 
by BN-PAGE. Import experiments were performed in the presence or absence of the 
mitochondrial membrane potential (Δψ). (E) Assembly of the radiolabeled COX7A2L, 
COX6A and RISP into complexes and SC in intact heart mitochondria from wild type 
and Lrpprc knockout mice. After the indicated times of incubation (in minutes), 
mitochondria were solubilized in digitonin (6 g/g mitochondrial protein) and analyzed by 
BN-PAGE. I+III2+IVn, SC containing CI, CIII and CIV. I+III2, SC containing CI and CIII. 
III2+IV, SC containing CIII and CIV. III2, complex III dimer; IV, complex IV; IVn, complex 
IV oligomers. II, complex II. 
      
    Figure S2 
 
Figure S2. COX7A2L comigrates with respiratory chain supercomplexes and free 
complexes III and IV. (A) Mitochondria from control 143B cells and from three mutant 
cybrids respectively defective in complexes I (CI-KD), III (CIII-KO) and IV (CIV-KO) 
were analyzed by BN-PAGE, followed by CI in gel activity (IGA) assay, or alternatively, 
blotted on nitrocellulose and incubated with antibodies raised against human COX7A2L 
and the indicated OXPHOS subunits. Asterisks indicate unspecific signals that do not 
appear on 2D-BN/SDS-PAGE gels. (B) 2D-BN/SDS-PAGE and western-blot analyses 
of COX7A2L distribution in control and mutant cybrids at long exposure times. 
I+III2+IVn, SC containing CI, CIII and CIV. I+III2, SC containing CI and CIII. III2+IV, SC 
containing CIII and CIV. I*, complex I-containing structure. III2, complex III dimer; IV, 
complex IV; IV2, complex IV dimers. II, complex II. 
 
     
 
     
    Figure S3 
 
Figure S3. Tagged-COX7A2L is efficiently overexpressed and imported into 
mitochondrial respiratory chain complexes and supercomplexes. (A) Western blot 
analysis of the over expressed COX7A2L-GFP or GFP-empty constructs in 143B cells, 
and (B) of the COX7A2L-MYC-DDK construct and its corresponding empty vector 
(Myc) in 143B and HEK293 cells. Lanes were immunodecorated with an antibody 
against COX7A2L to differentiate endogenous COX7A2L (̴12.6 kDa) from either 
exogenous COX7A2L-GFP (̴39.3 kDa) or COX7A2L-MYC-DDK (̴16.2 kDa). 
Membranes were further incubated with antibodies against the GFP and MYC 
epitopes. (C) 2D-BN/SDS-PAGE analysis of control 143B cells transiently transfected 
with the COX7A2L-MYC-DDK construct, and with the MYC-empty vector. Membranes 
were incubated with antibodies raised against COX7A2L and the CIII RISP subunit. (D) 
BN-PAGE followed by western-blot analyses of control HEK293 cells transiently 
transfected either with the COX7A2L-MYC-DDK construct, or with the MYC-empty 
vector. Membranes were incubated with antibodies raised against COX7A2L and the 
indicated OXPHOS subunits. Two independent transfection experiments per 
experimental condition are shown on the same gel. Asterisks indicate unspecific 
signals that do not appear on 2D-BN/SDS-PAGE gels. I+III2+IVn, SC containing CI, CIII 
and CIV. I+III2, SC containing CI and CIII. III2+IV, SC containing CIII and CIV. III2, 
complex III dimer; IV, complex IV; IV2, complex IV dimer. II, complex II. 
 
 
 
 
 
 
 
 
 
      
 
    Figure S4 
 
Figure S4. Assembly of COX7A2L, CORE2, RISP and COX5A in complex III- and 
complex IV- containing structures. (A) Incorporation rates of COX7A2L into the CIII 
dimer relative to the RISP and CORE2 subunits. (B) Incorporation rates of COX7A2L 
and COX5A into free CIV. (C) Assembly rates of COX7A2L, RISP, CORE2 and COX5A 
in SC III2+IV. (D) Incorporation rates of COX7A2L, RISP, CORE2 and COX5A into SC 
I+III2+IV. The COX7A2L signals from three independent experiments, and the CORE2, 
RISP and COX5A signals from at least ten independent experiments were quantified 
and normalized by the signal corresponding to the CII subunit SDHA. Time point values 
are expressed as percentages of the untreated cells (SS), and indicated as means ± 
SD. I+III2+IVn, SC containing CI, CIII and CIV. III2+IV, SC containing CIII and CIV. III2, 
complex III dimer. IV, complex IV. (E) Human COX7A2L-mediated SC III2+IV assembly 
steps. Model based on (Fernandez-Vizarra and Zeviani, 2015). The UQCRB and 
UQCRQ subunits first bind to MT-CYB, to form the early-stage CIII intermediary MT-
CYB+UQCRB+UQCRQ. Additional subunits, i.e., UQCRC1, UQCRC2 and CYC1 are 
incorporated in a second step, followed by UQCRH and later UQCR10, to form pre-
complex III. At this point, the complex is already dimeric (pre-III2) and COX7A2L is 
bound to it. According to the incorporation kinetics, CIV binds to COX7A2L-containing 
pre-III2 prior to the incorporation of RISP (UQCRFS1). RISP is bound and stabilized by 
MZM1L in the mitochondrial matrix, from where it is translocated into the inner 
membrane through the action of BCS1L, and gets incorporated into pre-III2+IV to allow 
the formation of mature SC III2+IV. If SC III2+IV followed the same pathway as 
described for CIII2, the last assembly step would include the incorporation of subunit 
UQCR11 to complete the nascent supercomplex. 
 
 
 
  
    Figure S5 
 
Figure S5. COX7A2L knock-down efficiency. (A) To characterize the functional role 
of COX7A2L in the OXPHOS system, silencing assays were performed with a mix of 
two COX7A2L siRNAs in control 143B cells as well as in mutant cybrids lacking 
complex IV (CIV-KO). Upon two rounds of transfection and silencing for 48 hours, cells 
were collected and whole cell extracts were analyzed by SDS-PAGE and western blot 
using antibodies targeted against COX7A2L and β-actin as a loading control. (B) The 
COX7A2L signals from five independent siRNA silencing experiments were quantified, 
normalized by β-actin and expressed as the percentages relative to the cells 
transfected with the scramble siRNA (C-). (C) To address the relative amounts of SC 
I+III2+IV, and (D) of complexes III and IV in 143B cells after COX7A2L silencing, we 
measured the optical densities of immunoreactive bands that had not reached 
saturation levels with the ImageLab™ software of the ChemiDoc™ MP Image Analyzer 
(Biorad). The signals from each antibody within the different structures were quantified, 
normalized by CII, and indicated as means ± SD from five independent siRNA 
experiments. Numerical values are expressed as percentages of the signals obtained 
for each antibody in cells transfected with the scramble siRNA (C-, represented as a 
horizontal bar). I+III2+IVn, SC containing CI, CIII and CIV. III2, complex III dimer. IV, 
complex IV. CO, cells only treated with the transfection reagent; C-, cells transfected 
with a scrambled siRNA; i, cells transfected with a combination of two specific 
COX7A2L siRNAs.  
 
 
 
 
 
 
 
 
  
     Figure S6 
Figure S6. COX7A2L down regulation neither alters the biogenesis of OXPHOS 
structures nor affects mitochondrial function. (A) Representative 2D-BN/SDS-
PAGE analysis of the CIV-KO mutant cybrids analyzed in Figure 7A. Shown are the 
immunodetections of CIII subunits CORE2 and RISP in untreated (CO), mock-
transfected (C-), and COX7A2L siRNA-transfected (i) cybrids lacking CIV (CIV-KO). (B) 
To address the relative amounts of III2 and SC I+III2 in the CIV-KO mutants after 
COX7A2L silencing, the signals from each antibody within these structures were 
quantified, normalized by CII, and indicated as means ± SD from three independent 
siRNA experiments. Numerical values are expressed as percentages of the signals 
obtained for each antibody in cells transfected with the scramble RNA (C-, represented 
as a horizontal bar). I+III2, SC containing CI and CIII. III2, complex III dimer. (C) Oxygen 
consumption rates (OCR) measured in 143B cells respiring in 1 g/l glucose-containing 
medium that were previously transfected either with a scrambled siRNA (C-, negative 
control), or with a combination of two specific COX7A2L siRNAs (COX7A2L-). Ten 
measurements per sample were performed each time in three independent 
experiments. Data are expressed as the mean± standard deviation of the percentages 
of the negative control. (D) Oxygen consumption rates (OCR) measured in control 
143B cells and CI-defective mutant cybrids (CI-KD) respiring in 1 g/l glucose-containing 
medium. Five measurements per sample were performed each time in two 
independent experiments. Data are expressed as the mean± range of the percentages 
of the control 143B cells. OCR values were calculated in pmol O2.min-1.μg protein-1 in 
all experiments. (E) Spectrophotometric measurements of the individual activities of 
MRC complexes I to IV (CI-CIV) in 143B cells transfected either with a scrambled 
siRNA (C-), or with a mix of two specific COX7A2L siRNAs (COX7A2L-). Enzyme 
activities are expressed as cU/U citrate synthase (CS). 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Protein identification by liquid chromatography coupled to tandem mass 
spectrometry  
Gel bands of interest were excised from blue native gels. All samples were reduced by 
adding 10 mM DTT for 30 min at 37ºC and alkylated with 55 mM iodacetamide during 
20 min in the dark. Next, digestion was performed by adding recombinant sequencing 
grade Trypsin (Roche) 1:20 (w/w) overnight at 37ºC. The produced peptides were 
cleaned up with Omix tips (Agilent technologies), eluted with 80% ACN in 0.1% TFA, 
dried in a Speed-vac and resuspended in 0.1% formic acid.  
To identify proteins, the resulting tryptic peptide mixtures were analyzed by 
nano-liquid chromatography coupled to mass spectrometry. Peptides were loaded onto 
a C18-A1 ASY-Column 2 cm precolumn (Thermo Fisher Scientific) and then eluted 
onto a Biosphere C18 analytic column (C18, inner diameter 75 µm, 15 cm long, 3 µm 
particle size) (NanoSeparations) and separated using a 150 min gradient from 0-45% 
Buffer B (Buffer A: 0.1% formic acid/2% ACN; Buffer B: 0.1% formic acid in ACN) at a 
flow-rate of 250 nL/min on a nanoEasy HPLC (Proxeon) coupled to a nanoelectrospay 
ion source (Proxeon). Mass spectra were acquired on the LTQ-Orbitrap Velos (Thermo 
Scientific) in the positive ion mode. Full-scan MS spectra (m/z 400-1800) were 
acquired in the Orbitrap at a resolution of 60,000 at m/z 400 and the 15 most intense 
ions were selected for collision induced dissociation (CID) fragmentation in the LTQ 
with a normalized collision energy of 35%. Precursor ion charge state screening and 
monoisotopic precursor selection were enabled. Singly charged ions and unassigned 
charge states were rejected. Dynamic exclusion was enabled with a repeat count of 1 
and exclusion duration of 45s.  
 Peptide identification from raw data (MS/MS spectra) was carried out using a 
licensed version of search engine MASCOT 2.3.0 through Proteome Discoverer 
Software 1.2.0.208 (Thermo Fisher Scientific). Database search was performed against 
a Uniprot- SwissProt with taxonomy restriction to Human (date 2012/12/11; 20233 
sequences). The following parameters were used for the searches: tryptic cleavage 
after Arg and Lys, up to two missed cleavage sites allowed, tolerances of 10 ppm for 
precursor ions and 0.8 Da for MS/MS fragment ions. Oxidation of Methionine was 
selected as dynamic modification and carbamidomethylation of Cysteine as fixed 
modification. Search against decoy database (integrated decoy approach in MASCOT) 
was used for FDR calculation and this filter was applied to MASCOT results. The 
acceptance criteria for proteins identification were FDR < 1% and at least one peptide 
identified with high confidence (CI>95%). These results were filtered and annotated 
with R (www.R-project.org) and biomaRt package (Durinck et al., 2009). 
 
Plasmids and COX7A2L Over expression 
Vectors pCMV6-Entry (C-terminal Myc-DDK-tagged), pCMV6-COX7A2L-Myc-DDK, 
pCMV6-AC-GFP and pCMV6-AC-COX7A2L-GFP were purchased from Origene 
(catalog numbers PS100001, RC202697, PS100010 and RG202697, respectively) and 
amplified using PureLinkTM HiPure Plasmid Filter Midiprep Kit (Invitrogen). For DNA 
transfection, 143B cells cultured in serum-free medium were transfected for 48 h with 
10 µg of plasmid DNA using 40 µl of FuGENE® HD Transfection Reagent (Promega), 
and alternatively, HEK293 cells were transfected with LipofectaminTM (Thermo Fisher) 
according to the manufacturer’s instructions. 
 
COX7A2L siRNA Transfection 
For siRNA transfection, 143B cells and CIV-KO mutant cybrids were plated in 10 ml of 
DMEM supplemented with 10% FBS in 10-cm dishes with a cell density of 7.8x105 cells 
per plate. The next day, cells were transfected with two mixed COX7A2L siRNAs 
(references SASI_Hs01_00081409 and SASI_Hs02_00338185, Sigma Aldrich) in the 
presence of 52 µl X-treme GENE siRNA Transfection Reagent (Roche) to achieve a 
final concentration of 0.15 µM siRNA in a total volume of 10 ml per plate. The negative 
control used was MISSION® siRNA Universal Negative Control (Sigma Aldrich). Cells 
were incubated at 37 ºC in a CO2 incubator for 48 hours prior to experimental analyses. 
 
Cell respiration 
Oxygen consumption rates were measured in 143B cells and 
transmitochondrial cybrids using an XF24 Extracellular Flux Analyzer (Seahorse 
Bioscience). The day before the experiment, around 9.0 ×104 143B cells per well were 
plated in order to obtain a total amount of 150-200 µg protein per well on the day of 
the experiment. The cells were previously incubated with either scrambled or specific 
COX7A2L siRNAs for 24 h. As controls for the oxygen consumption measurements in 
siRNA-treated cells, around 5.0 ×103 143B cells and 1.0 ×104 CI-KD cells (CI defective 
mutant cybrids) per well were plated two days before the experiment, from which 150-
200 µg protein per well were obtained on the day of the experiment. The cells were 
then incubated for 1 h in unbuffered DMEM supplemented with 1 g/l glucose, 1 mM 
sodium pyruvate and 2 mM glutamine at 37ºC in a CO2-free incubator. Respiration was 
calculated after the addition of mitochondrial inhibitors rotenone and antimycin at 1 µM 
final concentration. In all experiments, the protein concentration in each well was 
determined using the Pierce BCA Protein Assay Kit (Thermo Scientific) after cell lysis 
in extraction buffer, and was used to calibrate the oxygen consumption data.  
 
Respiratory Chain Enzyme Activities 
Mitochondrial respiratory chain enzyme activities were performed according to 
established methods (Medja et al., 2009). 
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